OBO_ID (LABEL):	UBERON_0002113 (kidney)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC1252725	10/2005	S126-PMC1252725	['during the critical period of Renal a/dysgenesis.']	N/A	N/A	[('UBERON_0002113', 'kidney', 30, 'renal')]
PMC1592148	7/2006	S238-PMC1592148	['chronic Kidney disease or diabetes).']	N/A	N/A	[('UBERON_0002113', 'kidney', 8, 'kidney')]
PMC1592148	7/2006	S331-PMC1592148	['systemic lupus erythematosus or Renal disease).']	N/A	N/A	[('UBERON_0002113', 'kidney', 32, 'renal')]
PMC2290997	4/2008	S22-PMC2290997	['another set of transformations occurs in the Kidney and other Tissues, forming 1,25(Oh)D. this form of the Vitamin is actually a hormone, chemically akin to the Steroid hormones.']	N/A	N/A	[('UBERON_0002113', 'kidney', 45, 'kidney'), ('UBERON_0000479', 'tissue', 62, 'tissues'), ('CHEBI_71657', 'versiconol acetate', 81, '25(OH)D'), ('CHEBI_33229', 'vitamin (role)', 107, 'vitamin'), ('CHEBI_35341', 'steroid', 161, 'steroid')]
PMC2658734	4/2009	S185-PMC2658734	['the rapid emergence and advances in high throughput screening techniques facilitate focused research of both Genome-wide and cell-specific epigenetic and post-transcriptional imprints in diabetes and Kidney disease.']	N/A	N/A	[('SO_0001026', 'genome', 109, 'genome'), ('UBERON_0002113', 'kidney', 200, 'kidney')]
PMC2672359	2/2009	S99-PMC2672359	['finally, Cocoa beans are some of the principal dietary sources of ochratoxin a, a Mycotoxin that causes adducts in Testicular dna of Rats and is an established cause of Liver and Kidney tumors in rodents and is a Testicular Toxicant [28,29].']	N/A	N/A	[('CHEBI_15346', 'coenzyme A', 9, 'cocoa'), ('CHEBI_25441', 'mycothiols', 82, 'mycotoxin'), ('UBERON_0000473', 'testis', 115, 'testicular'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 133, 'rats'), ('UBERON_0002107', 'liver', 169, 'liver'), ('UBERON_0002113', 'kidney', 179, 'kidney'), ('UBERON_0000473', 'testis', 213, 'testicular'), ('CHEBI_27014', 'tocoquinone-10', 224, 'toxicant')]
PMC2756957	10/2009	S171-PMC2756957	['the Heart and Kidney[29],[30].']	N/A	N/A	[('UBERON_0000948', 'heart', 4, 'heart'), ('UBERON_0002113', 'kidney', 14, 'kidney')]
PMC2872349	4/2010	S32-PMC2872349	['“critical periods” are specific periods of rapid Cell Division, which occur at different times during Gestation in different Tissues [18], for example the Kidney has a critical period in the weeks immediately before Birth.']	N/A	N/A	[('GO_0051301', 'cell division', 49, 'cell division'), ('GO_0007565', 'female pregnancy', 102, 'gestation'), ('UBERON_0000479', 'tissue', 125, 'tissues'), ('UBERON_0002113', 'kidney', 155, 'kidney'), ('GO_0007567', 'parturition', 216, 'birth')]
PMC2991548	10/2010	S103-PMC2991548	['detailed measurements of fetal Brain, Cardiac and Kidney Development have been performed in the subcohort [126–129].']	N/A	N/A	[('GO_0007567', 'parturition', 31, 'brain ...'), ('UBERON_0000955', 'brain', 31, 'brain'), ('GO_0005007', 'fibroblast growth factor-activated receptor activity', 38, 'cardiac ...'), ('UBERON_0000948', 'heart', 38, 'cardiac'), ('GO_0001822', 'kidney development', 50, 'kidney development'), ('UBERON_0002113', 'kidney', 50, 'kidney')]
PMC2991548	10/2010	S152-PMC2991548	['measurements at these visits included physical examinations (height, weight, Head circumference, Skinfold thickness and waist- hip ratio, touwen’s Neurodevelopmental examination at the ages of 1.5, 6, 14, and 24\xa0months) and ultrasound examinations (Brain structures at 1.5\xa0months and Cardiac and Kidney structures at the ages of 1.5, 6 and 24\xa0months, Abdominal Fat at the age of 24\xa0months) [224–237].']	N/A	N/A	[('UBERON_0000033', 'head', 77, 'head'), ('UBERON_0009007', 'superficial inguinal lymph node', 97, 'skinfold'), ('GO_0007285', 'primary spermatocyte growth', 147, 'Neurodevelopmental'), ('UBERON_0000955', 'brain', 249, 'brain'), ('UBERON_0000948', 'heart', 284, 'cardiac'), ('UBERON_0002113', 'kidney', 296, 'kidney'), ('UBERON_0007808', 'adipose tissue of abdominal region', 351, 'abdominal fat')]
PMC2994393	8/2010	S4-PMC2994393	['at 7-8 weeks of age, Renal function was studied in conscious, restrained Rats.']	N/A	N/A	[('UBERON_0002113', 'kidney', 21, 'renal'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 73, 'rats')]
PMC2994393	8/2010	S6-PMC2994393	['effective Renal Blood flows were lower in tdf, tdl, and tsf Rats (tdf 4.6±0.8 ml/min/g Kidney weight (kw), tdl 3.0±0.9 ml/min/g kw, and tsf 2.8±0.7 ml/min/g kw) than in tsl (7.7±0.9 ml/min/g kw) or control Rats (7.3±1.6 ml/min/g kw).']	N/A	N/A	[('UBERON_0002113', 'kidney', 10, 'renal'), ('UBERON_0000178', 'blood', 16, 'blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 60, 'rats'), ('UBERON_0002113', 'kidney', 87, 'kidney'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 206, 'rats')]
PMC2994393	8/2010	S11-PMC2994393	['background\nTaurine, 2-Aminoethanesulfonic Acid, is present at a high concentration in many Organs including Liver, Brain, Heart, Kidneys, and Reproductive Organs [1].']	N/A	N/A	[('CHEBI_15884', 'tropine', 11, 'Taurine'), ('CHEBI_15753', '2-oxoadipic acid', 20, '2-aminoethanesulfonic acid'), ('UBERON_0000062', 'organ', 91, 'organs'), ('UBERON_0002107', 'liver', 108, 'liver'), ('UBERON_0000955', 'brain', 115, 'brain'), ('UBERON_0000948', 'heart', 122, 'heart'), ('UBERON_0002113', 'kidney', 129, 'kidneys'), ('GO_0000003', 'reproduction', 142, 'reproductive'), ('UBERON_0003133', 'reproductive organ', 142, 'reproductive organs')]
PMC2994393	8/2010	S21-PMC2994393	['Perinatal Taurine depletion impairs Renal function in Adult female Rats.']	N/A	N/A	[('GO_0036268', 'swimming', 0, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 0, 'Perinatal'), ('CHEBI_15891', 'taurine', 10, 'taurine'), ('UBERON_0002113', 'kidney', 36, 'renal'), ('UBERON_0007023', 'adult organism', 54, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 67, 'rats')]
PMC2994393	8/2010	S24-PMC2994393	['moreover, Perinatal Taurine depletion heightens Sympathetic Nerve overactivity [13] and Renal dysregulation [12] induced by a high Sugar Intake in Adult Rats.']	N/A	N/A	[('GO_0036268', 'swimming', 10, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 10, 'perinatal'), ('CHEBI_15891', 'taurine', 20, 'taurine'), ('UBERON_0034729', 'sympathetic nerve', 48, 'sympathetic nerve'), ('UBERON_0002113', 'kidney', 88, 'renal'), ('CHEBI_24870', 'ion', 131, 'sugar'), ('GO_0007631', 'feeding behavior', 137, 'intake'), ('UBERON_0007023', 'adult organism', 147, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 153, 'rats')]
PMC2994393	8/2010	S26-PMC2994393	['however, differentiation and maturation of Renal function continue several weeks after Delivery.']	N/A	N/A	[('UBERON_0002113', 'kidney', 43, 'renal'), ('GO_0007567', 'parturition', 87, 'delivery')]
PMC2994393	8/2010	S36-PMC2994393	['Renal function was studied before, during, and after an intravenous isotonic saline infusion (a Mixture of 0.5% inulin and 0.5% pah in isotonic saline, 5% of body weight, 0.5 ml/min).']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Renal'), ('CHEBI_60004', 'mixture', 96, 'mixture')]
PMC2994393	8/2010	S37-PMC2994393	['at the end of experiments, all Animals were sacrificed and Kidney (kw) and Heart (hw) weights were measured.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 31, 'animals'), ('UBERON_0002113', 'kidney', 59, 'kidney'), ('UBERON_0000948', 'heart', 75, 'heart')]
PMC2994393	8/2010	S41-PMC2994393	['results\nPrenatal or Postnatal Taurine under or over exposure did not alter body or Kidney weights in all mature Rats.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 8, 'Prenatal'), ('GO_0007567', 'parturition', 20, 'postnatal'), ('CHEBI_15891', 'taurine', 30, 'taurine'), ('UBERON_0002113', 'kidney', 83, 'kidney'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 112, 'rats')]
PMC2994393	8/2010	S46-PMC2994393	['caption (table-wrap): table 1\n\nAdult body (Bw), Kidney (Kw), and Heart weights (hw) in experimental groups.treatmentbw(g)kw(g)hw(g)kw/bw(%)hw/bw(%)control(n=9)212 ± 41.85 ± 0.090.71 ± 0.030.87 ± 0.040.33 ± 0.01tdf (n=9)223 ± 71.95 ± 0.100.89 ± 0.00*0.87 ± 0.030.40 ± 0.01*tdl (n=9)214 ± 62.00 ± 0.100.73 ± 0.010.93 ± 0.040.34 ± 0.01tsf (n=10)216 ± 32.02 ± 0.090.72 ± 0.030.93 ± 0.030.34 ± 0.01tsl (n=10)215 ± 61.83 ± 0.090.74 ± 0.030.85 ± 0.040.35 ± 0.01\ndata are mean ± sem.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 31, 'Adult'), ('UBERON_0002531', 'paired fin bud', 43, 'BW'), ('UBERON_0002113', 'kidney', 48, 'kidney'), ('UBERON_0001465', 'knee', 56, 'KW'), ('UBERON_0000948', 'heart', 65, 'heart')]
PMC2994393	8/2010	S79-PMC2994393	['in general, the Kidneys will Excrete sufficient Water and sodium to reduce Arterial pressure to normal levels.']	N/A	N/A	[('UBERON_0002113', 'kidney', 16, 'kidneys'), ('GO_0007588', 'excretion', 29, 'excrete'), ('CHEBI_15377', 'water', 48, 'water'), ('UBERON_0001637', 'artery', 75, 'arterial')]
PMC2994393	8/2010	S94-PMC2994393	['list of abbreviations used\ncw: control with Water Intake alone; cg: control with high Sugar Intake; td: Taurine depletion; tdf: Prenatal Taurine depletion; tdl: Postnatal Taurine depletion; ts: Taurine supplementation; tsf: Prenatal Taurine supplementation; tsl: Postnatal Taurine supplementation; bw: body weight; hw: Heart weight; kw: Kidney weight; sd: sprague dawley; i.p.']	N/A	N/A	[('CHEBI_15377', 'water', 44, 'water'), ('GO_0007631', 'feeding behavior', 50, 'intake'), ('CHEBI_24870', 'ion', 86, 'sugar'), ('GO_0007631', 'feeding behavior', 92, 'intake'), ('CHEBI_15891', 'taurine', 104, 'taurine'), ('GO_0007565', 'female pregnancy', 128, 'prenatal'), ('CHEBI_15891', 'taurine', 137, 'taurine'), ('GO_0007567', 'parturition', 161, 'postnatal'), ('CHEBI_15891', 'taurine', 171, 'taurine'), ('CHEBI_15891', 'taurine', 194, 'taurine'), ('GO_0007565', 'female pregnancy', 224, 'prenatal'), ('CHEBI_15891', 'taurine', 233, 'taurine'), ('GO_0007567', 'parturition', 263, 'postnatal'), ('CHEBI_15891', 'taurine', 273, 'taurine'), ('UBERON_0000948', 'heart', 319, 'heart'), ('UBERON_0002113', 'kidney', 337, 'kidney')]
PMC2994393	8/2010	S95-PMC2994393	[': Intraperitoneal; sem: standard error of means; na: Sodium; Pah: P-Aminohippuric Acid; gfr: Glomerular filtration rate; erbf: effective Renal Blood flow; rvr: Renal Vascular resistance; map: mean Arterial pressure; Feh2O: fractional Water Excretion; fena: fractional Sodium Excretion\n\ncompeting interests\nthe authors declare that they have no competing interests.']	N/A	N/A	[('UBERON_2001932', 'sensory canal tubular ossicle', 2, 'intraperitoneal'), ('CHEBI_52632', 'potassium-39 atom', 53, 'sodium'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 61, 'PAH'), ('CHEBI_35697', 'trans-cinnamic acid', 66, 'p-aminohippuric acid'), ('UBERON_0000074', 'renal glomerulus', 93, 'glomerular'), ('UBERON_0002113', 'kidney', 137, 'renal'), ('UBERON_0000178', 'blood', 143, 'blood'), ('UBERON_0002113', 'kidney', 160, 'renal'), ('UBERON_0000116', 'lung saccule', 166, 'vascular'), ('UBERON_0001637', 'artery', 197, 'arterial'), ('CHEBI_65894', 'F390C', 216, 'FEH2O'), ('CHEBI_15377', 'water', 234, 'water'), ('GO_0007588', 'excretion', 240, 'excretion'), ('CHEBI_52632', 'potassium-39 atom', 268, 'sodium'), ('GO_0007588', 'excretion', 275, 'excretion')]
PMC3001618	1/2011	S20-PMC3001618	['2009), together with molecular markers of inflammation in the Kidney and Adipose Tissue (sharkey et al .']	N/A	N/A	[('UBERON_0002113', 'kidney', 62, 'kidney'), ('UBERON_0001013', 'adipose tissue', 73, 'adipose tissue')]
PMC3032617	5/2010	S41-PMC3032617	['exclusion criteria were: referred Pregnancy of more than three months by lmp, concomitant hiv infection status, active or recent (< two weeks) Sexually Transmitted disease (std) infection, medical record of any severe Organ disease such as Heart, Liver or Renal failure at the time of assessment, diagnosis of Pregnancy during inpatient admission for any other reason, recent history of multivitamin supplementation (<12 weeks) for any reason, except for Pregnancy, and patients incapable to read and write.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 34, 'pregnancy'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 143, 'sexually transmitted'), ('UBERON_0000062', 'organ', 218, 'organ'), ('UBERON_0000948', 'heart', 240, 'heart'), ('UBERON_0002107', 'liver', 247, 'liver'), ('UBERON_0002113', 'kidney', 256, 'renal'), ('GO_0007565', 'female pregnancy', 310, 'pregnancy'), ('GO_0007565', 'female pregnancy', 455, 'pregnancy')]
PMC3095978	4/2011	S44-PMC3095978	['the subjects were the participants of the “programme for detection and management of chronic Kidney disease, hypertension, diabetes and Cardiovascular disease,” a community-based screening programme in eastern nepal [12].']	N/A	N/A	[('UBERON_0002113', 'kidney', 93, 'Kidney'), ('UBERON_0004535', 'cardiovascular system', 136, 'Cardiovascular')]
PMC3095978	4/2011	S56-PMC3095978	['the data recorded included family and medical history for Kidney disease, high Blood pressure, diabetes, Cardiovascular disease and any current medication or treatment.']	N/A	N/A	[('UBERON_0002113', 'kidney', 58, 'kidney'), ('UBERON_0000178', 'blood', 79, 'blood'), ('UBERON_0004535', 'cardiovascular system', 105, 'cardiovascular')]
PMC3098253	5/2011	S41-PMC3098253	['subjects with a history of Cardiovascular, Pulmonary, Kidney, or malignant disease as well as those currently taking Medications were excluded from the study.']	N/A	N/A	[('UBERON_0004535', 'cardiovascular system', 27, 'cardiovascular'), ('UBERON_0002048', 'lung', 43, 'pulmonary'), ('UBERON_0002113', 'kidney', 54, 'kidney'), ('CHEBI_25441', 'mycothiols', 117, 'medications')]
PMC3102012	10/2011	S42-PMC3102012	['the affected Person is often acutely ill and shocked with widespread hemorrhage (common bleeding sites are Mouth, Nose, and venepuncture sites), extensive bruising, Renal failure, and gangrene.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 13, 'person'), ('UBERON_0000165', 'mouth', 107, 'mouth'), ('UBERON_0000004', 'nose', 114, 'nose'), ('UBERON_0002113', 'kidney', 165, 'renal')]
PMC3104979	5/2011	S109-PMC3104979	['medical risk factors include acute or chronic Lung disease; anemia (hemoglobin <10 gm/dl or hematocrit <30%); Cardiac disease; diabetes; eclampsia; Genital herpes; hemoglobinopathy; hydramnios/oligohydramnios; chronic hypertension; Pregnancy-induced hypertension, incompetent Cervix; previous infant >4,000 g; previous preterm, sga, or low Birth weight Delivery; Renal disease; rh sensitization; rubella; syphilis; and Uterine bleeding.']	N/A	N/A	[('UBERON_0002048', 'lung', 46, 'lung'), ('UBERON_0000948', 'heart', 110, 'cardiac'), ('UBERON_3011048', 'genital system', 148, 'genital'), ('GO_0007565', 'female pregnancy', 232, 'pregnancy'), ('UBERON_0000029', 'lymph node', 276, 'cervix'), ('GO_0007567', 'parturition', 340, 'birth'), ('GO_0007567', 'parturition', 353, 'delivery'), ('UBERON_0002113', 'kidney', 363, 'renal'), ('UBERON_0000995', 'uterus', 419, 'uterine')]
PMC3131279	7/2011	S57-PMC3131279	['no other Genes were among the twenty most altered Genes in more than one generation.10.1371/journal.pone.0021668.t001\n\ncaption (table-Wrap): table 1\nHepatic Genes showing the greatest difference between pr and ps offspring.difference between ps and pr offspring (fold differences between pr and ps)f1f2f3up-regulateddown-regulatedup-regulateddown-regulatedup-regulateddown-regulatedcytochrome P450, 3,A nm_153312 (69.4)Transmembrane Protein 27 nm_020976 (174.3) Trefoil Factor 2 nm_053844 (13.9) Olfactory receptor 144 nm_001000164 (15.3)Surfactant associated protein c nm_017342 (25.1)Pancreatic Lipase Related Protein 1 nm_032081 (47.5)α2μ globulin nm_001024248 (40.2)Uromodulin nm_017082 (105.3)Hyaluronan mediated motility receptor nm_012964 (12.9)Egf-Like Domain 7 nm_139104 (14) Lymphocyte-Activation Gene 3 nm_212513 (17.4) Pancreatic lipase nm_013161 (39.6)α2μ globulin Pgcl4 nm_147215 (38.3)Cytochrome P450 (11B) nm_012537 (104.9)Sarcolipin nm_001013247 (10.0)Type i keratin Ka11 nm_001008750 (7.1)Caveolin 3 nm_019155 (11.2) Pancreatic Amylase 2 nm_031502 (39.4)Lymphocyte-Activation Gene 3 nm_212513 (35.9) Chromogranin B nm_012526 (98.8)Cathepsin R nm_001017509 (7.9)T-Cell receptor Β-Chain mrna v-region m23885 (6.6)Telethonin xm_001081394 (9.9)Glycoprotein 2 nm_134418 (38.5)Α2Μ Globulin Pgcl3 nm_147212 (29.1)Chloride channel kb nm_173103 (98.1)Threonyl-Trna Synthetase-Like 2 nm_001014020 (7.6)Stathmin-Like 3 nm_024346 (5.5)Bile Acid Coenzyme A: amino acid n-acyltransferasexm_001055067 (9.7)Cationic Trypsinogen nm_173127 (34.4)α2μ globulin Pgcl1 nm_147214 (16.4)Solute Carrier Family 7 (y+ system) member 13 nm_001012100 (92.6) Lymphocyte-Activation Gene 3 nm_212513 (7.5) Myelin-Associated Basic Protein-99 X89638 (5.2)riken nm_001039686 (7.9)Serine Protease-2 nm_012729 (26.0)myosin ixb xm_346173 (15.2)Defensin Β1 nm_031810 (81.4)C-Myc Promoter binding protein xr_009072 (7.3)Cystatin nm_133566 (5.0)Myosin, Light Polypeptide 3 nm_012606 (7.9)Pancreatic Trypsin 1 nm_012635 (24.8)α2μ globulin Pgcl5 nm_147213 (12.8)Solute Carrier Family 26 (4) nm_019214 (80.1)Gastrokine 1 Xm_001074955 (6.4)Socs Box-Containing Protein 3 Xm_344277 (4.5)Immunoglobulin variable region z93370 (7.8)Pancreatic lipase-related Protein-2 nm_057206 (22.5)Caldesmon 1 nm_013146 (12.3)Protein Phosphatase 1, Regulatory Subunit 1A nm_022676 (76.6)Membrane-associated dhhc17 zinc finger protein nm_001039340 (5.8)Fun14 Domain Containing-1 nm_001025027 (4.5)Pancreatitis-Associated Protein nm_053289 (7.8)Ribonuclease A nm_001029904 (19.8)Major Urinary Protein 5 nm_203325 (11.3)Solute Carrier Family 3 nm_017216 (71.0)unknown af433878 (5.3)arachidonate 5-lipoxygenase nm_012822 (4.5)Actin-Α Cardiac- 1 nm_019183 (7.7)Chymotrypsin C nm_001077649 (19.1)Cytochrome P450 (2C13) nm_138514 (10.4)Kidney Androgen Regulated Protein nm_052802 (67.6)Glycosylation Dependent Cell Adhesion Molecule 1 nm_012794 (5.2)Protocadherin-Α nm_201422 (4.5)Ec1-V2R Pheromone Receptor Xm_236825 (7.0)Pancreatic Elastase-1 nm_012552 (18.9)α2μ globulin (l type) nm_001003409 (10.1)Deoxyribonuclease 1 nm_013097 (60.8)Actin Α Cardiac 1 nm_019183 (5.2)Thioesterase Superfamily Member 4 (Them4), mrna nm_001025017 (4.4)S100 Calcium Binding protein g nm_012521 (7.0)Chymotrypsin-Like nm_054009 (17.0)Kpl2 protein nm_022620 (10.0)Degenerative Spermatocyte Homolog 2 nm_001017457 (58.0)serine dehydratase x13119 (5.0)Endothelial differentiation, Sphingolipid G-Protein-Coupled Receptor, 8 nm_021775 (4.3) Trefoil Factor 2 nm_053844 (6.9) Carboxypeptidase B1 nm_012533 (16.5)Cytochrome P450 (iic) nm_019184 (8.1)solute carrier family 5 (Sodium/Glucose co-Transporter), nm_022590 (57.6)phosphodiesterase 4d interacting protein nm_022382 (4.9)Olfactory Receptor 74 nm_001000134 (4.3)Type i keratin Ka15 nm_001004022 (6.9)Trypsin 10 nm_001004097 (16.5)protein tyrosine kinase c-yes xm_343644 (7.5)Tonin nm_012677 (49.7)Olfactory receptor 1250 nm_001000806 (4.8)Olfactory Receptor 821 nm_001000842 (4.3)Topoisomerase -2Α nm_022183 (6.7)chymotrypsinogen b nm_012536 (15.1)Diamine Acetyltransferase 1 Xm_228448 (7.0)myosin, heavy polypeptide 7 nm_017240 (48.1)pparγ1 co-activator 1α nm_031347 (4.6)Kiss1 receptor nm_023992 (4.2)cleavage and Polyadenylation specificity Factor 3 Xr_005746 (6.3)Elastase 2 nm_012553 (11.9) Pancreatic Amylase 2 nm_031502 (6.8) Cadherin 16 nm_001012055 (47.6)Olfactory receptor 1467 nm_001000025 (4.6)Calmodulin-sensitive Plasma Membrane Ca2+-Transporting atpase j05087 (4.2)atp-binding Cassette (Sub-Family B, Member 11) xm_579531 (6.2)Pancreatic colipase nm_013139 (10.6)absent 1 Isoform b xm_232591 (6.8)Solute Carrier Family 7 (y+ system), member 12 nm_001017465 (47.1)Cysteine And Tyrosine-Rich Protein 1 nm_001013980 (4.6)Seminal Vesicle Protein 4 nm_012662 (4.1)Annexin A8 nm_001031654 (6.1)syncollin nm_139086 (9.4)Glandular Kallikrein 11 nm_001003977 (5.5)Hydroxyacid Oxidase-2 nm_032082 (45.1)Neurogenic Differentiation- 2 nm_019326 (4.6)Rt1 class ib Gene nm_012646 (4.1)Olfactory receptor 272 nm_001000230 (6.0)serpin x99773 (9.2)Rab3A nm_013018 (5.5)Solute Carrier Family 12, Member 1 nm_019134 (41.9)Rt1 Class Ii, locus dob nm_001008846 (4.3)Dual Oxidase 1 nm_153739 (4.1)lectin, Galactose binding, soluble 4 nm_012975 (5.8)Carboxyl Ester lipase nm_016997 (9.2)\nGenes which were among the twenty most different between pr and ps offspring in more than one generation are in bold font.']	N/A	N/A	[('SO_0000704', 'gene', 9, 'genes'), ('SO_0000704', 'gene', 50, 'genes'), ('PR_000017453', 'protein Wnt-9b', 134, 'WRAP'), ('UBERON_0002107', 'liver', 149, 'Hepatic'), ('SO_0000704', 'gene', 157, 'genes'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 393, 'P450'), ('PR_000013139', "serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha", 393, 'P450, 3,a'), ('GO_0032588', 'trans-Golgi network membrane', 419, 'Transmembrane'), ('PR_000029823', 'E3 ubiquitin ligase TRIM40', 419, 'Transmembrane protein 27'), ('PR_000016470', 'transmembrane and ubiquitin-like domain-containing protein 1', 462, 'Trefoil factor 2'), ('GO_0007608', 'sensory perception of smell', 496, 'Olfactory'), ('CHEBI_35195', 'surfactant', 538, 'Surfactant'), ('PR_000012527', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF4', 586, 'Pancreatic lipase related protein 1'), ('UBERON_0001264', 'pancreas', 586, 'Pancreatic'), ('PR_000004483', 'V-type proton ATPase subunit C 1', 670, 'Uromodulin'), ('CHEBI_5828', 'Hymexazol O-glucoside', 698, 'Hyaluronan'), ('PR_000006911', 'selenocysteine-specific elongation factor', 752, 'EGF-like domain 7'), ('SO_0000417', 'polypeptide_domain', 761, 'domain'), ('CL_0000824', 'mature natural killer cell', 785, 'Lymphocyte'), ('GO_0036364', 'transforming growth factor beta1 activation', 785, 'Lymphocyte-activation'), ('PR_000009658', 'laminin subunit gamma-1', 785, 'Lymphocyte-activation gene 3'), ('SO_0000704', 'gene', 807, 'gene'), ('UBERON_0001264', 'pancreas', 831, 'Pancreatic'), ('PR_000012388', 'protocadherin gamma-A10', 878, 'PGCL4'), ('CHEBI_4056', 'cytochrome', 900, 'Cytochrome'), ('PR_000006137', 'cytochrome P450 4B1', 900, 'Cytochrome P450'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 917, '11B'), ('PR_000000364', 'smad2', 939, 'Sarcolipin'), ('PR_000016580', 'tropomyosin beta chain', 969, 'Type'), ('PR_000009255', 'potassium voltage-gated channel subfamily E member 1', 984, 'KA11'), ('PR_000004967', 'calbindin', 1007, 'Caveolin 3'), ('PR_000012527', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF4', 1035, 'Pancreatic amylase 2'), ('UBERON_0001264', 'pancreas', 1035, 'Pancreatic'), ('CL_0000824', 'mature natural killer cell', 1072, 'Lymphocyte'), ('GO_0036364', 'transforming growth factor beta1 activation', 1072, 'Lymphocyte-activation'), ('PR_000009658', 'laminin subunit gamma-1', 1072, 'Lymphocyte-activation gene 3'), ('SO_0000704', 'gene', 1094, 'gene'), ('CHEBI_68805', 'chaetomugilin A', 1118, 'Chromogranin B'), ('PR_000001204', 'C-C chemokine receptor type 8', 1149, 'Cathepsin R'), ('CL_0000084', 'T cell', 1179, 'T-cell'), ('PR_000003676', 'actin, cytoplasmic 1', 1195, 'β-chain'), ('PR_000016393', 'transmembrane channel-like protein 2', 1229, 'Telethonin'), ('CHEBI_17089', 'glycoprotein', 1258, 'Glycoprotein'), ('PR_000007898', 'glutamate--cysteine ligase regulatory subunit', 1258, 'Glycoprotein 2'), ('PR_000001990', 'C-C motif chemokine 18', 1289, 'α2μ'), ('CHEBI_5386', 'globin', 1293, 'globulin'), ('PR_000012591', 'pepsin A-5', 1302, 'PGCL3'), ('CHEBI_17996', 'chloride', 1324, 'Chloride'), ('PR_000016296', 'protein-glutamine gamma-glutamyltransferase 5', 1360, 'Threonyl-tRNA synthetase-like 2'), ('PR_000015293', 'sphingomyelin phosphodiesterase 2', 1410, 'Stathmin-like 3'), ('CHEBI_3098', 'bile acid', 1441, 'Bile acid'), ('UBERON_0001970', 'bile', 1441, 'Bile'), ('CHEBI_15346', 'coenzyme A', 1451, 'Coenzyme A'), ('CHEBI_36916', 'cation', 1509, 'Cationic'), ('PR_000016770', 'testis-specific serine/threonine-protein kinase 1', 1518, 'trypsinogen'), ('PR_000013059', 'peroxisome proliferator-activated receptor gamma coactivator 1-alpha', 1559, 'PGCL1'), ('PR_000015439', 'nuclear body protein SP140-like protein', 1581, 'Solute carrier family 7 ...'), ('CL_0000824', 'mature natural killer cell', 1647, 'Lymphocyte'), ('PR_000004680', 'breast carcinoma-amplified sequence 3', 1657, '-activation gene 3'), ('SO_0000704', 'gene', 1669, 'gene'), ('PR_000029266', 'alkylglycerol monooxygenase', 1692, 'Myelin-associated Basic Protein-99 X89638'), ('UBERON_0000345', 'myelin', 1692, 'Myelin'), ('PR_000014506', 'secretoglobin family 1D member 1', 1763, 'Serine protease-2'), ('PR_000006525', 'delta-like protein 4', 1824, 'Defensin β1'), ('PR_000000084', 'c-myc protein', 1852, 'C-myc'), ('SO_0000167', 'promoter', 1858, 'promoter'), ('PR_000005890', 'crooked neck-like protein 1', 1898, 'Cystatin'), ('PR_000010876', 'myoferlin', 1922, 'Myosin, light polypeptide 3'), ('PR_000014709', 'neuroserpin', 1965, 'Pancreatic'), ('UBERON_0001264', 'pancreas', 1965, 'Pancreatic'), ('PR_000027795', 'trypsin', 1976, 'trypsin 1'), ('PR_000012388', 'protocadherin gamma-A10', 2015, 'PGCL5'), ('PR_000015229', 'solute carrier organic anion transporter family member 4A1', 2037, 'Solute carrier family 26'), ('PR_000007220', 'ethanolamine kinase 2', 2082, 'Gastrokine 1 XM_001074955'), ('PR_000029264', 'AT-hook DNA-binding motif-containing protein 1', 2113, 'SOCS box-containing protein 3 XM_344277'), ('GO_0019815', 'B cell receptor complex', 2158, 'Immunoglobulin'), ('UBERON_0001264', 'pancreas', 2201, 'Pancreatic'), ('PR_000014700', 'serpin B9', 2227, 'protein-2'), ('PR_000002199', 'cytochrome c protein', 2253, 'Caldesmon 1'), ('PR_000013086', 'peptidyl-prolyl cis-trans isomerase-like 4', 2281, 'Protein phosphatase 1, regulatory subunit 1A'), ('GO_0065007', 'biological regulation', 2304, 'regulatory'), ('GO_0016020', 'membrane', 2342, 'Membrane'), ('PR_000007693', 'ferritin, mitochondrial', 2407, 'FUN14 domain containing-1'), ('SO_0000417', 'polypeptide_domain', 2413, 'domain'), ('PR_000013199', 'prolargin', 2451, 'Pancreatitis-associated protein'), ('PR_000023799', 'ribonuclease R', 2498, 'Ribonuclease A'), ('PR_000010045', 'transcription factor Maf', 2532, 'Major urinary protein 5'), ('UBERON_0001088', 'urine', 2538, 'urinary'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 2572, 'Solute carrier family 3'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 2677, 'Actin-α cardiac- 1'), ('UBERON_0000948', 'heart', 2685, 'cardiac'), ('PR_000006022', 'lysosomal protective protein', 2711, 'Chymotrypsin C'), ('CHEBI_4056', 'cytochrome', 2745, 'Cytochrome'), ('PR_000006137', 'cytochrome P450 4B1', 2745, 'Cytochrome P450'), ('PR_000005173', 'CD59 glycoprotein', 2762, '2c13'), ('PR_000009204', 'lysine-specific demethylase 5A', 2784, 'Kidney androgen regulated protein'), ('UBERON_0002113', 'kidney', 2784, 'Kidney'), ('CHEBI_50113', 'androgen', 2791, 'androgen'), ('GO_0065007', 'biological regulation', 2800, 'regulated'), ('GO_0006277', 'DNA amplification', 2834, 'Glycosylation'), ('PR_000007775', 'gamma-aminobutyric acid receptor subunit delta', 2834, 'Glycosylation dependent cell adhesion molecule 1'), ('CHEBI_36357', 'polyatomic entity', 2872, 'molecule'), ('PR_000012194', 'P2X purinoceptor 7', 2898, 'Protocadherin-α'), ('PR_000006897', 'endothelin-1', 2929, 'EC1-'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 2933, 'V2R pheromone receptor XM_236825'), ('PR_000012529', 'PDZK1-interacting protein 1', 2971, 'Pancreatic elastase-1'), ('UBERON_0001264', 'pancreas', 2971, 'Pancreatic'), ('PR_000006605', 'dynamin-binding protein', 3050, 'Deoxyribonuclease 1'), ('PR_000003564', 'ATP-binding cassette sub-family C member 9', 3086, 'Actin α cardiac 1'), ('UBERON_0000948', 'heart', 3094, 'cardiac'), ('PR_000016139', 'TATA box-binding protein-like 2', 3119, 'Thioesterase superfamily member 4'), ('PR_000016329', 'T-lymphoma invasion and metastasis-inducing protein 2', 3154, 'Them4'), ('PR_000014411', 'protein S100-A4', 3185, 'S100 calcium binding'), ('PR_000005875', 'cysteine-rich protein 3', 3231, 'Chymotrypsin-like'), ('PR_000009329', 'killer cell immunoglobulin-like receptor 2DL3', 3265, 'KPL2'), ('PR_000006460', 'dihydroorotate dehydrogenase (quinone), mitochondrial', 3294, 'Degenerative spermatocyte homolog 2'), ('CL_0000017', 'spermatocyte', 3307, 'spermatocyte'), ('SO_0000853', 'homologous_region', 3320, 'homolog'), ('UBERON_0001986', 'endothelium', 3380, 'Endothelial'), ('CHEBI_26739', 'sphingolipid', 3409, 'sphingolipid'), ('PR_000001703', 'mas-related G-protein coupled receptor X2', 3409, 'sphingolipid G-protein-coupled receptor, 8'), ('PR_000016470', 'transmembrane and ubiquitin-like domain-containing protein 1', 3468, 'Trefoil factor 2'), ('PR_000005347', 'centrosome-associated protein CEP250', 3501, 'Carboxypeptidase B1'), ('CHEBI_4056', 'cytochrome', 3537, 'Cytochrome'), ('PR_000006137', 'cytochrome P450 4B1', 3537, 'Cytochrome P450'), ('CHEBI_52632', 'potassium-39 atom', 3599, 'sodium'), ('CHEBI_17234', 'glucose', 3606, 'glucose'), ('PR_000014938', 'urea transporter 1', 3617, 'transporter'), ('GO_0007608', 'sensory perception of smell', 3703, 'Olfactory'), ('PR_000014368', 'RuvB-like 1', 3713, 'receptor'), ('PR_000016580', 'tropomyosin beta chain', 3743, 'Type'), ('PR_000009486', 'keratin, type II cytoskeletal 71', 3758, 'KA15'), ('PR_000016869', 'thioredoxin-like protein 4A', 3781, 'Trypsin 10'), ('PR_000016331', 'tigger transposable element-derived protein 1', 3856, 'Tonin'), ('GO_0007608', 'sensory perception of smell', 3878, 'Olfactory'), ('GO_0007608', 'sensory perception of smell', 3920, 'Olfactory'), ('PR_000029714', 'roquin-2', 3930, 'receptor 821'), ('PR_000016842', 'trafficking regulator of GLUT4 1', 3961, 'Topoisomerase -2α'), ('CHEBI_4514', 'dicyclomine', 4029, 'Diamine'), ('PR_000029427', 'DnaJ homolog subfamily C member 7', 4029, 'Diamine acetyltransferase 1 XM_228448'), ('PR_000009329', 'killer cell immunoglobulin-like receptor 2DL3', 4154, 'KISS1'), ('GO_0043631', 'RNA polyadenylation', 4197, 'polyadenylation'), ('PR_000049700', 'protein Wnt-9b, signal peptide removed form (human)', 4225, 'factor 3 XR_005746'), ('PR_000007002', 'eukaryotic translation initiation factor 5', 4249, 'Elastase 2'), ('PR_000012527', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF4', 4277, 'Pancreatic amylase 2'), ('UBERON_0001264', 'pancreas', 4277, 'Pancreatic'), ('PR_000004968', 'calretinin', 4314, 'Cadherin 16'), ('GO_0007608', 'sensory perception of smell', 4345, 'Olfactory'), ('PR_000004967', 'calbindin', 4387, 'Calmodulin'), ('GO_0005886', 'plasma membrane', 4408, 'plasma membrane'), ('CHEBI_81233', 'Schizonepetoside B', 4424, 'Ca2+-'), ('GO_0016554', 'cytidine to uridine editing', 4424, 'Ca2+-transporting'), ('SO_0005853', 'gene_cassette', 4473, 'cassette'), ('PR_000015900', 'putative synaptotagmin-14-like protein', 4483, 'sub-family B, member 11'), ('UBERON_0001264', 'pancreas', 4523, 'Pancreatic'), ('SO_0001060', 'sequence_variant', 4568, 'isoform'), ('PR_000015439', 'nuclear body protein SP140-like protein', 4593, 'Solute carrier family 7 ...'), ('PR_000005866', 'cAMP-responsive element modulator', 4659, 'Cysteine and tyrosine-rich protein 1'), ('PR_000014892', 'NAD-dependent protein deacetylase sirtuin-6', 4714, 'Seminal vesicle protein 4'), ('UBERON_0000997', 'mammalian vulva', 4714, 'Seminal'), ('PR_000004080', 'annexin A7', 4755, 'Annexin A8'), ('UBERON_0002530', 'gland', 4809, 'Glandular'), ('PR_000009309', 'kinesin-like protein KIF2B', 4819, 'kallikrein 11'), ('CHEBI_16240', 'hydrogen peroxide', 4851, 'Hydroxyacid'), ('PR_000008453', 'hepatitis A virus cellular receptor 1', 4851, 'Hydroxyacid oxidase-2'), ('GO_0001822', 'kidney development', 4889, 'Neurogenic'), ('PR_000011461', 'endonuclease III-like protein 1', 4889, 'Neurogenic differentiation- 2'), ('PR_000012993', 'DNA-directed RNA polymerase II subunit RPB7', 4934, 'RT1'), ('SO_0000704', 'gene', 4947, 'gene'), ('GO_0007608', 'sensory perception of smell', 4967, 'Olfactory'), ('PR_000013610', 'Ras-related protein Rab-34', 5027, 'RAB3A'), ('PR_000015229', 'solute carrier organic anion transporter family member 4A1', 5048, 'Solute carrier family 12, member 1'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 5099, 'RT1 class II'), ('PR_000006745', 'dual specificity protein phosphatase 19', 5141, 'Dual oxidase 1'), ('CHEBI_28260', 'galactose', 5179, 'galactose'), ('CHEBI_3385', 'carbachol', 5223, 'Carboxyl ester'), ('SO_0000704', 'gene', 5261, 'Genes')]
PMC3134395	6/2011	S37-PMC3134395	['because Iodine is passively Excreted, increased Renal Glomerular filtration results in increased losses of Ingested Iodine [5].']	N/A	N/A	[('CHEBI_24859', 'iodine atom', 8, 'iodine'), ('GO_0007588', 'excretion', 28, 'excreted'), ('UBERON_0002113', 'kidney', 48, 'renal'), ('UBERON_0000074', 'renal glomerulus', 54, 'glomerular'), ('GO_0007631', 'feeding behavior', 107, 'ingested'), ('CHEBI_24859', 'iodine atom', 116, 'iodine')]
PMC3184661	9/2006	S13-PMC3184661	[': chronic Renal failure, congestive Heart failure) (5).']	N/A	N/A	[('UBERON_0002113', 'kidney', 10, 'renal'), ('UBERON_0000948', 'heart', 36, 'heart')]
PMC3240629	12/2011	S20-PMC3240629	['in the Sheep, reductions in Maternal Food Intake, or Feeding of diets deficient in b Vitamins and methionine during the Periconceptional period (between 60 days Preconception to 31 days Gestational age), elevates fetal Blood pressure, induces Cardiovascular and Renal abnormalities, impairs Glucose tolerance and Insulin resistance and increases adiposity in Adult offspring[18],[19],[20],[21].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 7, 'sheep'), ('GO_0007618', 'mating', 28, 'maternal'), ('CHEBI_33290', 'food', 37, 'food'), ('GO_0007631', 'feeding behavior', 37, 'food intake'), ('GO_0007631', 'feeding behavior', 53, 'feeding'), ('CHEBI_33277', 'gamma-tocotrienol', 85, 'vitamins'), ('GO_0007565', 'female pregnancy', 120, 'periconceptional'), ('GO_0007565', 'female pregnancy', 161, 'preconception'), ('GO_0007565', 'female pregnancy', 186, 'gestational'), ('UBERON_0000178', 'blood', 219, 'blood'), ('UBERON_0004535', 'cardiovascular system', 243, 'cardiovascular'), ('UBERON_0002113', 'kidney', 262, 'renal'), ('CHEBI_17234', 'glucose', 291, 'glucose'), ('PR_000045358', 'insulin family protein', 313, 'insulin'), ('UBERON_0007023', 'adult organism', 359, 'adult')]
PMC3240629	12/2011	S53-PMC3240629	['Mesenteric (surrounding the Small Intestine), Retroperitoneal (from the Perirenal Capsules as well as that attached to the dorsal Body Wall near the Kidneys), Gonadal (surrounding Epididymal and vesicular Glands in males and the Ovaries and Uterus in females) and Inguinal (subcutaneous depot anterior to the upper segment of the Hind Limbs) white Adipose Pads as well as Interscapular (between shoulder blades) Brown Adipose Tissue (Ibat) were removed, weighed and stored as above to assess offspring fat deposition.']	N/A	N/A	[('UBERON_0000956', 'cerebral cortex', 0, 'Mesenteric'), ('UBERON_0002108', 'small intestine', 28, 'small intestine'), ('UBERON_0003693', 'retroperitoneal space', 46, 'retroperitoneal'), ('UBERON_0001845', 'perilymph', 72, 'perirenal capsules'), ('UBERON_0000309', 'body wall', 130, 'body wall'), ('UBERON_0002113', 'kidney', 149, 'kidneys'), ('UBERON_0000991', 'gonad', 159, 'gonadal'), ('UBERON_0001301', 'epididymis', 180, 'epididymal'), ('UBERON_0002530', 'gland', 205, 'glands'), ('UBERON_0000992', 'ovary', 229, 'ovaries'), ('UBERON_0000995', 'uterus', 241, 'uterus'), ('UBERON_0008337', 'inguinal part of abdomen', 264, 'inguinal'), ('UBERON_0002103', 'hindlimb', 330, 'hind limbs'), ('UBERON_0001098', 'incisor tooth', 348, 'adipose pads'), ('UBERON_4200094', 'inner digits of hand', 372, 'interscapular ...'), ('UBERON_0001348', 'brown adipose tissue', 412, 'brown adipose tissue'), ('UBERON_0001348', 'brown adipose tissue', 434, 'IBAT')]
PMC3241920	4/2011	S4-PMC3241920	['the levels of Fe, zn, and cu in the Livers and Kidneys were determined by the f-aas method.']	N/A	N/A	[('CHEBI_33290', 'food', 14, 'Fe'), ('UBERON_0002107', 'liver', 36, 'livers'), ('UBERON_0002113', 'kidney', 47, 'kidneys')]
PMC3241920	4/2011	S7-PMC3241920	['both Prenatal protein restriction and Folic Acid supplementation increased the Liver zn content ( p \u2009<\u20090.05) and the Kidney zn content ( p \u2009<\u20090.001; p \u2009<\u20090.05, respectively), while Folic Acid supplementation resulted in a reduction in Renal Cu level ( p \u2009<\u20090.05).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 5, 'prenatal'), ('CHEBI_30751', 'formic acid', 38, 'folic acid'), ('UBERON_0002107', 'liver', 79, 'liver'), ('UBERON_0002113', 'kidney', 117, 'kidney'), ('CHEBI_30751', 'formic acid', 181, 'folic acid'), ('UBERON_0002113', 'kidney', 235, 'renal'), ('CHEBI_17996', 'chloride', 241, 'Cu')]
PMC3241920	4/2011	S46-PMC3241920	['the Liver and Kidneys were dissected, accurately weighted, and kept frozen (−70°c) until analysis for Fe, zn, and Cu contents.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('UBERON_0002113', 'kidney', 14, 'kidneys'), ('CHEBI_33290', 'food', 102, 'Fe'), ('CHEBI_17996', 'chloride', 114, 'Cu')]
PMC3241920	4/2011	S49-PMC3241920	['the accuracy of the quantitative Mineral determinations was assured by simultaneous analysis of the certified reference material (Pig Kidney bcr® no.']	N/A	N/A	[('CHEBI_46662', 'mineral', 33, 'mineral'), ('NCBITaxon_10088', 'Mus <genus>', 130, 'pig'), ('UBERON_0002113', 'kidney', 134, 'kidney')]
PMC3241920	4/2011	S57-PMC3241920	['within each row, values without a common letter differ at p \u2009<\u20090.05\n\ncaption (table-wrap): table\xa03\n\nHepatic and Renal Mineral contents in the offspringgroupfezncuhepatic Fe contentrenal Fe contenthepatic zn contentrenal zn contenthepatic Cu contentrenal Cu contentmeansemeansemeansemeansemeansemeansenp-nf ainfemale1,250.1191463.824108.43112.7515.0158.4ab6male522.643337.135123.31295.8515.4236.8a3np-nf hffemale2,266.679565.612133.75102.6718.7147.9ab11male505.536511.21588.84113.659.4140.6ab8pr-Nf Ainfemale1,278.4128527.044139.05115.01019.4190.7b4male426.13428.530116.03113.5211.6036.4a1pr-Nf hffemale1,655.8197444.99136.510108.3916.3342.4ab2male562.720486.745120.55114.7211.7031.0a2pr-fs ainfemale1,719.9180437.517157.111129.4220.4343.5ab8male300.414443.985134.58125.4112.5330.3a2pr-fs hffemale1,858.7178549.130130.56135.5615.3235.6a4male614.56350.74102.322123.4167.9131.5a13np-fs ainfemale1,192.955523.614124.66105.7323.1778.7ab16male532.915363.925144.2790.8114.3130.0a2np-fs hffemale1,442.995401.123138.312125.7914.9138.5ab9male660.920472.991104.28100.0311.0233.9a0\nvalues are given in micrograms per gram of dry mass.']	N/A	N/A	[('UBERON_0002107', 'liver', 100, 'Hepatic'), ('UBERON_0002113', 'kidney', 112, 'renal'), ('CHEBI_46662', 'mineral', 118, 'mineral'), ('CHEBI_33290', 'food', 170, 'Fe'), ('CHEBI_33290', 'food', 186, 'Fe'), ('CHEBI_17996', 'chloride', 238, 'Cu'), ('CHEBI_17996', 'chloride', 254, 'Cu'), ('GO_0005883', 'neurofilament', 495, 'NF'), ('PR_000003888', 'A-kinase anchor protein 14', 498, 'AINFemale1'), ('GO_0005883', 'neurofilament', 591, 'NF')]
PMC3241920	4/2011	S58-PMC3241920	['within a column, values without a common letter differ at p \u2009<\u20090.05\n\ncaption (table-wrap): table\xa04\n\neffects of experimental factors on mineral levels in offspring’s Liver and Kidneysmineral contentmain effectsinteraction effectspfafsp\u2009×\u2009fafa\u2009×\u2009sfa\u2009×\u2009ff\u2009×\u2009sp\u2009×\u2009f\u2009×\u2009sp\u2009×\u2009Fa\u2009×\u2009fp\u2009×\u2009Fa\u2009×\u2009sfa\u2009×\u2009f\u2009×\u2009sp\u2009×\u2009Fa\u2009×\u2009f×\u2009sfe Liver***************fe Kidneys****zn Liver***********zn Kidneys********cu Liver****cu Kidneys*************\np maternal dietary protein, Fa maternal dietary Folic Acid, f dietary fat, s offspring sex\n* p \u2009<\u20090.05; ** p \u2009<\u20090.01; *** p \u2009<\u20090.001; significant levels\n\nresults\nthe average Intakes of dietary Micronutrients (Fe, zn, and cu) were significantly different between the groups.']	N/A	N/A	[('UBERON_0002107', 'liver', 165, 'liver'), ('UBERON_0001224', 'renal pelvis', 175, 'kidneysMineral'), ('CHEBI_30751', 'formic acid', 269, 'FA'), ('CHEBI_30751', 'formic acid', 279, 'FA'), ('CHEBI_30751', 'formic acid', 299, 'FA'), ('UBERON_0002107', 'liver', 311, 'liver'), ('UBERON_0002113', 'kidney', 334, 'kidneys'), ('UBERON_0002107', 'liver', 348, 'liver'), ('UBERON_0002113', 'kidney', 367, 'kidneys'), ('UBERON_0002107', 'liver', 385, 'liver'), ('UBERON_0002113', 'kidney', 397, 'kidneys'), ('CHEBI_30751', 'formic acid', 446, 'FA'), ('CHEBI_30751', 'formic acid', 466, 'folic acid'), ('GO_0007631', 'feeding behavior', 592, 'intakes'), ('CHEBI_33839', 'macromolecule', 611, 'micronutrients'), ('CHEBI_33290', 'food', 627, 'Fe')]
PMC3241920	4/2011	S73-PMC3241920	['Postnatal exposure to the high-fat diet did not significantly affect Renal zn contents.']	N/A	N/A	[('GO_0007567', 'parturition', 0, 'Postnatal'), ('UBERON_0002113', 'kidney', 69, 'renal')]
PMC3241920	4/2011	S78-PMC3241920	['in the Rats Fed the high-fat diet, Hepatic Cu contents were decreased by 20% ( p \u2009<\u20090.05), independently of Prenatal nutrition, and Renal Cu levels declined by 25% ( p \u2009<\u20090.001).']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 7, 'rats'), ('GO_0007631', 'feeding behavior', 12, 'fed'), ('UBERON_0002107', 'liver', 35, 'hepatic'), ('CHEBI_17996', 'chloride', 43, 'Cu'), ('GO_0007565', 'female pregnancy', 108, 'prenatal'), ('UBERON_0002113', 'kidney', 132, 'renal'), ('CHEBI_17996', 'chloride', 138, 'Cu')]
PMC3241920	4/2011	S86-PMC3241920	['the lowest level of Cu in Kidneys was observed in the pr-fs hf group (34.0\u2009±\u20094.7\xa0μg/g d.m.']	N/A	N/A	[('CHEBI_17996', 'chloride', 20, 'Cu'), ('UBERON_0002113', 'kidney', 26, 'kidneys')]
PMC3257641	3/2010	S15-PMC3257641	['conversion to the active form of the hormone requires a further hydroxylation, primarily in the Kidney, under the Control of a 1α-hydroxylase, forming 1, 25-Dihydroxyvitamin D (1,25(Oh)2D) [4].']	N/A	N/A	[('UBERON_0002113', 'kidney', 96, 'kidney'), ('GO_0065007', 'biological regulation', 114, 'control'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 154, '25-dihydroxyvitamin D'), ('CHEBI_37958', 'dye', 177, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 179, '25(OH)2D')]
PMC3268605	8/2011	S0-PMC3268605	['Perinatal exogenous Nitric Oxide in fawn-hooded hypertensive Rats reduces Renal Ribosomal Biogenesis in early Life\n\nabstract\nNitric Oxide (No) is known to depress Ribosome Biogenesis in vitro .']	N/A	N/A	[('GO_0036268', 'swimming', 0, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 0, 'Perinatal'), ('CHEBI_44445', 'nimesulide', 20, 'Nitric Oxide'), ('NCBITaxon_10088', 'Mus <genus>', 61, 'Rats'), ('UBERON_0002113', 'kidney', 74, 'Renal'), ('GO_0005768', 'endosome', 80, 'Ribosomal'), ('GO_0022613', 'ribonucleoprotein complex biogenesis', 80, 'Ribosomal Biogenesis'), ('UBERON_0000104', 'life cycle', 110, 'Life'), ('CHEBI_16480', 'nitric oxide', 125, 'Nitric oxide'), ('CHEBI_16382', 'iodide', 139, 'NO'), ('GO_0005840', 'ribosome', 163, 'ribosome'), ('GO_0042254', 'ribosome biogenesis', 163, 'ribosome biogenesis')]
PMC3268605	8/2011	S2-PMC3268605	['fawn-hooded hypertensive Rat (fhh) dams were supplied with the No-Donor Molsidomine in drinking Water from 2 weeks before to 4 weeks after Birth, and the Kidneys were subsequently collected from 2\u2009day, 2 week, and 9 to 10-month-old Adult offspring.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 25, 'rat'), ('CHEBI_16382', 'iodide', 63, 'NO'), ('CHEBI_13193', 'hydrogen acceptor', 66, 'donor'), ('CHEBI_30629', 'diethylenetriamine', 72, 'molsidomine'), ('CHEBI_15377', 'water', 96, 'water'), ('GO_0007567', 'parturition', 139, 'birth'), ('UBERON_0002113', 'kidney', 154, 'kidneys'), ('UBERON_0007023', 'adult organism', 232, 'adult')]
PMC3268605	8/2011	S5-PMC3268605	['such differential Regulation of Renal Ribosomal protein Genes was not observed in females.']	N/A	N/A	[('GO_0065007', 'biological regulation', 18, 'regulation'), ('UBERON_0002113', 'kidney', 32, 'renal'), ('GO_0005840', 'ribosome', 38, 'ribosomal'), ('SO_0000704', 'gene', 56, 'genes')]
PMC3268605	8/2011	S8-PMC3268605	['no direct effects of Molsidomine were observed on Cellular Proliferation in Kidneys at any age, and the changes induced by Molsidomine in Renal polysome profiles at 2 weeks were absent in the Livers of the same Rats.']	N/A	N/A	[('CHEBI_30629', 'diethylenetriamine', 21, 'molsidomine'), ('GO_0008283', 'cell proliferation', 50, 'cellular proliferation'), ('UBERON_0002113', 'kidney', 76, 'kidneys'), ('CHEBI_30629', 'diethylenetriamine', 123, 'molsidomine'), ('UBERON_0002113', 'kidney', 138, 'renal'), ('UBERON_0002107', 'liver', 192, 'livers'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 211, 'rats')]
PMC3268605	8/2011	S24-PMC3268605	['for instance, compensatory Renal hypertrophy involves a global increase in Polysome profiles within less than 1\u2009day after uninephrectomy (chen et al.,2005).']	N/A	N/A	[('UBERON_0002113', 'kidney', 27, 'renal'), ('SO_0000610', 'polyA_sequence', 75, 'polysome')]
PMC3268605	8/2011	S38-PMC3268605	['Kidneys were isolated and snap-frozen (for microarray analysis), kept on ice (for western blotting and polysome profiling), or fixed in Formaldehyde (for immunohistochemistry).']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidneys'), ('CHEBI_16842', 'formaldehyde', 136, 'formaldehyde')]
PMC3268605	8/2011	S45-PMC3268605	['in short, a piece of snap-frozen Kidney was put in 1\u2009ml trizol (invitrogen, breda, netherlands) containing 100–150\u2009mg 1\u2009mm glass beads (biospec products, bartlesville, ok, usa) and immediately homogenized in 30\u2009s using a mini-beadbeater (biospec).']	N/A	N/A	[('UBERON_0002113', 'kidney', 33, 'kidney')]
PMC3268605	8/2011	S62-PMC3268605	['western blot analysis\nfresh Kidney samples were Lysed on ice in Lysis buffer (50\u2009mm Tris–Hcl ph 7.5, 150\u2009mm Nacl, 2\u2009mm edta, 1% Triton x-100; all from sigma-aldrich) plus protease inhibitors (santa cruz biotech, #29130) and subjected to centrifugation at 14k rpm at 4°c for 10\u2009min.']	N/A	N/A	[('UBERON_0002113', 'kidney', 28, 'kidney'), ('GO_0019835', 'cytolysis', 48, 'lysed'), ('GO_0019835', 'cytolysis', 64, 'lysis'), ('CHEBI_9754', 'tris', 84, 'Tris'), ('CHEBI_17883', 'hydrogen chloride', 89, 'HCl'), ('CHEBI_26710', 'sodium chloride', 108, 'NaCl'), ('CHEBI_29236', 'protium atom', 128, 'Triton')]
PMC3268605	8/2011	S70-PMC3268605	['polysome profiling\nthe Kidneys from fhh pups from control dams or dams treated with Molsidomine were collected at age 2\u2009days and 2 weeks, maintained fresh on ice, and processed for Polysome profiling on the same day.']	N/A	N/A	[('UBERON_0002113', 'kidney', 23, 'kidneys'), ('CHEBI_30629', 'diethylenetriamine', 84, 'molsidomine'), ('GO_0005844', 'polysome', 181, 'polysome'), ('SO_0000610', 'polyA_sequence', 181, 'polysome')]
PMC3268605	8/2011	S71-PMC3268605	['for Polysome profiling of Adult Tissue frozen Kidney Tissue was used.']	N/A	N/A	[('SO_0000610', 'polyA_sequence', 4, 'polysome'), ('UBERON_0007023', 'adult organism', 26, 'adult'), ('UBERON_0000479', 'tissue', 32, 'tissue'), ('UBERON_0002113', 'kidney', 46, 'kidney'), ('UBERON_0000479', 'tissue', 53, 'tissue')]
PMC3268605	8/2011	S76-PMC3268605	['Kidneys were Lysed in 500\u2009μl Polysome Lysis buffer (gradient buffer containing 100\u2009mm Kcl, 10\u2009mm Mgcl2, 0.1% Np-40, 2\u2009mm Dtt, and 40\u2009u/ml rnasin; promega, leiden, netherlands) using a dounce homogenizer.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidneys'), ('GO_0019835', 'cytolysis', 13, 'lysed'), ('GO_0007565', 'female pregnancy', 29, 'polysome'), ('GO_0019835', 'cytolysis', 38, 'lysis'), ('CHEBI_32588', 'potassium chloride', 86, 'KCl'), ('CHEBI_6636', 'magnesium dichloride', 97, 'MgCl2'), ('CHEBI_63016', 'nonyl phenoxypolyethoxylethanol', 109, 'NP-40'), ('CHEBI_18320', '1,4-dithiothreitol', 121, 'DTT')]
PMC3268605	8/2011	S82-PMC3268605	['Tissue No content\nendogenous No levels in Kidney and Liver Tissues of fhh pups were assayed at 2 weeks by No trapping with Iron-Dithiocarbamate (Fe-Detc) Complexes, as previously described (koeners et al.,2007; van faassen et al.,2008).']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissue'), ('CHEBI_16382', 'iodide', 7, 'NO'), ('CHEBI_16382', 'iodide', 29, 'NO'), ('UBERON_0002113', 'kidney', 42, 'kidney'), ('UBERON_0002107', 'liver', 53, 'liver'), ('UBERON_0000479', 'tissue', 59, 'tissues'), ('CHEBI_16382', 'iodide', 106, 'NO'), ('CHEBI_75832', 'iron(2+) sulfate (anhydrous)', 123, 'iron-dithiocarbamate'), ('CHEBI_33290', 'food', 145, 'Fe'), ('CHEBI_15946', 'keto-D-fructose 6-phosphate', 148, 'DETC'), ('GO_0032991', 'protein-containing complex', 154, 'complexes')]
PMC3268605	8/2011	S85-PMC3268605	['immunohistochemistry\nKidneys were fixed overnight at room temperature in 4% Formaldehyde.']	N/A	N/A	[('UBERON_0002113', 'kidney', 21, 'Kidneys'), ('CHEBI_16842', 'formaldehyde', 76, 'formaldehyde')]
PMC3268605	8/2011	S94-PMC3268605	['the number of positive cells was counted in three fields of two sections per Kidney.']	N/A	N/A	[('UBERON_0002113', 'kidney', 77, 'kidney')]
PMC3268605	8/2011	S101-PMC3268605	['note that Adult Kidney weight and Tail-Cuff Blood pressure data, which were published previously (koeners et al.,2008b), are included in the table for the sake of convenience.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 10, 'adult'), ('UBERON_0002113', 'kidney', 16, 'kidney'), ('UBERON_0008894', 'pharyngeal gill precursor', 34, 'tail-cuff'), ('UBERON_0000178', 'blood', 44, 'blood')]
PMC3268605	8/2011	S112-PMC3268605	['caption (table-wrap): table 2\n\nNitric Oxide yields (pmol mnic/mg Tissue) determined by epr in Kidneys and Liver in of 2-week-old control fhh and 2-week-old fhh offspring of dams treated with Molsidomine .malesfemalescontrolsmolsidominecontrolsmolsidomine 2 weeks number/litters4/27/44/28/4No yield in Kidney (left and right)0.49\u2009±\u20090.030.53\u2009±\u20090.010.50\u2009±\u20090.040.49\u2009±\u20090.02no yield in Liver1.30\u2009±\u20090.081.39\u2009±\u20090.041.35\u2009±\u20090.081.32\u2009±\u20090.04\nmnic, mononitrosyl-Iron Complexes .']	N/A	N/A	[('CHEBI_16480', 'nitric oxide', 31, 'Nitric oxide'), ('UBERON_0000479', 'tissue', 65, 'tissue'), ('UBERON_0002113', 'kidney', 94, 'kidneys'), ('UBERON_0002107', 'liver', 106, 'liver'), ('CHEBI_30629', 'diethylenetriamine', 191, 'molsidomine'), ('CHEBI_37042', "purine 2'-deoxyribonucleoside 5'-triphosphate", 288, '4NO'), ('UBERON_0002113', 'kidney', 301, 'kidney'), ('UBERON_0002107', 'liver', 380, 'liver1'), ('GO_0030054', 'cell junction', 449, 'iron'), ('GO_0032991', 'protein-containing complex', 454, 'complexes')]
PMC3268605	8/2011	S137-PMC3268605	['western blot analysis was performed on Kidneys lysates from 2\u2009day and 2 week control and Molsidomine fhh Rats of both genders using an Antibody against Ribosomal Protein L36A (upper panel).']	N/A	N/A	[('UBERON_0002113', 'kidney', 39, 'kidneys'), ('CHEBI_30629', 'diethylenetriamine', 89, 'molsidomine'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 105, 'rats'), ('GO_0042571', 'immunoglobulin complex, circulating', 135, 'antibody'), ('GO_0005840', 'ribosome', 152, 'ribosomal'), ('PR_000014178', 'ribulose-phosphate 3-epimerase', 152, 'ribosomal protein L36a')]
PMC3268605	8/2011	S142-PMC3268605	['caption (fig): figure 4\n\npolysome profiles of Kidneys .']	N/A	N/A	[('UBERON_0002113', 'kidney', 46, 'kidneys')]
PMC3268605	8/2011	S143-PMC3268605	['Kidneys from control 2\u2009day old (males n \u2009=\u20095, females n \u2009=\u20096), 2 week old ( n \u2009=\u20098 in both genders), and adult ( n \u2009=\u20094 in both genders) and Molsidomine-treated 2\u2009day old (males n \u2009=\u20094, females n \u2009=\u20096), 2 week old ( n \u2009=\u20099 in both genders) and Adult ( n \u2009=\u20095 in both genders) fhh Rats were profiled to measure the total number of assembled Ribosome structures.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidneys'), ('CHEBI_30629', 'diethylenetriamine', 141, 'molsidomine'), ('UBERON_0007023', 'adult organism', 244, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 280, 'rats'), ('GO_0005840', 'ribosome', 340, 'ribosome')]
PMC3268605	8/2011	S148-PMC3268605	['northern blotting was performed on total rna from 2 week fhh Kidneys in order to determine rates of Rrna Processing (figurea2in appendix).']	N/A	N/A	[('UBERON_0002113', 'kidney', 61, 'kidneys'), ('GO_0000002', 'mitochondrial genome maintenance', 100, 'rRNA processing')]
PMC3268605	8/2011	S155-PMC3268605	['we saw no difference in the number of Ph3-positive cells on Molsidomine-treated fhh Rat Kidney slices compared to controls.']	N/A	N/A	[('PR_000007227', 'ETS translocation variant 4', 38, 'pH3'), ('CHEBI_30629', 'diethylenetriamine', 60, 'molsidomine'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 84, 'rat'), ('UBERON_0002113', 'kidney', 88, 'kidney')]
PMC3268605	8/2011	S159-PMC3268605	['histology was performed on the Kidneys from 2\u2009day, 2 week and Adult control and Molsidomine fhh Rats of both genders for ph3.']	N/A	N/A	[('UBERON_0002113', 'kidney', 31, 'kidneys'), ('UBERON_0007023', 'adult organism', 62, 'adult'), ('CHEBI_30629', 'diethylenetriamine', 80, 'molsidomine'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 96, 'rats')]
PMC3272870	12/2011	S49-PMC3272870	['the active Metabolite of Vitamin D, 1,25-Dihydroxyvitamin D [1,25(Oh)2D] increases Intestinal calcium absorption and decreases Renal calcium Excretion, thus increasing the pool of calcium available both for mother and foetus.']	N/A	N/A	[('CHEBI_39382', 'flufenoxuron', 11, 'metabolite'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_67472', '15-epi-lupulin B', 36, '1,25-dihydroxyvitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 61, '1,25(OH)2D'), ('UBERON_0000160', 'intestine', 83, 'intestinal'), ('UBERON_0002113', 'kidney', 127, 'renal'), ('GO_0007588', 'excretion', 141, 'excretion')]
PMC3278486	1/2012	S71-PMC3278486	['caption (table-wrap): table 1\n\ncharacteristics of included rctsstudyparticipants n: total (ntot), Folic Acid (nint); countrypopulation characteristics intervention/control group: sex (% females); age in years (mean ± sd); characteristics; % smokersintervention/controltime of treatment/follow-up monthsoutcomeslogan (2008)22(ukcap)\nntot: 939, nint: 470; uk, denmark\n% f: 39/42; mean age: 58±9/58±9; Colorectal adenoma*; % smokers: not reportedfolic Acid 0.5\u2005mg/day ±Aspirin/placebo ± Aspirin36†/36total and site-specific cancer incidencewu (2009)23\nntot: 672, nint: 338; usa\n% f: 61/62; mean age:65±7/66±7; Colorectal adenoma*; % smokers: 7/7Folic Acid 1\u2005mg/day/placebomean 64/64 + up to 12total and site-specific cancer incidencecole (2007)11(afpps)\nntot: 1021, nint: 516;\nusa, canada\n% f: 36/36; mean age: 57±10/57±10; Colorectal adenoma*; % smokers: 15/14folic Acid 1\u2005mg/day ±Aspirin/placebo ± Aspirinmean 33 + mean 42‡/75total and site-specific cancer incidencejamison (2007)24(host)/clarke (2010)3\nntot: 2056, nint: 1032; usa\n% f: 2/2; mean age: 65±12/66±12; chronic Renal disease; % smokers: 21/19folic Acid 40\u2005mg/day +vit b12+b6/placebomedian 38/38total cancer incidencetoole (2004)25(visp)/clarke (2010)3\nntot: 3680, nint: 1827; usa, canada, scotland\n% f: 38/37; mean age: 66±11/66±11; Cardiovascular disease; % smokers: 18/16folic Acid 2.5\u2005mg/day +vitb6+vitb12/Folic Acid 20\u2005μg +vitb6+vitb12mean 20/20total cancer incidencezhang (2008)26(wafacs)\nntot: 5442, nint: 2721; usa\n% f: 100/100; mean age:63±9/63±9; Cardiovascular disease; % smokers: 11/12folic Acid 2.5\u2005mg/day + vit b12+b6/placebomean 88/88total and site-specific cancer incidence and mortalityebbing (2009)12(wenbit14+ norvit13)§\nntot6837, nint3411; norway\n% f: 23/24; mean age: 63±11/62±11; Cardiovascular disease; % smokers: 38/41folic Acid 0.8\u2005mg/day +vitb12±vit b6/Placebo ±vit b6median 39/77total and site-specific cancer incidence and mortalitylonn (2006)27(Hope-2)\nntot: 5522, nint: 2758; europe, canada, usa\n% f: 29/28; mean age: 69±7/69±7; cardiovascular disease; % smokers: 11/12folic Acid 2.5\u2005mg/day + vit b12+b6/placebomean 60/60total and site-specific cancer incidence and mortalitysearch (2010)28\nntot12\u2008064, nint6033; uk\n% f: 17/17; mean age: 64±9¶; Cardiovascular disease; % smokers: 12/12folic Acid 2\u2005mg/day + vit B12/placebomean 80/80total and site-specific cancer incidence/total cancer mortalitycharles (2004)29/charles (2005)30\nntot: 2462, nint: 485; scotland\n% f: 100/100; mean age: 26±5/26±6; Pregnancy; % smokers: 45/46folic Acid 5\u2005mg/day/placeboin Pregnancy/36\u2005yearstotal and Breast cancer mortalityzhu (2003)31\nntot: 98, nint: 44; china\n% f: 41/30; mean age 57±12/57±11; atrophic gastritis; % smokers: not reportedfolic Acid 20\u2005mg/day first year, 20\u2005mg twice weekly second year +vit B12/placebo12+12/mean 73gastrointestinal cancer incidence\nColorectal adenoma: history of Colorectal adenoma (removed before randomisation).']	N/A	N/A	[('CHEBI_30751', 'formic acid', 98, 'folic acid'), ('UBERON_0012652', 'colorectum', 399, 'colorectal'), ('CHEBI_37527', 'acid', 449, 'acid'), ('CHEBI_2904', 'atenolol', 466, 'aspirin'), ('CHEBI_47785', 'AMP-PNP', 484, 'aspirin36'), ('UBERON_0012652', 'colorectum', 607, 'colorectal'), ('CHEBI_30778', 'gallic acid', 641, '7Folic acid'), ('UBERON_0012652', 'colorectum', 821, 'colorectal'), ('CHEBI_37527', 'acid', 864, 'acid'), ('CHEBI_2904', 'atenolol', 879, 'aspirin'), ('CHEBI_2887', 'Aspidofractine', 897, 'aspirinMean'), ('UBERON_0002113', 'kidney', 1072, 'renal'), ('CHEBI_37527', 'acid', 1109, 'acid'), ('UBERON_0004535', 'cardiovascular system', 1294, 'cardiovascular'), ('CHEBI_37527', 'acid', 1340, 'acid'), ('CHEBI_30751', 'formic acid', 1370, 'folic acid'), ('UBERON_0004535', 'cardiovascular system', 1517, 'cardiovascular'), ('CHEBI_37527', 'acid', 1563, 'acid'), ('UBERON_0004535', 'cardiovascular system', 1762, 'cardiovascular'), ('CHEBI_37527', 'acid', 1808, 'acid'), ('CHEBI_26130', 'biological pigment', 1839, 'placebo'), ('CHEBI_36328', 'HODE', 1934, 'HOPE'), ('CHEBI_37527', 'acid', 2065, 'acid'), ('UBERON_0004535', 'cardiovascular system', 2235, 'cardiovascular'), ('CHEBI_37527', 'acid', 2281, 'acid'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 2301, 'B12'), ('GO_0007565', 'female pregnancy', 2486, 'pregnancy'), ('CHEBI_37527', 'acid', 2519, 'acid'), ('GO_0007565', 'female pregnancy', 2543, 'pregnancy'), ('UBERON_0000310', 'breast', 2571, 'breast'), ('CHEBI_37527', 'acid', 2716, 'acid'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 2779, 'B12'), ('UBERON_0012652', 'colorectum', 2837, 'Colorectal'), ('UBERON_0012652', 'colorectum', 2868, 'colorectal')]
PMC3290837	10/2011	S49-PMC3290837	['five minutes after the second bolus, the Kidney was removed and the Capsule was discarded.']	N/A	N/A	[('UBERON_0002113', 'kidney', 41, 'kidney'), ('UBERON_0003893', 'capsule', 68, 'capsule')]
PMC3290837	10/2011	S50-PMC3290837	['the Kidney was minced using a single edged razor blade, placed in 1% Ammonium Chloride Solution (sigma) and incubated for 5 min at room temperature.']	N/A	N/A	[('UBERON_0002113', 'kidney', 4, 'kidney'), ('CHEBI_63040', 'ammonium iodide', 69, 'ammonium chloride'), ('CHEBI_75958', 'solution', 87, 'solution')]
PMC3290837	10/2011	S52-PMC3290837	['the Kidney Tissue was then mixed vigorously until all pieces were dissolved.']	N/A	N/A	[('UBERON_0002113', 'kidney', 4, 'kidney'), ('UBERON_0000479', 'tissue', 11, 'tissue')]
PMC3290837	10/2011	S56-PMC3290837	['thirty 10-μl samples of Glomeruli were counted and the total number of Glomeruli in the Kidney was then determined from the mean of the number of Glomeruli in 10-μl samples.']	N/A	N/A	[('UBERON_0000074', 'renal glomerulus', 24, 'glomeruli'), ('UBERON_0000074', 'renal glomerulus', 71, 'glomeruli'), ('UBERON_0002113', 'kidney', 88, 'kidney'), ('UBERON_0000074', 'renal glomerulus', 146, 'glomeruli')]
PMC3290837	10/2011	S67-PMC3290837	['at the time of sacrifice, the Kidneys of the switched Rats were weighed.']	N/A	N/A	[('UBERON_0002113', 'kidney', 30, 'kidneys'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 54, 'rats')]
PMC3290837	10/2011	S68-PMC3290837	['the Kidneys of the 20% group raised by a 20% foster mother weighed 1.45 ± 0.09 g. this Kidney weight was greater than in all the other groups (p < 0.05).']	N/A	N/A	[('UBERON_0002113', 'kidney', 4, 'kidneys'), ('UBERON_0002113', 'kidney', 87, 'kidney')]
PMC3290837	10/2011	S69-PMC3290837	['the Kidneys of the low protein group raised by a mother that Ate a low protein diet weighed 1.21 ± 0.05 g, which was not different from than that of the 6% group raised by a mother who ate a 20% protein diet during Pregnancy 1.27 ± 0.03 g, or the 20% group raised by a mother who ate a 6% diet during Pregnancy 1.20 ± 0.08 g.\nBlood pressure of control diet Rats raised by their mothers was 134 ± 5 mm hg, which was not different from the control Rats that were fostered to controls (133 ± 4 mm hg).']	N/A	N/A	[('UBERON_0002113', 'kidney', 4, 'kidneys'), ('GO_0009636', 'response to toxic substance', 61, 'ate'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('GO_0007565', 'female pregnancy', 301, 'pregnancy'), ('UBERON_0000178', 'blood', 326, 'Blood'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 357, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 446, 'rats')]
PMC3321454	3/2012	S1-PMC3321454	['Pregnant Rats were Fed either control or low-protein (lp) diets, and Kidneys from their male offspring were collected at 4, 13, or 16 weeks of age.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 9, 'rats'), ('GO_0007631', 'feeding behavior', 19, 'fed'), ('UBERON_0002113', 'kidney', 69, 'kidneys')]
PMC3321454	3/2012	S10-PMC3321454	['in the Kidney, the number of Nephrons is reduced through exposure to maternal undernutrition, and with Ageing, low-protein-exposed Animals develop Glomerular injury and progressive loss of Renal function [10,12,13].']	N/A	N/A	[('UBERON_0002113', 'kidney', 7, 'kidney'), ('UBERON_0001285', 'nephron', 29, 'nephrons'), ('GO_0007568', 'aging', 103, 'ageing'), ('NCBITaxon_33208', 'Metazoa', 131, 'animals'), ('UBERON_0000074', 'renal glomerulus', 147, 'glomerular'), ('UBERON_0002113', 'kidney', 189, 'renal')]
PMC3321454	3/2012	S20-PMC3321454	['in Rats exposed to a maternal high-fat diet, Kidney Mitochondrial Dna was decreased, and Expression of the Mitochondrial Genome in Aorta was downregulated [18].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('UBERON_0002113', 'kidney', 45, 'kidney'), ('GO_0005739', 'mitochondrion', 52, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 52, 'mitochondrial DNA'), ('GO_0010467', 'gene expression', 89, 'expression'), ('GO_0005739', 'mitochondrion', 107, 'mitochondrial'), ('SO_0000172', 'CAAT_signal', 107, 'mitochondrial'), ('SO_0001026', 'genome', 121, 'genome'), ('UBERON_0000947', 'aorta', 131, 'aorta')]
PMC3321454	3/2012	S36-PMC3321454	['both Kidneys were collected from a second male from each litter, and these were used for fresh preparation of Mitochondria and analysis of Respiratory Chain function.']	N/A	N/A	[('UBERON_0002113', 'kidney', 5, 'kidneys'), ('GO_0005739', 'mitochondrion', 110, 'mitochondria'), ('GO_0045472', 'response to ether', 139, 'respiratory chain')]
PMC3321454	3/2012	S42-PMC3321454	['Kidneys were collected, snap-frozen in liquid nitrogen, and stored at −80°c.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidneys')]
PMC3321454	3/2012	S43-PMC3321454	['Kidney samples from male offspring used for histochemistry, immunohistochemistry, and analysis of Mitochondrial Dna copy number (experiment two) were resnap frozen in Isopentane and stored in a −80°c freezer.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidney'), ('GO_0005739', 'mitochondrion', 98, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 98, 'mitochondrial DNA'), ('CHEBI_30362', 'isopentane', 167, 'isopentane')]
PMC3321454	3/2012	S75-PMC3321454	['Rat Kidney Mitochondrial function\nwhole Kidneys from experiment two were chopped and minced, then homogenised in ste (250\u2009mm Sucrose, 5\u2009mm Tris/Hcl at ph 7.4, and 2\u2009mm egta) medium using a teflon dounce homogeniser.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rat'), ('UBERON_0002113', 'kidney', 4, 'Kidney'), ('GO_0005739', 'mitochondrion', 11, 'Mitochondrial'), ('UBERON_0002113', 'kidney', 40, 'kidneys'), ('CHEBI_17992', 'sucrose', 125, 'sucrose'), ('CHEBI_9754', 'tris', 139, 'Tris'), ('CHEBI_17883', 'hydrogen chloride', 144, 'HCl')]
PMC3321454	3/2012	S95-PMC3321454	['Tpmp binding correction was assumed to be 0.4\u2009 μ l/mg protein for Kidney [26].']	N/A	N/A	[('PR_000016585', 'tripeptidyl-peptidase 1', 0, 'TPMP'), ('UBERON_0002113', 'kidney', 66, 'kidney')]
PMC3321454	3/2012	S99-PMC3321454	['total rna was extracted from the Kidneys (experiment 1) using a trizol extraction (invitrogen, uk).']	N/A	N/A	[('UBERON_0002113', 'kidney', 33, 'kidneys')]
PMC3321454	3/2012	S116-PMC3321454	['Mitochondria are the primary source of Reactive Oxygen Species, so functional studies of Mitochondria isolated from Kidneys of control and protein-restricted offspring, were performed.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondria'), ('CHEBI_26523', 'reactive oxygen species', 39, 'reactive oxygen species'), ('GO_0005739', 'mitochondrion', 89, 'mitochondria'), ('UBERON_0002113', 'kidney', 116, 'kidneys')]
PMC3321454	3/2012	S117-PMC3321454	['as shown infigure 1, Mitochondrial Respiration in Kidneys from Adult Rats was reduced by maternal protein restriction.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 21, 'mitochondrial'), ('GO_0045333', 'cellular respiration', 35, 'respiration'), ('UBERON_0002113', 'kidney', 50, 'kidneys'), ('UBERON_0007023', 'adult organism', 63, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 69, 'rats')]
PMC3321454	3/2012	S119-PMC3321454	['the maximal Respiratory rate for the Renal Mitochondria was reduced by 17% in the lp group.']	N/A	N/A	[('GO_0045333', 'cellular respiration', 12, 'respiratory'), ('UBERON_0002113', 'kidney', 37, 'renal'), ('GO_0005739', 'mitochondrion', 43, 'mitochondria')]
PMC3356951	4/2012	S163-PMC3356951	['it becomes active by the Liver without needing to go through hydroxylation in the Kidneys.']	N/A	N/A	[('UBERON_0002107', 'liver', 25, 'liver'), ('UBERON_0002113', 'kidney', 82, 'kidneys')]
PMC3404653	3/2012	S165-PMC3404653	['cell culture experiments in Human Lung, Kidney, and Keratinocytes show that as increases methylation within the Promoter regions of the tumor suppressor Gene P53 , the noncanonical wnt Signaling Pathway and the death-Associated Protein Kinase ( dapk ) Gene, but reduces global Dna Methylation (chen et al.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 28, 'human'), ('UBERON_0002048', 'lung', 34, 'lung'), ('UBERON_0002113', 'kidney', 40, 'kidney'), ('CL_0000312', 'keratinocyte', 52, 'keratinocytes'), ('SO_0000167', 'promoter', 112, 'promoter'), ('SO_0000704', 'gene', 153, 'gene'), ('PR_000003035', 'cellular tumor antigen p53', 158, 'p53'), ('GO_0045500', 'sevenless signaling pathway', 185, 'signaling pathway'), ('PR_000004670', 'protein PTHB1', 216, '-associated protein kinase'), ('SO_0000704', 'gene', 252, 'gene'), ('GO_0006306', 'DNA methylation', 277, 'DNA methylation')]
PMC3407995	7/2012	S125-PMC3407995	['in a healthy non-Pregnant woman with adequate Iodine Intake, the absorbed dietary Iodine balances Renal Iodide clearance and the Thyroid maintains a normal Iodine store of 15–20 mg [69].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 17, 'pregnant'), ('CHEBI_24859', 'iodine atom', 46, 'iodine'), ('GO_0007631', 'feeding behavior', 53, 'intake'), ('CHEBI_24859', 'iodine atom', 82, 'iodine'), ('UBERON_0002113', 'kidney', 98, 'renal'), ('CHEBI_16382', 'iodide', 104, 'iodide'), ('UBERON_0002046', 'thyroid gland', 129, 'thyroid'), ('CHEBI_24859', 'iodine atom', 156, 'iodine')]
PMC3420688	5/2012	S36-PMC3420688	['Liver, Renal function, and Bilirubin were normal.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0002113', 'kidney', 7, 'renal'), ('CHEBI_16990', 'bilirubin IXalpha', 27, 'bilirubin'), ('UBERON_0004058', 'biliary ductule', 27, 'bilirubin')]
PMC3424155	8/2012	S2-PMC3424155	['functional and developmental Kidney measurements were taken.']	N/A	N/A	[('UBERON_0002113', 'kidney', 29, 'kidney')]
PMC3424155	8/2012	S52-PMC3424155	['Kidney stereology\nwe studied the f1 and f2 generations of both diet groups.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidney')]
PMC3424155	8/2012	S54-PMC3424155	['we studied Kidney stereology at Birth, 10 days and 6 months of age in each generation (n\u200a=\u200a6 for each group).']	N/A	N/A	[('UBERON_0002113', 'kidney', 11, 'kidney'), ('GO_0007567', 'parturition', 32, 'birth')]
PMC3424155	8/2012	S55-PMC3424155	['each Mouse was decapitated, and the Kidneys were rapidly removed and weighed.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 5, 'mouse'), ('UBERON_0002113', 'kidney', 36, 'kidneys')]
PMC3424155	8/2012	S56-PMC3424155	['briefly, the Left Kidneys were fixed in freshly prepared Fixative (1.27 m Formaldehyde in 0.1 m phosphate buffer, ph 7.2) for 48 h at room temperature, longitudinally divided into two halves, embedded face down in paraplast plus (sigma-aldrich, st louis, mo, usa), serially sectioned at a nominal thickness of 5 µm and stained with Hematoxylin and eosin.']	N/A	N/A	[('UBERON_0013698', 'strand of pubic hair', 13, 'left'), ('UBERON_0002113', 'kidney', 18, 'kidneys'), ('CHEBI_50913', 'fixative', 57, 'fixative'), ('CHEBI_16842', 'formaldehyde', 74, 'formaldehyde'), ('CHEBI_51686', 'haematoxylin', 332, 'hematoxylin')]
PMC3424155	8/2012	S63-PMC3424155	['the total number of Glomeruli per Kidney, adjusted to the entire Organ, was estimated from the analyzed fraction of the Kidney[17],[18].']	N/A	N/A	[('UBERON_0000074', 'renal glomerulus', 20, 'glomeruli'), ('UBERON_0002113', 'kidney', 34, 'kidney'), ('UBERON_0000062', 'organ', 65, 'organ'), ('UBERON_0002113', 'kidney', 120, 'kidney')]
PMC3424155	8/2012	S64-PMC3424155	['the “fraction” of the Kidney that we used to count Glomeruli considered the size of the Glomeruli.']	N/A	N/A	[('UBERON_0002113', 'kidney', 22, 'kidney'), ('UBERON_0000074', 'renal glomerulus', 51, 'glomeruli'), ('UBERON_0000074', 'renal glomerulus', 88, 'glomeruli')]
PMC3424155	8/2012	S95-PMC3424155	['Kidney structure\nKidney mass (km) and Glomerular diameter (gd) differed between the vitd- and sc offspring in both the f1 and f2 generations.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidney'), ('UBERON_0002113', 'kidney', 17, 'Kidney'), ('UBERON_0000074', 'renal glomerulus', 38, 'glomerular')]
PMC3424155	8/2012	S97-PMC3424155	["data are reported as means ± sem; p<0.05, one-way anova and post-hoc of tukey's test: † compared to sc counterpart; ‡ compared to f1 generation.10.1371/journal.pone.0041740.g005\n\ncaption (fig): figure 5\nphotomicrographs of the developing Kidneys of offspring at Birth."]	N/A	N/A	[('UBERON_0002113', 'kidney', 238, 'kidneys'), ('GO_0007567', 'parturition', 262, 'birth')]
PMC3424155	8/2012	S100-PMC3424155	['the mean Kidney mass (km; mean ± sem, n\u200a=\u200a6 Animals each group) varied from 8.2±0.2 mg for the f1-sc Mice to 10.3±0.4 mg for the f1-vitd- Mice ( p<0.05, t -test), with more than 25% variation between the groups ( p<0.0001).']	N/A	N/A	[('UBERON_0002113', 'kidney', 9, 'kidney'), ('NCBITaxon_33208', 'Metazoa', 44, 'animals'), ('NCBITaxon_10088', 'Mus <genus>', 101, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 138, 'mice')]
PMC3424155	8/2012	S107-PMC3424155	["data are reported as means ± sem; p<0.05, one-way anova and post-hoc of tukey's test: † compared to sc counterpart; ‡ compared to f1 generation.10.1371/journal.pone.0041740.g007\n\ncaption (fig): figure 7\nphotomicrographs of developing Kidneys from offspring at 10 days of age."]	N/A	N/A	[('UBERON_0002113', 'kidney', 234, 'kidneys')]
PMC3424155	8/2012	S141-PMC3424155	['Renin Expression (figure 8) and At1R Expression (figure 9)10.1371/journal.pone.0041740.g008\n\ncaption (fig): figure 8\nwestern blotting analysis of Renal Tissue at weaning and 6 months of age for Renin Expression.']	N/A	N/A	[('PR_000014370', 'RWD domain-containing protein 1', 0, 'Renin'), ('GO_0010467', 'gene expression', 6, 'expression'), ('PR_000029299', 'B-cell CLL/lymphoma 7 protein family member A', 32, 'AT1r'), ('GO_0010467', 'gene expression', 37, 'expression'), ('UBERON_0002113', 'kidney', 146, 'renal'), ('UBERON_0000479', 'tissue', 152, 'tissue'), ('PR_000014368', 'RuvB-like 1', 194, 'renin'), ('GO_0010467', 'gene expression', 200, 'expression')]
PMC3424155	8/2012	S143-PMC3424155	["data are reported as means ± sem; p<0.05, one-way anova and post-hoc of tukey's test: † compared to sc counterpart; ‡ compared to f1 generation.10.1371/journal.pone.0041740.g009\n\ncaption (fig): figure 9\nwestern blotting analysis of Renal Tissue at weaning and 6 months of age for At1 Receptor Expression."]	N/A	N/A	[('UBERON_0002113', 'kidney', 232, 'renal'), ('UBERON_0000479', 'tissue', 238, 'tissue'), ('PR_000004455', 'ATP synthase subunit gamma, mitochondrial', 280, 'AT1 receptor'), ('GO_0010467', 'gene expression', 293, 'expression')]
PMC3424155	8/2012	S153-PMC3424155	['Podocin Expression (figure 10)10.1371/journal.pone.0041740.g010\n\ncaption (fig): figure 10\nwestern blotting analysis of Renal Tissue at weaning and 6 months of age for Podocin Expression.']	N/A	N/A	[('PR_000001245', 'rhodopsin', 0, 'Podocin'), ('GO_0010467', 'gene expression', 8, 'expression'), ('UBERON_0002113', 'kidney', 119, 'renal'), ('UBERON_0000479', 'tissue', 125, 'tissue'), ('PR_000012775', 'polycystic kidney disease 2-like 2 protein', 167, 'podocin'), ('GO_0010467', 'gene expression', 175, 'expression')]
PMC3424155	8/2012	S160-PMC3424155	['Wt1 Expression (figure 11)10.1371/journal.pone.0041740.g011\n\ncaption (fig): figure 11\nwestern blotting analysis of Renal Tissue at Birth for Wt1 Expression.']	N/A	N/A	[('PR_000017450', 'protein Wnt-8a', 0, 'WT1'), ('GO_0010467', 'gene expression', 4, 'expression'), ('UBERON_0002113', 'kidney', 115, 'renal'), ('UBERON_0000479', 'tissue', 121, 'tissue'), ('GO_0007567', 'parturition', 131, 'birth'), ('PR_000017450', 'protein Wnt-8a', 141, 'WT1'), ('GO_0010467', 'gene expression', 145, 'expression')]
PMC3424155	8/2012	S187-PMC3424155	['in the present study, no significant reduction in the Expression of Wt1 in the Kidneys at Birth was observed in either the f1 or f2 generation.']	N/A	N/A	[('GO_0010467', 'gene expression', 54, 'expression'), ('PR_000017450', 'protein Wnt-8a', 68, 'WT1'), ('UBERON_0002113', 'kidney', 79, 'kidneys'), ('GO_0007567', 'parturition', 90, 'birth')]
PMC3424155	8/2012	S194-PMC3424155	['after Kidney damage occurs, chronic Renal disease progresses through a cycle that passes the damage from lost or damaged Nephrons to healthy Nephrons.']	N/A	N/A	[('UBERON_0002113', 'kidney', 6, 'kidney'), ('UBERON_0002113', 'kidney', 36, 'renal'), ('UBERON_0001285', 'nephron', 121, 'nephrons'), ('UBERON_0001285', 'nephron', 141, 'nephrons')]
PMC3426771	1/2012	S85-PMC3426771	['Feeding a low protein diet during Rat Pregnancy, particularly during the later stages of Gestation, results in a Kidney of normal size but with a reduced (up to 30%) complement of Nephrons.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 0, 'Feeding'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 34, 'rat'), ('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('GO_0007565', 'female pregnancy', 89, 'gestation'), ('UBERON_0002113', 'kidney', 113, 'kidney'), ('UBERON_0001285', 'nephron', 180, 'nephrons')]
PMC3426771	1/2012	S97-PMC3426771	['the Kidney Secretes the enzyme Renin, which cleaves the Liver produced angiotensinogen to produce angiotensin i (ang i).']	N/A	N/A	[('UBERON_0002113', 'kidney', 4, 'kidney'), ('GO_0046903', 'secretion', 11, 'secretes'), ('PR_000014368', 'RuvB-like 1', 31, 'renin'), ('UBERON_0002107', 'liver', 56, 'liver')]
PMC3427250	8/2012	S23-PMC3427250	['25-(Oh)D is then Metabolized in the Kidney by the 1-α hydroxylase to the active Steroid Hormone 1,25-Dihydroxyvitamin D [1,25-(Oh)2D].']	N/A	N/A	[('CHEBI_72657', '19,20-DiHDPA', 0, '25-(OH)D'), ('GO_0008152', 'metabolic process', 17, 'metabolized'), ('UBERON_0002113', 'kidney', 36, 'kidney'), ('CHEBI_26764', 'steroid hormone', 80, 'steroid hormone'), ('CHEBI_67472', '15-epi-lupulin B', 96, '1,25-dihydroxyvitamin D'), ('CHEBI_72613', '16-HDoHE', 123, '25-(OH)2D')]
PMC3427250	8/2012	S25-PMC3427250	['the Expression of 1-α hydroxylase is increased in the Kidney and Placenta and the concentration of Serum 1,25-(Oh)2D increases in normal pregnancy from the first to the third trimester.']	N/A	N/A	[('GO_0010467', 'gene expression', 4, 'expression'), ('UBERON_0002113', 'kidney', 54, 'kidney'), ('UBERON_0001987', 'placenta', 65, 'placenta'), ('UBERON_0001977', 'blood serum', 99, 'serum'), ('CHEBI_63216', '5(S),8(R)-DiHODE', 105, '1,25-(OH)2D')]
PMC3436706	2/2011	S78-PMC3436706	['these include Cardiac, Skeletal, Renal, skin and Genital malformations.']	N/A	N/A	[('UBERON_0000948', 'heart', 14, 'cardiac'), ('UBERON_0004288', 'skeleton', 23, 'skeletal'), ('UBERON_0002113', 'kidney', 33, 'renal'), ('UBERON_3011048', 'genital system', 49, 'genital')]
PMC3458940	9/2012	S124-PMC3458940	['Expression of the validated Genes in native Tissues was determined using two geo series deemed relevant to mimcd-3 cells: (i) e11.5 Mouse ubs and e15.5 Mouse Medullary Cd Cells (geo accession: gse6290), contributed by Genitourinary development molecular anatomy project (gudmap) (http://www.gudmap.org/), and (ii) inner Medullary cd Cells derived from 6- and 10-week-old Rat Kidney (geo accession: gse7891), contributed by uawithya et al[28].']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('SO_0000704', 'gene', 28, 'genes'), ('UBERON_0000479', 'tissue', 44, 'tissues'), ('NCBITaxon_10088', 'Mus <genus>', 132, 'mouse'), ('NCBITaxon_10088', 'Mus <genus>', 152, 'mouse'), ('CL_0002365', 'medullary thymic epithelial cell', 158, 'medullary CD cells'), ('UBERON_0000958', 'medulla of organ', 158, 'medullary'), ('UBERON_0003124', 'chorion', 218, 'GenitoUrinary'), ('UBERON_0000958', 'medulla of organ', 320, 'medullary'), ('CL_0002200', 'oxyphil cell of thyroid', 333, '... cells'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 371, 'rat'), ('UBERON_0002113', 'kidney', 375, 'kidney')]
PMC3465343	10/2012	S17-PMC3465343	['congenital Heart disease and Kidney defect)[2],[3].']	N/A	N/A	[('UBERON_0000948', 'heart', 11, 'heart'), ('UBERON_0002113', 'kidney', 29, 'kidney')]
PMC3465343	10/2012	S35-PMC3465343	['abnormalities at lower penetrance were noted in other Systems including the Genitourinary Tract, Kidney, Diaphrapm, Lung, Aortic Arch, and Heart.']	N/A	N/A	[('UBERON_0000467', 'anatomical system', 54, 'systems'), ('UBERON_0022262', 'auditory radiation', 76, 'genitourinary tract'), ('UBERON_0002113', 'kidney', 97, 'kidney'), ('UBERON_0001103', 'diaphragm', 105, 'diaphrapm'), ('UBERON_0002048', 'lung', 116, 'lung'), ('UBERON_0001508', 'arch of aorta', 122, 'aortic arch'), ('UBERON_0000948', 'heart', 139, 'heart')]
PMC3465343	10/2012	S122-PMC3465343	['Spinal Cord, Heart, Lung, Kidney, etc.)[3].']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 0, 'spinal cord'), ('UBERON_0000948', 'heart', 13, 'heart'), ('UBERON_0002048', 'lung', 20, 'lung'), ('UBERON_0002113', 'kidney', 26, 'kidney')]
PMC3470091	9/2012	S13-PMC3470091	['trial registration number: irct138902113840n1\n\nintroduction\nVitamin D is a Secosteroid, which is Metabolized in Liver and Kidney.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 60, 'Vitamin D'), ('CHEBI_35785', 'sphingoid', 75, 'secosteroid'), ('GO_0008152', 'metabolic process', 97, 'metabolized'), ('UBERON_0002107', 'liver', 112, 'liver'), ('UBERON_0002113', 'kidney', 122, 'kidney')]
PMC3470091	9/2012	S28-PMC3470091	['the patients had gdm if 50 g resulted in a Glucose Serum concentration of 7.2 mmol/lit, and if 100 g gtt test was disturbed on the basis of carpenter and coustan criteria.25the study inclusion criteria were the absence of Thyroid, Kidney and Liver diseases as well as malabsorption.']	N/A	N/A	[('CHEBI_17234', 'glucose', 43, 'glucose'), ('UBERON_0001977', 'blood serum', 51, 'serum'), ('UBERON_0002046', 'thyroid gland', 222, 'thyroid'), ('UBERON_0002113', 'kidney', 231, 'kidney'), ('UBERON_0002107', 'liver', 242, 'liver')]
PMC3476426	8/2012	S15-PMC3476426	['the fully active form 1, 25 Dihydroxy Vitamin D3, is synthesized in the Kidneys by the 25-Hydroxy Vitamin D-1A hydroxylase, an enzyme which is mainly induced by the Parathyroid hormone (pth).']	N/A	N/A	[('CHEBI_50341', '1-hydroxyethyl group', 22, '1, 25 dihydroxy'), ('CHEBI_33279', 'vitamin D5', 38, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 38, 'vitamin D3'), ('UBERON_0002113', 'kidney', 72, 'kidneys'), ('CHEBI_43141', '3-hydroxypropoxy group', 87, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('PR_000017255', 'Vang-like protein 1', 98, 'vitamin D-1a'), ('UBERON_0001132', 'parathyroid gland', 165, 'parathyroid')]
PMC3518064	11/2012	S62-PMC3518064	['for example, Lambs are Born with almost 100% Bat [52,53], with majority of this Adipose Tissue located around the Kidneys [33,34].']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 13, 'lambs'), ('GO_0007567', 'parturition', 23, 'born'), ('UBERON_0001348', 'brown adipose tissue', 45, 'BAT'), ('UBERON_0001013', 'adipose tissue', 80, 'adipose tissue'), ('UBERON_0002113', 'kidney', 114, 'kidneys')]
PMC3527219	11/2012	S22-PMC3527219	['for example, a low protein diet in Rodent Pregnancy has induced high Blood pressure and Renal dysfunction in the offspring [25], and Prenatal high dietary protein exposure resulted in increased adiposity in young Rats [26].']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 35, 'rodent'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('UBERON_0000178', 'blood', 69, 'blood'), ('UBERON_0002113', 'kidney', 88, 'renal'), ('GO_0007565', 'female pregnancy', 133, 'prenatal'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 213, 'rats')]
PMC3538633	1/2013	S107-PMC3538633	['there were no effects of maternal diet or pre-weaning gh treatment on Adult body lengths, Kidney or Adrenal weights (data not shown).']	N/A	N/A	[('UBERON_0007023', 'adult organism', 70, 'adult'), ('UBERON_0002113', 'kidney', 90, 'kidney'), ('UBERON_0002369', 'adrenal gland', 100, 'adrenal')]
PMC3556301	1/2013	S23-PMC3556301	['Left Ventricular hypertrophy, Carotid Artery abnormalities and reduced Renal function.']	N/A	N/A	[('UBERON_0002084', 'heart left ventricle', 0, 'left ventricular'), ('UBERON_0005396', 'carotid artery segment', 30, 'carotid artery'), ('UBERON_0002113', 'kidney', 71, 'renal')]
PMC3575022	2/2013	S9-PMC3575022	['Renal Tissue noradrenaline (na) content was markedly raised in the Osf vs. oc (na [pg/ml/mg Tissue] mean ± sem, male Osf, 2.28 ± 0.19 vs. oc 0.84 ± 0.09, n = 6, p< 0.01).']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Renal'), ('UBERON_0000479', 'tissue', 6, 'tissue'), ('UBERON_0008832', 'outer spiral sulcus', 67, 'OSF'), ('UBERON_0000479', 'tissue', 92, 'tissue'), ('UBERON_0008832', 'outer spiral sulcus', 117, 'OSF')]
PMC3575022	2/2013	S59-PMC3575022	['Renal noradrenaline analysis\nAnimals were humanely killed at 3 months of age.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Renal'), ('NCBITaxon_33208', 'Metazoa', 29, 'Animals')]
PMC3575022	2/2013	S61-PMC3575022	['whole Kidneys were then homogenized in 0.01 m Hcl in the presence of edta (1 mm) and Sodium Metabisulfite (4 mm).']	N/A	N/A	[('UBERON_0002113', 'kidney', 6, 'kidneys'), ('CHEBI_17883', 'hydrogen chloride', 46, 'HCl'), ('CHEBI_86477', 'sodium sulfite', 85, 'sodium metabisulfite')]
PMC3575022	2/2013	S64-PMC3575022	['na content was expressed as pg/ml/mg Renal Tissue weight.']	N/A	N/A	[('UBERON_0002113', 'kidney', 37, 'renal'), ('UBERON_0000479', 'tissue', 43, 'tissue')]
PMC3575022	2/2013	S106-PMC3575022	['caption (table-wrap): table 2\n\nbody weight (bw), Inguinal Fat Pad mass, Heart, Liver, and muscle weights (Tibialis Anterior) of 3 months old offspring of control and high Sucrose Fed dams ( n = 6–8 per group) .sex/groupbody weight (g)Fat Pad weight (mg/g bw)Heart weight (mg/g bw)Liver weight(mg/g bw)Muscle weight (mg/g bw)Kidney weight(mg/g bw)male oc23.2 ± 0.412.7 ± 0.87.1 ± 0.338.9 ± 1.76.5 ± 0.217.4 ± 0.8osf24.9 ± 0.712.4 ± 1.87.2 ± 0.439.7 ± 2.65.7 ± 0.516.9 ± 0.9 female oc20.8 ± 0.411.7 ± 0.97.2 ± 0.237.4 ± 0.86.3 ± 0.215.4 ± 0.7osf22.2 ± 0.1*15.1 ± 0.7*8.3 ± 0.3*40.5 ± 1.0*5.1 ± 0.2†9.8 ± 0.6$\np < 0.05;\np < 0.01;\np < 0.001 vs. offspring of control dams (two-tailed t-test).']	N/A	N/A	[('UBERON_0010410', 'inguinal fat pad', 49, 'Inguinal fat pad'), ('UBERON_0000948', 'heart', 72, 'heart'), ('UBERON_0002107', 'liver', 79, 'liver'), ('UBERON_0001385', 'tibialis anterior', 106, 'tibialis anterior'), ('CHEBI_17992', 'sucrose', 171, 'sucrose'), ('GO_0007631', 'feeding behavior', 179, 'fed'), ('UBERON_0003123', 'pharyngeal arch artery 6', 234, 'Fat pad'), ('UBERON_0000948', 'heart', 258, 'Heart'), ('UBERON_0002107', 'liver', 280, 'Liver'), ('UBERON_0001015', 'musculature', 301, 'Muscle'), ('UBERON_0002113', 'kidney', 324, 'Kidney')]
PMC3575022	2/2013	S123-PMC3575022	['Tissue noradrenaline\nthe Renal na concentration was significantly increased in the osf male and female offspring compared with controls, at 3 months of age (figure5).']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissue'), ('UBERON_0002113', 'kidney', 25, 'renal')]
PMC3575022	2/2013	S125-PMC3575022	['caption (fig): figure 5\n\nRenal Noradrenaline (Na) concentrations (pg/ml per mg Kidney weight) in 3 month old male and female offspring of control (oc, open symbols) and Sucrose Fed dams (osf, closed symbols).†p< 0.01,$p< 0.001 vs. control, two-way anova (diet × sex), n = 6–8 per group, kw, Kidney weight.']	N/A	N/A	[('UBERON_0002113', 'kidney', 25, 'Renal'), ('CHEBI_7621', 'norajmaline', 31, 'Noradrenaline'), ('CHEBI_30362', 'isopentane', 46, 'null'), ('UBERON_0002113', 'kidney', 79, 'kidney'), ('CHEBI_17992', 'sucrose', 169, 'sucrose'), ('GO_0007631', 'feeding behavior', 177, 'fed'), ('UBERON_0002113', 'kidney', 291, 'kidney')]
PMC3586494	2/2013	S264-PMC3586494	['these Animals also had proteinuria, higher Lipid Peroxidation end products, and evidence of increased Renal Apoptosis and fibrosis [114,115].']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 6, 'animals'), ('CHEBI_18059', 'lipid', 43, 'lipid'), ('GO_0032622', 'interleukin-19 production', 43, 'lipid peroxidation'), ('UBERON_0002113', 'kidney', 102, 'renal'), ('GO_0006915', 'apoptotic process', 108, 'apoptosis')]
PMC3600625	2/2013	S7-PMC3600625	['no association was observed between early Arsenic or cadmium exposure and Kidney volume at 4.5 years assessed by ultrasound.']	N/A	N/A	[('CHEBI_27563', 'arsenic atom', 42, 'arsenic'), ('UBERON_0002113', 'kidney', 74, 'kidney')]
PMC3600625	2/2013	S35-PMC3600625	['Kidney function was assessed by calculation of Glomerular filtration rate (gfr) estimated from Plasma cystatin C (cysc), analysed from stored frozen samples using the immunoturbidimetric analysis,27in uppsala university hospital, sweden.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidney'), ('UBERON_0000074', 'renal glomerulus', 47, 'glomerular'), ('UBERON_0001969', 'blood plasma', 95, 'plasma'), ('CHEBI_18245', 'carboxylato group', 111, 'C'), ('PR_000004900', 'complement C3', 111, 'C')]
PMC3600625	2/2013	S56-PMC3600625	['there were no marked differences in available characteristics between Individuals who were lost to follow-up and those who were recruited into the current study, or between the different sub-samples of Kidney function assessment (table 1).']	N/A	N/A	[('NCBITaxon_1', 'root', 70, 'individuals'), ('UBERON_0002113', 'kidney', 202, 'kidney')]
PMC3600625	2/2013	S63-PMC3600625	['u-as 18 months refers to child Urinary Arsenic measurements at 18 months of age\n\ncaption (table-wrap): table 1\n\ncharacteristics of study cohortlost to follow-uparecruited into 4.5 y follow-upblood pressure samplegfr samplekidney volume samplenmean (sd)bnmean (sd)bnmean (sd)bnmean (sd)bmaternal characteristics\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003age (y)76826.1 (5.8)249926.6 (6.0)133426.7 (6.0)114526.6 (6.0)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003wealth indexc7250.63 (−1.76, 2.00)23860.38 (−1.65, 1.80)13320.10 (−1.93, 1.74)10380.68 (−1.26, 1.91)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003early Pregnancy (week 8) bmi (kg/m2)76720.2 (2.7)249020.1 (2.7)132819.9 (2.6)114220.3 (2.8)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Maternal Urinary Arsenic (µg/l) week 8 gest−−169280.5 (38, 208)117885 (38, 216)67570 (37, 182)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003week 30 gest−−178082.5 (42, 228)128382 (41, 228)66183 (44, 243)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003maternal Urinary cadmium(µg/l) week 8 gest−−12800.63 (0.38, 1.0)11590.63 (0.38, 1.01)2800.63 (0.41, 1.06)children characteristics,\u2003infancy\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Gestational age (weeks)76839.1 (1.9)249939.2 (1.6)133439.2 (1.7)114539.2 (1.6)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Birth weight (kg)7682.67 (0.45)24982.70 (0.40)13332.69 (0.40)11452.73 (0.40)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Birth length (cm)76748.0 (4.9)249747.86 (2.39)133248.0 (2.54)114547.74 (2.14)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Breastfeeding pattern at 4 monthsd67354.7% exclusive, 33.1% predominant248459.7% exclusive, 28.3% predominant132860.8% exclusive, 27.7% predominant113658.3% exclusive, 30.2% predominant\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Urinary Arsenic at 18 months (µg/l)−−181633.9 (18.2, 77.4)127533.6 (18.1, 76.5)70133.4 (17.9, 73.6)\u20034.5 y follow-up\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003age (y)−−24994.6 (0.14)13344.5 (0.14)11454.6 (0.10)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003male (%)−−249951.6%133452.7%114550.9%\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003height (cm)−−249999.8 (4.3)133399.6 (4.7)114599.8 (4.1)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003weight (kg)−−249913.76 (1.66)133413.67 (1.62)114513.81 (1.63)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003impedance indexe−−22660.13 (0.01)12100.13 (0.01)10260.13 (0.01)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003systolic Blood pressure (mmhg)−−249991.4 (7.6)132191.3 (7.9)113691.7 (7.5)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003diastolic Blood pressure (mmhg)−−249954.4 (6.5)132154.2 (6.8)113654.8 (6.1)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Glomerular filtration ratef(ml/min/1.73 m2)−−1321158.3 (35.2)1334158.2 (35.2)150164.0 (35.1)\u2003\u2003\u2003\u2003\u2003\u2003\u2003\u2003Kidney volume (cm3/m2)g−−1136103.7 (15.5)150104.7 (15.1)1145103.8 (15.5)\nabbreviations: gfr, Glomerular filtration rate; bmi, body mass index.']	N/A	N/A	[('UBERON_0001088', 'urine', 31, 'urinary'), ('CHEBI_27563', 'arsenic atom', 39, 'arsenic'), ('GO_0007565', 'female pregnancy', 502, 'pregnancy'), ('UBERON_0000976', 'humerus', 595, 'Maternal'), ('UBERON_0001088', 'urine', 604, 'urinary'), ('CHEBI_27563', 'arsenic atom', 612, 'arsenic'), ('UBERON_0001088', 'urine', 777, 'urinary'), ('GO_0007565', 'female pregnancy', 914, 'Gestational'), ('GO_0007567', 'parturition', 1000, 'Birth'), ('GO_0007567', 'parturition', 1084, 'Birth'), ('UBERON_0000165', 'mouth', 1169, 'Breastfeeding'), ('UBERON_0001088', 'urine', 1362, 'Urinary'), ('CHEBI_27563', 'arsenic atom', 1370, 'arsenic'), ('UBERON_0000178', 'blood', 1801, 'blood'), ('UBERON_0000178', 'blood', 1884, 'blood'), ('UBERON_0000074', 'renal glomerulus', 1957, 'Glomerular'), ('UBERON_0002113', 'kidney', 2057, 'Kidney'), ('UBERON_0000074', 'renal glomerulus', 2150, 'glomerular')]
PMC3600625	2/2013	S69-PMC3600625	['fglomerular filtration rate calculated from Plasma Cystatin C using prediction equations.28\ngaverage Kidney volume from Right and Left Kidney adjusted for body surface area.29\nPregnant women participating in the minimat trial were on average 26 years of age with a median parity of 1 (range: 0, 10).']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 44, 'plasma'), ('PR_000006022', 'lysosomal protective protein', 51, 'cystatin C'), ('CHEBI_18245', 'carboxylato group', 60, 'C'), ('UBERON_0002113', 'kidney', 101, 'kidney'), ('UBERON_0002078', 'right cardiac atrium', 120, 'right ...'), ('UBERON_0004538', 'left kidney', 130, 'left kidney'), ('GO_0007565', 'female pregnancy', 176, 'Pregnant')]
PMC3600625	2/2013	S81-PMC3600625	['mean Kidney volume adjusted for body surface area was 103.8 ± 15.5 cm3/m2for boys and 104.0 ± 15.9 cm3/m2for girls.']	N/A	N/A	[('UBERON_0002113', 'kidney', 5, 'kidney')]
PMC3600625	2/2013	S95-PMC3600625	['similarly there was no interaction between child sex, parental wealth index, maternal early Pregnancy (week 8) bmi or maternal Blood pressure and the effect of u-as and u-cd on Blood pressure or Kidney function at 4.5 years (data not shown).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 92, 'pregnancy'), ('UBERON_0000178', 'blood', 127, 'blood'), ('UBERON_0000178', 'blood', 177, 'blood'), ('UBERON_0002113', 'kidney', 195, 'kidney')]
PMC3600625	2/2013	S128-PMC3600625	['Kidney volume was not affected by Arsenic or cadmium exposure in this study.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidney'), ('CHEBI_27563', 'arsenic atom', 34, 'arsenic')]
PMC3614838	9/2011	S19-PMC3614838	['Glucose Transporter 2 (Glut2) and glucokinase (gk) represent Glucose sensors that are functional in the Liver, Pancreatic Beta Cells, Kidneys and Brain.']	N/A	N/A	[('CHEBI_17234', 'glucose', 0, 'Glucose'), ('PR_000015060', 'solute carrier family 2, facilitated glucose transporter member 11', 0, 'Glucose transporter 2'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 23, 'GLUT2'), ('CHEBI_17234', 'glucose', 61, 'glucose'), ('UBERON_0002107', 'liver', 104, 'liver'), ('CL_0000169', 'type B pancreatic cell', 111, 'pancreatic beta cells'), ('UBERON_0001264', 'pancreas', 111, 'pancreatic'), ('UBERON_0002113', 'kidney', 134, 'kidneys'), ('UBERON_0000955', 'brain', 146, 'brain')]
PMC3615950	3/2013	S219-PMC3615950	['in children hypertension due to Renal causes (chronic Kidney disease or renovascular hypertension) and Aortic coarctation accounts for 70 to 90% of the secondary forms [68,69].']	N/A	N/A	[('UBERON_0002113', 'kidney', 32, 'renal'), ('UBERON_0002113', 'kidney', 54, 'kidney'), ('UBERON_0000947', 'aorta', 103, 'aortic')]
PMC3615950	3/2013	S275-PMC3615950	['in subjects with preserved Renal function the Blood pressure lowering efficacy is practically identical for renin-angiotensin-Aldosterone system Blockers, beta-Blockers, Calcium Antagonists and Diuretics.']	N/A	N/A	[('UBERON_0002113', 'kidney', 27, 'renal'), ('UBERON_0000178', 'blood', 46, 'blood'), ('CHEBI_27584', 'aldosterone', 126, 'aldosterone'), ('CHEBI_35225', 'buffer', 145, 'blockers'), ('CHEBI_35225', 'buffer', 160, 'blockers'), ('CHEBI_38808', 'calcium channel modulator', 170, 'calcium antagonists'), ('CHEBI_35498', 'diuretic', 194, 'diuretics')]
PMC3622346	3/2013	S117-PMC3622346	['Nifedipine improves Renal Blood flow which resulted in diuresis.']	N/A	N/A	[('CHEBI_7575', 'nimodipine', 0, 'Nifedipine'), ('UBERON_0002113', 'kidney', 20, 'renal'), ('UBERON_0000178', 'blood', 26, 'blood')]
PMC3641012	4/2013	S79-PMC3641012	['participants with screen-positive Urine ca:cr as defined by one of the above three criteria were also referred for Renal ultrasound to rule-out the presence of nephrocalcinosis or Urinary Tract calculi.']	N/A	N/A	[('UBERON_0001088', 'urine', 34, 'urine'), ('UBERON_0002113', 'kidney', 115, 'renal'), ('UBERON_0001553', 'medial tarsal artery', 180, 'urinary tract')]
PMC3657451	4/2013	S83-PMC3657451	['Pregnancy causes increased Thyroid Gland vascularity, increased Renal Iodide clearance, and Iodide losses to the foetus [1].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('UBERON_0002046', 'thyroid gland', 27, 'thyroid gland'), ('UBERON_0002113', 'kidney', 64, 'renal'), ('CHEBI_16382', 'iodide', 70, 'iodide'), ('CHEBI_16382', 'iodide', 92, 'iodide')]
PMC3659910	1/2013	S53-PMC3659910	['synthesis of 1,25(Oh) 2Din the Kidney increases during Pregnancy.']	N/A	N/A	[('CHEBI_37958', 'dye', 13, '1,'), ('CHEBI_77851', '(2S)-2-ammonio-3-oxo-4-(phosphonatooxy)butanoate(2-)', 15, '25(OH) 2Din'), ('UBERON_0002113', 'kidney', 31, 'kidney'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy')]
PMC3668200	5/2013	S7-PMC3668200	['in the Kidney, 25(Oh)D, the nutritional indicator of Vitamin D, is hydroxylated into 1,25-Dihydroxyvitamin D (1,25-Oh2-d).']	N/A	N/A	[('UBERON_0002113', 'kidney', 7, 'kidney'), ('CHEBI_71657', 'versiconol acetate', 15, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_67472', '15-epi-lupulin B', 85, '1,25-dihydroxyvitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 115, 'OH2')]
PMC3672018	5/2013	S22-PMC3672018	['7-Dehydro-Cholesterol is converted to Cholecalciferol (Vitamin D3) which is then, in Kidneys, modified further to form the active Vitamin binding to vdr.']	N/A	N/A	[('CHEBI_17500', '7alpha-hydroxycholesterol', 0, '7-dehydro-cholesterol'), ('CHEBI_52550', 'theopalauamide', 38, 'cholecalciferol'), ('CHEBI_33279', 'vitamin D5', 55, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 55, 'vitamin D3'), ('UBERON_0002113', 'kidney', 85, 'kidneys'), ('CHEBI_33229', 'vitamin (role)', 130, 'vitamin')]
PMC3685533	6/2013	S46-PMC3685533	['exclusion criteria were the presence of any organic diseases in particular Neurological, Endocrine, Liver and Kidney abnormalities in the mother or in the newborns.']	N/A	N/A	[('UBERON_0001016', 'nervous system', 75, 'neurological'), ('GO_0006397', 'mRNA processing', 89, 'endocrine'), ('UBERON_0002049', 'vasculature', 89, 'endocrine'), ('UBERON_0002107', 'liver', 100, 'liver'), ('UBERON_0002113', 'kidney', 110, 'kidney')]
PMC3691177	6/2013	S31-PMC3691177	['exclusion criteria were known sarcoidosis, osteomalacia, Renal dysfunction or tuberculosis.']	N/A	N/A	[('UBERON_0002113', 'kidney', 57, 'renal')]
PMC3702339	6/2013	S127-PMC3702339	['in the reference period, 549 (78.4%), 369 (52.7%), and 366 (52.2%) Consumed roots and tubers (mainly enset), cereals (mainly Maize), and Legumes (mainly broad Bean and Kidney bean) respectively.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 67, 'consumed'), ('NCBITaxon_40674', 'Mammalia', 125, 'maize'), ('NCBITaxon_7955', 'Danio rerio', 137, 'legumes'), ('NCBITaxon_33208', 'Metazoa', 159, 'bean'), ('UBERON_0002113', 'kidney', 168, 'kidney')]
PMC3717170	5/2013	S101-PMC3717170	['today, in addition to Lung function impairment, copd is recognized as a systemic disease with multiple comorbidities, such as osteoporosis, Cardiovascular disease, Renal impairment, and psychological disorders.']	N/A	N/A	[('UBERON_0002048', 'lung', 22, 'lung'), ('UBERON_0004535', 'cardiovascular system', 140, 'cardiovascular'), ('UBERON_0002113', 'kidney', 164, 'renal')]
PMC3717170	5/2013	S118-PMC3717170	['among patients with end-stage Renal disease (esrd) on hemodialysis, 25(Oh)D3Deficiency is common, reported at greater than 80%.32esrd patients are commonly treated with 1,25(Oh)2D3For prevention of secondary hyperparathyroidism and bone loss.']	N/A	N/A	[('UBERON_0002113', 'kidney', 30, 'renal'), ('CHEBI_59934', 'tripyrrane', 68, '25(OH)D3deficiency'), ('PR_000001880', 'low affinity immunoglobulin epsilon Fc receptor', 68, '25 ... OH ... D3deficiency'), ('CHEBI_86922', 'Pinoresinol biphenyl', 169, '1,25(OH)2D3for')]
PMC3720837	7/2013	S71-PMC3720837	['the total weight of the foetus and the weights of the Head, Trunk and main Organs (Brain, Heart, Liver, Intestine and Kidneys) were also assessed.']	N/A	N/A	[('UBERON_0000033', 'head', 54, 'head'), ('UBERON_0002100', 'trunk', 60, 'trunk'), ('UBERON_0000062', 'organ', 75, 'organs'), ('UBERON_0000955', 'brain', 83, 'brain'), ('UBERON_0000948', 'heart', 90, 'heart'), ('UBERON_0002107', 'liver', 97, 'liver'), ('UBERON_0000160', 'intestine', 104, 'intestine'), ('UBERON_0002113', 'kidney', 118, 'kidneys')]
PMC3720837	7/2013	S72-PMC3720837	['afterwards, the following weight ratios were considered: weight of the Uterus relative to the Individual and total foetal weight, weight of the foetal Head relative to total weight and Trunk weight and Brain weight relative to the weight of total Viscera, Heart, Liver, Kidneys and Intestine.']	N/A	N/A	[('UBERON_0000995', 'uterus', 71, 'uterus'), ('NCBITaxon_1', 'root', 94, 'individual'), ('UBERON_0000033', 'head', 151, 'head'), ('UBERON_0002100', 'trunk', 185, 'trunk'), ('UBERON_0000955', 'brain', 202, 'brain'), ('UBERON_0002075', 'viscus', 247, 'viscera'), ('UBERON_0000948', 'heart', 256, 'heart'), ('UBERON_0002107', 'liver', 263, 'liver'), ('UBERON_0002113', 'kidney', 270, 'kidneys'), ('UBERON_0000160', 'intestine', 282, 'intestine')]
PMC3749995	8/2013	S4-PMC3749995	['increased Extracellular Salt impeded Murine Kidney Development in vitro , but had little effect in vivo .']	N/A	N/A	[('GO_0005576', 'extracellular region', 10, 'extracellular'), ('CHEBI_24866', 'salt', 24, 'salt'), ('NCBITaxon_39107', 'Murinae', 37, 'murine'), ('GO_0001822', 'kidney development', 44, 'kidney development'), ('UBERON_0002113', 'kidney', 44, 'kidney')]
PMC3749995	8/2013	S35-PMC3749995	['that under conditions of normal dietary Salt, increased Renal Sodium retention could not explain hypernatraemia in both male and female offspring of Salt-loaded dams and hypertension in male offspring only) a further cohort was established in which we repeated our analyses of Renal function in the offspring (at 8 weeks of age) but also conducted a preliminary analysis of Gastrointestinal electrolyte handling and Faecal characteristics in the male and female offspring at this time.']	N/A	N/A	[('CHEBI_24866', 'salt', 40, 'salt'), ('UBERON_0002113', 'kidney', 56, 'renal'), ('CHEBI_52632', 'potassium-39 atom', 62, 'sodium'), ('CHEBI_24866', 'salt', 149, 'salt'), ('UBERON_0002113', 'kidney', 277, 'renal'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 374, 'gastrointestinal'), ('UBERON_0001988', 'feces', 416, 'faecal')]
PMC3749995	8/2013	S50-PMC3749995	['experimental procedures-offspring\nafter weaning and between 8–12 weeks of age, two siblings from each litter (one male, one female) were entered into one of four protocols:\nbaseline Renal function at 8 and 12 weeks of age.']	N/A	N/A	[('UBERON_0002113', 'kidney', 182, 'renal')]
PMC3749995	8/2013	S51-PMC3749995	['baseline Renal function was established in two cohorts of offspring at 8 and 12 weeks of age (control diet, male [n\u200a=\u200a6] female [n\u200a=\u200a5]; 4% Nacl, male [n\u200a=\u200a5] female [n\u200a=\u200a5]) by 24 h Urine collection in a Metabolic crate (after 24 h acclimatisation to the environment) with a paired Blood sample collected at 24 h.\nSalt-stimulated Renal function at 12 weeks of age.']	N/A	N/A	[('UBERON_0002113', 'kidney', 9, 'renal'), ('CHEBI_26710', 'sodium chloride', 140, 'NaCl'), ('UBERON_0001088', 'urine', 183, 'urine'), ('GO_0008152', 'metabolic process', 205, 'metabolic'), ('UBERON_0000178', 'blood', 283, 'blood'), ('CHEBI_17418', 'valeric acid', 315, 'Salt'), ('UBERON_0002113', 'kidney', 331, 'renal')]
PMC3749995	8/2013	S52-PMC3749995	['in a separate cohort, Salt-stimulated Renal function was established in 12 week old offspring (control diet, male [n\u200a=\u200a6] female [n\u200a=\u200a5]; 4% Nacl diet, male [n\u200a=\u200a5] female [n\u200a=\u200a5]).']	N/A	N/A	[('CHEBI_24866', 'salt', 22, 'salt'), ('UBERON_0002113', 'kidney', 38, 'renal'), ('CHEBI_26710', 'sodium chloride', 141, 'NaCl')]
PMC3749995	8/2013	S53-PMC3749995	['in brief, Renal function was assessed as described above but after Rats were Fed Salt-diet for 4-days (including 24 h acclimatisation to the met crate).']	N/A	N/A	[('UBERON_0002113', 'kidney', 10, 'renal'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 67, 'rats'), ('GO_0007631', 'feeding behavior', 77, 'fed'), ('CHEBI_24866', 'salt', 81, 'salt')]
PMC3749995	8/2013	S81-PMC3749995	['in brief, whole Kidneys were incubated in 1 mol/l Hydrochloric Acid for 30 minutes at 37°c, Acid was replaced with 0.5 ml pbs and Tissue homogenized.']	N/A	N/A	[('UBERON_0002113', 'kidney', 16, 'kidneys'), ('CHEBI_17883', 'hydrogen chloride', 50, 'hydrochloric acid'), ('CHEBI_37527', 'acid', 92, 'acid'), ('UBERON_0000479', 'tissue', 130, 'tissue')]
PMC3749995	8/2013	S84-PMC3749995	['Organ explant culture\nfemale Mice (outbred icr strain) were time Mated between 09.00 hrs and 13.00 hrs and at Embryonic day 12 dams were euthanized and the fetal Kidneys/Lungs were removed and cultured on Polyethylene Terephthalate Tissue culture plate inserts (millipore corporation, usa).']	N/A	N/A	[('UBERON_0000033', 'head', 0, 'Organ'), ('NCBITaxon_10088', 'Mus <genus>', 29, 'mice'), ('GO_0007618', 'mating', 65, 'mated'), ('UBERON_0000922', 'embryo', 110, 'embryonic'), ('UBERON_0002113', 'kidney', 162, 'kidneys'), ('UBERON_0002048', 'lung', 170, 'lungs'), ('CHEBI_34922', 'picloram', 205, 'polyethylene terephthalate'), ('UBERON_0000479', 'tissue', 232, 'tissue')]
PMC3749995	8/2013	S85-PMC3749995	['cultured Kidneys were maintained in dmem-f12 (sigma, uk; 330 mosmoles/l) supplemented with Insulin (10 mg/l), Transferrin (5.5 mg/l), Sodium Selenite (5 µg/l), Penicillin and Streptomycin.']	N/A	N/A	[('UBERON_0002113', 'kidney', 9, 'kidneys'), ('PR_000045358', 'insulin family protein', 91, 'insulin'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 110, 'transferrin'), ('CHEBI_77773', 'sodium selenide', 134, 'sodium selenite'), ('CHEBI_17334', 'penicillin', 160, 'penicillin'), ('CHEBI_17076', 'streptomycin', 175, 'streptomycin')]
PMC3749995	8/2013	S107-PMC3749995	['at day 20 Gestation, Salt-loaded Pregnant Rat dams had Renal hypertrophy (5.32±0.10 vs. 4.18±0.13 mg/g for sd vs. cd dams, respectively; p<0.001) accompanied by polydipsia and polyuria with significantly increased Free Water clearance (table 1).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 10, 'gestation'), ('CHEBI_24866', 'salt', 21, 'salt'), ('GO_0007565', 'female pregnancy', 33, 'pregnant'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 42, 'rat'), ('UBERON_0002113', 'kidney', 55, 'renal'), ('CHEBI_37958', 'dye', 214, 'free'), ('CHEBI_15377', 'water', 219, 'water')]
PMC3749995	8/2013	S110-PMC3749995	['a 24 h Urine collection with paired Blood sample enabled analysis of Renal function.']	N/A	N/A	[('UBERON_0001088', 'urine', 7, 'urine'), ('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0002113', 'kidney', 69, 'renal')]
PMC3749995	8/2013	S116-PMC3749995	['elevated Sodium Chloride in culture media significantly impedes Branching Morphogenesis in the Kidney, but not Lung\nusing an Organ explant culture system, Murine e12 fetal Kidneys and Lungs were Grown in the presence or absence of varying concentrations of Nacl or alternative Osmolytes known to cross (e.g.']	N/A	N/A	[('CHEBI_26710', 'sodium chloride', 9, 'sodium chloride'), ('GO_0001763', 'morphogenesis of a branching structure', 64, 'branching morphogenesis'), ('UBERON_0002113', 'kidney', 95, 'kidney'), ('UBERON_0002048', 'lung', 111, 'lung'), ('UBERON_0000062', 'organ', 125, 'organ'), ('NCBITaxon_39107', 'Murinae', 155, 'murine'), ('UBERON_0002113', 'kidney', 172, 'kidneys'), ('UBERON_0002048', 'lung', 184, 'lungs'), ('GO_0040007', 'growth', 195, 'grown'), ('CHEBI_26710', 'sodium chloride', 257, 'NaCl'), ('CHEBI_25671', 'oligoglycosylglucoses', 277, 'osmolytes')]
PMC3749995	8/2013	S122-PMC3749995	['at 100 mosmoles/kg, and for both substances, there was no blunting of Renal Branching Morphogenesis (figure 1h,j).']	N/A	N/A	[('GO_0006281', 'DNA repair', 70, 'renal'), ('UBERON_0002113', 'kidney', 70, 'renal'), ('GO_0001763', 'morphogenesis of a branching structure', 76, 'branching morphogenesis')]
PMC3749995	8/2013	S129-PMC3749995	['a–j : representative images of paired (left and right) Kidneys (n\u200a=\u200a4–6 replicates for analysis) cultured for 2 days in media with varying osmolality, generated using Nacl, Mannitol or Urea, at concentrations indicated on y -axes.']	N/A	N/A	[('UBERON_0002113', 'kidney', 55, 'kidneys'), ('CHEBI_26710', 'sodium chloride', 167, 'NaCl'), ('CHEBI_25169', 'mannoside', 173, 'mannitol'), ('CHEBI_16199', 'urea', 185, 'urea')]
PMC3749995	8/2013	S130-PMC3749995	['k : growth (fold-increase in normalised Surface area) of cultured Kidneys or Lungs ( l ).']	N/A	N/A	[('GO_0009986', 'cell surface', 40, 'surface'), ('UBERON_0002113', 'kidney', 66, 'kidneys'), ('UBERON_0002048', 'lung', 77, 'lungs')]
PMC3749995	8/2013	S135-PMC3749995	['in addition, Glomerular number, a marker for the degree of Branching Renal Morphogenesis at this time was not different between treatment groups (males, 1166±110vs.']	N/A	N/A	[('UBERON_0000074', 'renal glomerulus', 13, 'glomerular'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 59, 'branching'), ('GO_0022613', 'ribonucleoprotein complex biogenesis', 69, 'renal morphogenesis'), ('UBERON_0002113', 'kidney', 69, 'renal')]
PMC3749995	8/2013	S140-PMC3749995	['however, in the altricial, polytocous Rat the Kidneys continue to develop until 1.33–1.47 Gestation (Postnatal day 7–10) and the maternal diets are Fed throughout this time (to weaning at day 21).']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 38, 'rat'), ('UBERON_0002113', 'kidney', 46, 'kidneys'), ('GO_0007565', 'female pregnancy', 90, 'gestation'), ('GO_0007567', 'parturition', 101, 'postnatal'), ('GO_0007631', 'feeding behavior', 148, 'fed')]
PMC3749995	8/2013	S164-PMC3749995	['equivalent to their parents diet) for 5 days and repeated the Renal functional analyses.']	N/A	N/A	[('UBERON_0002113', 'kidney', 62, 'renal')]
PMC3749995	8/2013	S174-PMC3749995	['ns, not significant.10.1371/journal.pone.0072682.t003\n\ncaption (table-wrap): table 3\noffspring Renal function is unaffected by maternal Salt-exposure.Renal functional parameters at baseline in Adult offspring at 8 weeks of age ± maternal Salt p valuesex−ve+ves.e.d.saltsexsalt*sex Urine output (ml/min/kg bw)male 20.030.15.30.07<.001ns female 33.943.3 osmolal clearance (ml/min/kg bw)male 0.050.070.1ns0.002ns female 0.110.08 free Water clearance (ml/min/kg bw)male 20.027.93.3ns<.001ns female 34.735.2\na 24 h Urine collection with paired Blood sample enabled analysis of Renal function in offspring.']	N/A	N/A	[('UBERON_0002113', 'kidney', 95, 'renal'), ('CHEBI_24866', 'salt', 136, 'salt'), ('UBERON_0002113', 'kidney', 150, 'Renal'), ('UBERON_0007023', 'adult organism', 193, 'adult'), ('CHEBI_24866', 'salt', 238, 'salt'), ('UBERON_0001088', 'urine', 281, 'Urine'), ('CHEBI_15377', 'water', 431, 'water'), ('UBERON_0001088', 'urine', 510, 'urine'), ('UBERON_0000178', 'blood', 539, 'blood'), ('UBERON_0002113', 'kidney', 572, 'renal')]
PMC3749995	8/2013	S180-PMC3749995	['a 24 h Urine collection with paired Blood sample enabled analysis of Renal function in offspring.']	N/A	N/A	[('UBERON_0001088', 'urine', 7, 'urine'), ('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0002113', 'kidney', 69, 'renal')]
PMC3749995	8/2013	S186-PMC3749995	['a 24 h Urine collection with paired Blood sample enabled analysis of Renal function in Salt-loaded offspring.']	N/A	N/A	[('UBERON_0001088', 'urine', 7, 'urine'), ('UBERON_0000178', 'blood', 36, 'blood'), ('UBERON_0002113', 'kidney', 69, 'renal'), ('CHEBI_24866', 'salt', 87, 'salt')]
PMC3749995	8/2013	S287-PMC3749995	['caption (supplementary-material): figure s2\n\nRenal structure and hormone output is unaffected by maternal diet.']	N/A	N/A	[('UBERON_0002113', 'kidney', 45, 'Renal')]
PMC3756974	8/2013	S61-PMC3756974	['then, Pentobarbital anesthesia was induced and Blood samples were collected, then the Livers, Kidneys, and Heart were removed immediately and weighed.']	N/A	N/A	[('CHEBI_7983', 'pentobarbital', 6, 'pentobarbital'), ('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0002107', 'liver', 86, 'livers'), ('UBERON_0002113', 'kidney', 94, 'kidneys'), ('UBERON_0000948', 'heart', 107, 'heart')]
PMC3756974	8/2013	S62-PMC3756974	['the Kidneys were stored at -80°c for the evaluation of mrna and protein Expressions.']	N/A	N/A	[('UBERON_0002113', 'kidney', 4, 'kidneys'), ('GO_0010467', 'gene expression', 72, 'expressions')]
PMC3756974	8/2013	S65-PMC3756974	['western blotting\nthe Kidneys were homogenized in homogenizing buffer (50 mm N-2-Hydroxyethylpiperazine-N-2-Ethanesulphonic Acid [Hepes], 150 mm Nacl, 1 mm Dithiothreitol, and 0.5% (v/v) Tween-20; ph 7.4) containing protease inhibitor Cocktail tablets (roche applied science, indianapolis, in, usa).']	N/A	N/A	[('UBERON_0002113', 'kidney', 21, 'kidneys'), ('CHEBI_86555', 'pyridine-3-carbaldehyde oxime', 76, 'N-2-hydroxyethylpiperazine-N-2-ethanesulphonic acid'), ('CHEBI_46756', 'HEPES', 129, 'HEPES'), ('CHEBI_26710', 'sodium chloride', 144, 'NaCl'), ('CHEBI_18320', '1,4-dithiothreitol', 155, 'dithiothreitol'), ('CHEBI_53424', 'polysorbate 20', 186, 'Tween-20'), ('CHEBI_60004', 'mixture', 234, 'cocktail')]
PMC3756974	8/2013	S79-PMC3756974	['mrna Expression by real-time Reverse Transcription-polymerase chain reaction (real-time rt-pcr)\ntotal rna of Kidney Tissue of each offspring was prepared using the sv total rna isolation kit.']	N/A	N/A	[('GO_0010467', 'gene expression', 5, 'expression'), ('GO_0001171', 'reverse transcription', 29, 'reverse transcription'), ('UBERON_0002113', 'kidney', 109, 'kidney'), ('UBERON_0000479', 'tissue', 116, 'tissue')]
PMC3756974	8/2013	S95-PMC3756974	['; Kidney weights in all groups.']	N/A	N/A	[('UBERON_0002113', 'kidney', 2, 'kidney')]
PMC3756974	8/2013	S109-PMC3756974	['a ) Dnmt1 in the Kidneys of 3 week old Postnatal offspring, and b ) Dnmt3A in the Kidneys of 3 week old Postnatal offspring.']	N/A	N/A	[('PR_000006564', 'dynein heavy chain 5, axonemal', 4, 'DNMT1'), ('UBERON_0002113', 'kidney', 17, 'kidneys'), ('GO_0007567', 'parturition', 39, 'postnatal'), ('PR_000006609', 'DNA (cytosine-5)-methyltransferase 3-like', 68, 'DNMT3a'), ('UBERON_0002113', 'kidney', 82, 'kidneys'), ('GO_0007567', 'parturition', 104, 'postnatal')]
PMC3756974	8/2013	S117-PMC3756974	['to investigate changes of downstream of Sirt1, P53 contents were detected in Kidneys from offspring of undernourished Pregnant Rats with or without gte addition using western blotting (figure 4).']	N/A	N/A	[('PR_000014888', 'NAD-dependent protein deacetylase sirtuin-1', 40, 'SIRT1'), ('PR_000003035', 'cellular tumor antigen p53', 47, 'p53'), ('UBERON_0002113', 'kidney', 77, 'kidneys'), ('GO_0007565', 'female pregnancy', 118, 'pregnant'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 127, 'rats')]
PMC3756974	8/2013	S119-PMC3756974	['a ) Sirt1 in the Kidneys of 3 week old Postnatal offspring, and b ) Sirt2 in the Kidneys of 3 week old Postnatal offspring.']	N/A	N/A	[('PR_000014888', 'NAD-dependent protein deacetylase sirtuin-1', 4, 'SIRT1'), ('UBERON_0002113', 'kidney', 17, 'kidneys'), ('GO_0007567', 'parturition', 39, 'postnatal'), ('PR_000014888', 'NAD-dependent protein deacetylase sirtuin-1', 68, 'SIRT2'), ('UBERON_0002113', 'kidney', 81, 'kidneys'), ('GO_0007567', 'parturition', 103, 'postnatal')]
PMC3756974	8/2013	S122-PMC3756974	['cc, control on control; lp, control on protein restricted; lpcl, 0.12% gte diet on protein restricted; lpch, 0.24% gte diet on protein restricted.b*means p<0.05 against lp.10.1371/journal.pone.0074559.g004\n\ncaption (fig): figure 4\nprotein abundance of P53 to Β-Actin in the Kidneys of 3 week old Postnatal offspring using western blot analysis.']	N/A	N/A	[('PR_000003035', 'cellular tumor antigen p53', 252, 'p53'), ('PR_000003676', 'actin, cytoplasmic 1', 259, 'β-actin'), ('UBERON_0002113', 'kidney', 274, 'kidneys'), ('GO_0007567', 'parturition', 296, 'postnatal')]
PMC3756974	8/2013	S126-PMC3756974	['ampk phosphorylation in Kidneys from 3 week old offspring\nto detect Lipid-Metabolism in Kidneys of newborns from the low-protein group, total and phosphorylated ampks were measured in Kidneys from all groups by western blotting.']	N/A	N/A	[('UBERON_0002113', 'kidney', 24, 'kidneys'), ('CHEBI_18059', 'lipid', 68, 'lipid'), ('GO_0006629', 'lipid metabolic process', 68, 'lipid-metabolism'), ('UBERON_0002113', 'kidney', 88, 'kidneys'), ('UBERON_0002113', 'kidney', 184, 'kidneys')]
PMC3756974	8/2013	S127-PMC3756974	['as shown infigure 5, phosphorylated ampk Expression in Kidneys from low-protein group treated with high Gte dose was higher than in the low-protein group.']	N/A	N/A	[('GO_0010467', 'gene expression', 41, 'expression'), ('UBERON_0002113', 'kidney', 55, 'kidneys'), ('CHEBI_76780', 'G20', 104, 'GTE')]
PMC3756974	8/2013	S128-PMC3756974	['this difference markedly increased when phosphorylated ampk to ampk ratio was considered (figure 5c).10.1371/journal.pone.0074559.g005\n\ncaption (fig): figure 5\nprotein abundance of ampk in the Kidneys of 3 week old Postnatal offspring using western blot analysis.']	N/A	N/A	[('UBERON_0002113', 'kidney', 193, 'kidneys'), ('GO_0007567', 'parturition', 215, 'postnatal')]
PMC3756974	8/2013	S135-PMC3756974	['as shown infigure 6b and c, no significant difference was found, respectively, for Enos and phosphorylated Enos /enos ratio among all groups.10.1371/journal.pone.0074559.g006\n\ncaption (fig): figure 6\nprotein abundance of Enos in the Kidneys of 3 week old Postnatal offspring using western blot analysis.']	N/A	N/A	[('PR_000007020', 'ETS-related transcription factor Elf-1', 83, 'eNOS'), ('PR_000007020', 'ETS-related transcription factor Elf-1', 107, 'eNOS'), ('PR_000007020', 'ETS-related transcription factor Elf-1', 221, 'eNOS'), ('UBERON_0002113', 'kidney', 233, 'kidneys'), ('GO_0007567', 'parturition', 255, 'postnatal')]
PMC3756974	8/2013	S172-PMC3756974	['to estimate the phosphorylation state of ampk, which is a major regulator in Lipid Metabolism, total and phosphorylated ampk protein levels in Kidneys of young offspring were analyzed by western blotting (figure 5).']	N/A	N/A	[('CHEBI_18059', 'lipid', 77, 'lipid'), ('GO_0006629', 'lipid metabolic process', 77, 'lipid metabolism'), ('UBERON_0002113', 'kidney', 143, 'kidneys')]
PMC3756974	8/2013	S173-PMC3756974	['a similar pattern was observed between amounts of phosphorylated ampk in the Kidney of 3 week old female and in Liver of 3 week old male Animals.']	N/A	N/A	[('UBERON_0002113', 'kidney', 77, 'kidney'), ('UBERON_0002107', 'liver', 112, 'liver'), ('NCBITaxon_33208', 'Metazoa', 137, 'animals')]
PMC3756974	8/2013	S190-PMC3756974	['in addition, the increase of phosphorylated Enos in Kidneys of the high Gte dose treatment group was observed.']	N/A	N/A	[('PR_000007020', 'ETS-related transcription factor Elf-1', 44, 'eNOS'), ('UBERON_0002113', 'kidney', 52, 'kidneys'), ('CHEBI_76780', 'G20', 72, 'GTE')]
PMC3760821	9/2013	S64-PMC3760821	['patients with a history of hypertension, proteinuric Renal disease prior to Pregnancy, or who had a Urinary albumin >20 g/dl or an albumin/creatinine ratio >2.0 mg/mmol recorded at less than 20 weeks Gestation were excluded by definition.']	N/A	N/A	[('UBERON_0002113', 'kidney', 53, 'renal'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy'), ('UBERON_0001088', 'urine', 100, 'urinary'), ('GO_0007565', 'female pregnancy', 200, 'gestation')]
PMC3773449	8/2013	S16-PMC3773449	['chronic Kidney disease is defined as reduced Glomerular filtration rate (gfr) up to end-stage Renal disease (esrd), proteinuria, or both.']	N/A	N/A	[('UBERON_0002113', 'kidney', 8, 'kidney'), ('UBERON_0000074', 'renal glomerulus', 45, 'glomerular'), ('UBERON_0002113', 'kidney', 94, 'renal')]
PMC3773449	8/2013	S18-PMC3773449	['in turn, impaired Renal factor favors the development of and amplifies the severity of cvd [5–7].']	N/A	N/A	[('UBERON_0002113', 'kidney', 18, 'renal')]
PMC3773449	8/2013	S90-PMC3773449	['Nephrons undergo structural changes with Glomerular and Tubular enlargement responsible for Renal hypertrophy.']	N/A	N/A	[('UBERON_0001285', 'nephron', 0, 'Nephrons'), ('UBERON_0000074', 'renal glomerulus', 41, 'glomerular'), ('UBERON_0000025', 'tube', 56, 'tubular'), ('UBERON_0002113', 'kidney', 92, 'renal')]
PMC3773449	8/2013	S113-PMC3773449	['in the monash series, which included 420 Kidneys obtained at autopsy from Adults and children from different populations (aboriginal australians and white australians, senegalese, and white americans and african americans), the mean Nephron number per Kidney was around 900,000 ranging 13-fold from about 210,000 to more than 2,000\u2009000 [88,90,91].']	N/A	N/A	[('UBERON_0002113', 'kidney', 41, 'kidneys'), ('UBERON_0007023', 'adult organism', 74, 'adults'), ('UBERON_0001285', 'nephron', 233, 'nephron'), ('UBERON_0002113', 'kidney', 252, 'kidney')]
PMC3773449	8/2013	S143-PMC3773449	['in addition, we showed in the Kidneys of iugr fetal offspring changes in the Expression of Genes coding for specific enzymes involved in epigenetic machinery [119].']	N/A	N/A	[('UBERON_0002113', 'kidney', 30, 'kidneys'), ('GO_0010467', 'gene expression', 77, 'expression'), ('SO_0000704', 'gene', 91, 'genes')]
PMC3773449	8/2013	S174-PMC3773449	['when Nephrogenesis is severely impaired, that is, when the Nephron deficit is marked, the risk of early impaired Renal function and hypertension is elevated.']	N/A	N/A	[('GO_0001822', 'kidney development', 5, 'nephrogenesis'), ('UBERON_0001285', 'nephron', 59, 'nephron'), ('UBERON_0002113', 'kidney', 113, 'renal')]
PMC3773449	8/2013	S175-PMC3773449	['it is the case of infants Born with congenital anomaly of Kidney and Urinary Tract.']	N/A	N/A	[('GO_0007567', 'parturition', 26, 'born'), ('UBERON_0002113', 'kidney', 58, 'kidney'), ('UBERON_0001553', 'medial tarsal artery', 69, 'urinary tract')]
PMC3773449	8/2013	S187-PMC3773449	['indeed, Kidney of iugr overfed offspring which displayed a rapid Postnatal catch-up growth Expressed stress-induced senescence protein markers (P16, P21) and telomere shortening [135–140].']	N/A	N/A	[('UBERON_0002113', 'kidney', 8, 'kidney'), ('GO_0007567', 'parturition', 65, 'postnatal'), ('GO_0010467', 'gene expression', 91, 'expressed'), ('PR_000001245', 'rhodopsin', 144, 'p16'), ('PR_000000123', 'ribosomal protein S6 kinase beta-1', 149, 'p21')]
PMC3773449	8/2013	S196-PMC3773449	['at 6 months of age, while no differences were found between breastfed and low protein formula-Fed infants, the Kidney volume (and the relative volume of the Kidney/body surface area ratio) was 10% higher in high protein formula-Fed infants.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 94, 'fed'), ('UBERON_0002113', 'kidney', 111, 'kidney'), ('UBERON_0002113', 'kidney', 157, 'kidney'), ('GO_0007631', 'feeding behavior', 228, 'fed')]
PMC3773449	8/2013	S223-PMC3773449	['various Systems, including the Kidney, are permanently altered.']	N/A	N/A	[('UBERON_0000467', 'anatomical system', 8, 'systems'), ('UBERON_0002113', 'kidney', 31, 'kidney')]
PMC3813450	10/2013	S58-PMC3813450	['measurements of subcutaneous fat depots were based on the maximum length obtained tracing a line perpendicular to the Kidney at the level of the First Lumbar Vertebra.']	N/A	N/A	[('UBERON_0002113', 'kidney', 118, 'kidney'), ('UBERON_0004617', 'lumbar vertebra 1', 145, 'first lumbar vertebra')]
PMC3827489	10/2013	S14-PMC3827489	['in the Kidney, 25(Oh)D is converted to 1,25-Dihydroxyvitamin D (1,25[Oh]2D), the biologically active Metabolite.']	N/A	N/A	[('UBERON_0002113', 'kidney', 7, 'kidney'), ('CHEBI_71657', 'versiconol acetate', 15, '25(OH)D'), ('CHEBI_67472', '15-epi-lupulin B', 39, '1,25-dihydroxyvitamin D'), ('CHEBI_72785', '9-hydroxy-5E,7Z,11Z,14Z-eicosatetraenoic acid', 64, '1,25[OH]2D'), ('CHEBI_39382', 'flufenoxuron', 101, 'metabolite')]
PMC3850030	9/2013	S300-PMC3850030	[')- functional assessments (behavior, treadmill, Learning, Cognition, Renal function studies, Lung function studies, grip strength, etc.']	N/A	N/A	[('GO_0007612', 'learning', 48, 'learning'), ('GO_0050890', 'cognition', 58, 'cognition'), ('UBERON_0002113', 'kidney', 69, 'renal'), ('UBERON_0002048', 'lung', 93, 'lung')]
PMC3872504	8/2013	S105-PMC3872504	['avy/a Mice that either lost or gained weight from p140-p180 were necropsied at p180; the former all exhibited Kidney disease grossly resembling diabetic nephropathy (supplemental figure s4b) but no other overt pathology.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 6, 'mice'), ('UBERON_0002113', 'kidney', 110, 'kidney')]
PMC3914197	7/2012	S26-PMC3914197	['the hypernatremia and the acute Kidney injury corrected over a course of several days with continued Fluid administration.']	N/A	N/A	[('UBERON_0002113', 'kidney', 32, 'kidney'), ('CHEBI_37958', 'dye', 101, 'fluid'), ('UBERON_0006314', 'bodily fluid', 101, 'fluid')]
PMC3915248	2/2014	S37-PMC3915248	['one such study, led by maria limson-zamora, head of health canada’s bioassay section, compared biomarkers of Kidney function in the Urine of canadians chronically exposed to high (2–780 µg/l) or low (0.02 µg/l) levels of uranium in their drinking Water.']	N/A	N/A	[('UBERON_0002113', 'kidney', 109, 'kidney'), ('UBERON_0001088', 'urine', 132, 'urine'), ('CHEBI_15377', 'water', 247, 'water')]
PMC3970319	5/2013	S4-PMC3970319	['a total of 77% of eligible Individuals were recruited and Blood pressure, Kidney size by ultrasound, and Glomerular filtration rate (gfr; calculated from Plasma cystatin c) were assessed.']	N/A	N/A	[('NCBITaxon_1', 'root', 27, 'individuals'), ('UBERON_0000178', 'blood', 58, 'blood'), ('UBERON_0002113', 'kidney', 74, 'kidney'), ('UBERON_0000074', 'renal glomerulus', 105, 'glomerular'), ('UBERON_0001969', 'blood plasma', 154, 'plasma')]
PMC3970319	5/2013	S46-PMC3970319	['Kidney volume: number of Individuals recruited for Kidney size measurements by ultrasound, cm3/m2.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidney'), ('NCBITaxon_1', 'root', 25, 'individuals'), ('UBERON_0002113', 'kidney', 51, 'kidney')]
PMC3970319	5/2013	S55-PMC3970319	['for cost and logistic considerations, measurements of Kidney function were conducted on a subset of participants; Glomerular filtration rate (gfr) assessment was restricted to Individuals born during the first year of the minimat trial (june 2002–june 2003) and the Kidney biometric study was restricted to a different subsample of Individuals, born during the second half (june 2003–june 2004) of the trial to minimize participant burden.']	N/A	N/A	[('UBERON_0002113', 'kidney', 54, 'kidney'), ('UBERON_0000074', 'renal glomerulus', 114, 'glomerular'), ('NCBITaxon_1', 'root', 176, 'individuals'), ('UBERON_0002113', 'kidney', 266, 'kidney'), ('NCBITaxon_1', 'root', 332, 'individuals')]
PMC3970319	5/2013	S58-PMC3970319	['Kidney function was assessed by calculation of the gfr estimated from Plasma Cystatin C (cysc), which was analyzed from stored, frozen samples using the immunoturbidimetric analysis (16) in uppsala, sweden.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidney'), ('UBERON_0001969', 'blood plasma', 70, 'plasma'), ('PR_000006022', 'lysosomal protective protein', 77, 'cystatin C')]
PMC3970319	5/2013	S60-PMC3970319	['Kidney volume was assessed by ultrasonography conducted using a 3.75-mhz convex scanner (toshiba ssa- 510a/p3, famio-5, toshiba medical systems).']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidney')]
PMC3970319	5/2013	S83-PMC3970319	['linear regression models were fitted adjusted for covariates relating to Blood pressure and Kidney function as appropriate.']	N/A	N/A	[('UBERON_0000178', 'blood', 73, 'blood'), ('UBERON_0002113', 'kidney', 92, 'kidney')]
PMC3970319	5/2013	S100-PMC3970319	['the mean Kidney volume adjusted for body surface area was 104.0 ± 15.5 cm3/m2for boys and 104 ± 15.9 cm3/m2for girls.']	N/A	N/A	[('UBERON_0002113', 'kidney', 9, 'kidney')]
PMC3970319	5/2013	S102-PMC3970319	['neither Kidney volume nor gfr was associated with Blood pressure (data not shown).']	N/A	N/A	[('UBERON_0002113', 'kidney', 8, 'kidney'), ('UBERON_0000178', 'blood', 50, 'blood')]
PMC3970319	5/2013	S112-PMC3970319	['there was no association of this intervention with systolic Blood pressure or with either Kidney volume or gfr.']	N/A	N/A	[('UBERON_0000178', 'blood', 60, 'blood'), ('UBERON_0002113', 'kidney', 90, 'kidney')]
PMC3970319	5/2013	S117-PMC3970319	['in the unadjusted intention-to-treat analysis, there was no association between the Micronutrient intervention and offspring Blood pressure or Kidney function ( table 5 ).']	N/A	N/A	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 84, 'micronutrient'), ('UBERON_0000178', 'blood', 125, 'blood'), ('UBERON_0002113', 'kidney', 143, 'kidney')]
PMC3970319	5/2013	S120-PMC3970319	['there was also no effect of the Iron intervention on offspring Kidney function in unadjusted analysis, but in the adjusted analysis, Individuals whose mothers had received 60 mg of Iron during Pregnancy had a mean 4.98 ml/(min\u2009·\u20091.73 m2) [(95% ci: 0.30, 9.67); p = 0.04] higher gfr at 4.5 y of age than those whose mothers had received 30 mg of Iron during Pregnancy.']	N/A	N/A	[('CHEBI_24870', 'ion', 32, 'iron'), ('UBERON_0002113', 'kidney', 63, 'kidney'), ('NCBITaxon_1', 'root', 133, 'individuals'), ('CHEBI_24870', 'ion', 181, 'iron'), ('GO_0007565', 'female pregnancy', 193, 'pregnancy'), ('CHEBI_24870', 'ion', 345, 'iron'), ('GO_0007565', 'female pregnancy', 357, 'pregnancy')]
PMC3970319	5/2013	S121-PMC3970319	['caption (table-wrap): table 4\n\neffect of maternal Food intervention on offspring Blood pressure and Kidney function at 4.5 y in bangladesh1n model 12p value r2(%) n model 23p value r2(%) n model 34p value r2(%)systolic pressure (mm hg)23120.46 (−0.16, 1.08)0.15 (0.05)21960.42 (−0.21, 1.05)0.19 (0.03)19690.57 (−0.08, 1.21)0.09 (0.09)diastolic pressure (mm hg)23120.58 (0.06, 1.11)0.03 (0.16)21960.59 (0.05, 1.13)0.03 (0.16)19690.72 (0.16, 1.28)0.01 (0.26)Kidney volume (cm3/m2)1068−0.09 (−1.98, 1.79)0.92 (−0.09)9680.01 (−1.90, 1.91)0.99 (−0.09)8610.45 (−1.55, 2.45)0.66 (−0.08)Gfr5[ml/(min\u2009·\u20091.73 m2)]1224−1.86 (−5.79, 2.08)0.36 (−0.01)1222−1.92 (−5.77, 1.94)0.33 (−0.00)1093−1.23 (−5.27, 2.80)0.55 (−0.05)\nvalues are regression coefficients (β) showing the difference in mean Blood pressure (95% ci) for Individuals Born to women invited to receive Food Supplements early in Pregnancy (coded 0) compared with the usual time (coded 1), derived from linear regression analysis.']	N/A	N/A	[('CHEBI_33290', 'food', 50, 'food'), ('UBERON_0000178', 'blood', 81, 'blood'), ('UBERON_0002113', 'kidney', 100, 'kidney'), ('UBERON_0002113', 'kidney', 456, 'Kidney'), ('PR_000007949', 'GDNF family receptor alpha-2', 579, 'GFR5'), ('UBERON_0000178', 'blood', 779, 'blood'), ('NCBITaxon_1', 'root', 807, 'individuals'), ('GO_0007567', 'parturition', 819, 'born'), ('CHEBI_33290', 'food', 852, 'food'), ('CHEBI_33341', 'titanium atom', 857, 'supplements'), ('GO_0007565', 'female pregnancy', 878, 'pregnancy')]
PMC3970319	5/2013	S128-PMC3970319	['caption (table-wrap): table 5\n\neffect of maternal multiple Micronutrient supplementation on offspring Blood pressure and Kidney function at 4.5 y in bangladesh1n model 12p value r2(%) n model 23p value r2(%) n model 34p value r2(%)systolic pressure (mm hg)23120.05 (−0.71, 0.81)0.90 (−0.04)21960.05 (−0.73, 0.82)0.90 (−0.04)19690.22 (−0.58, 1.02)0.58 (−0.03)diastolic pressure (mm hg)23120.55 (−0.10, 1.20)0.09 (0.08)21960.60 (−0.07, 1.26)0.08 (0.09)19690.87 (0.18, 1.56)0.01 (0.25)Kidney volume (cm3/m2)1069−0.98 (−3.30, 1.34)0.41 (−0.03)968−1.75 (−4.09, 0.60)0.14 (0.11)861−1.45 (−3.89, 1.00)0.25 (0.04)Gfr5[ml/(min\u2009·\u20091.73 m2)]12241.30 (−3.55, 6.14)0.60 (−0.06)12222.08 (−2.66, 6.83)0.39 (−0.02)10933.43 (−1.56, 8.42)0.18 (0.07)\nvalues are regression coefficients (β) showing the difference in mean Blood pressure (95% ci) for Individuals Born to women in the mms compared with the fe30f intervention group, derived from linear regression analysis.']	N/A	N/A	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 59, 'micronutrient'), ('UBERON_0000178', 'blood', 102, 'blood'), ('UBERON_0002113', 'kidney', 121, 'kidney'), ('UBERON_0002113', 'kidney', 482, 'Kidney'), ('PR_000007949', 'GDNF family receptor alpha-2', 605, 'GFR5'), ('UBERON_0000178', 'blood', 801, 'blood'), ('NCBITaxon_1', 'root', 829, 'individuals'), ('GO_0007567', 'parturition', 841, 'born')]
PMC3970319	5/2013	S139-PMC3970319	['there was no association between the number of Food packets consumed and offspring Blood pressure, Kidney volume, or gfr ( supplemental table 2 ).']	N/A	N/A	[('CHEBI_33290', 'food', 47, 'food'), ('UBERON_0000178', 'blood', 83, 'blood'), ('UBERON_0002113', 'kidney', 99, 'kidney')]
PMC3970319	5/2013	S140-PMC3970319	['similarly, there was no association between tablet Consumption as measured by bottle opening and offspring Blood pressure, Kidney volume, or gfr ( supplemental table 3 ).']	N/A	N/A	[('GO_0007631', 'feeding behavior', 51, 'consumption'), ('UBERON_0000178', 'blood', 107, 'blood'), ('UBERON_0002113', 'kidney', 123, 'kidney')]
PMC3970319	5/2013	S144-PMC3970319	['no other effects of the Food or Micronutrient interventions on offspring Blood pressure, Kidney volume, or gfr were observed and there was no interaction between the interventions on the outcomes studied.']	N/A	N/A	[('CHEBI_33290', 'food', 24, 'food'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 32, 'micronutrient'), ('UBERON_0000178', 'blood', 73, 'blood'), ('UBERON_0002113', 'kidney', 89, 'kidney')]
PMC3994935	5/2014	S28-PMC3994935	['women with risk factors for Placental insufficiency and growth restriction (hypertension, Renal disease, thrombophilia, rheumatologic disease, use of β-Blockers, or history of Preeclampsia), or Preterm Delivery or with major medical disorders were excluded.']	N/A	N/A	[('UBERON_0001987', 'placenta', 28, 'placental'), ('UBERON_0002113', 'kidney', 90, 'renal'), ('CHEBI_35225', 'buffer', 152, 'blockers'), ('GO_0007128', 'meiotic prophase I', 176, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 194, 'preterm'), ('GO_0007567', 'parturition', 202, 'delivery')]
PMC4018592	4/2014	S32-PMC4018592	['multiparous women as well as those with hypertension, mild and severe pre-eclampsia, Intrauterine growth retardation (iugr), intra-Uterine fetal death, Gestational diabetes mellitus (gdm), completed bed rest (cbr), history or evidence of rheumatoid arthritis, Thyroid, Parathyroid or Adrenal diseases, Hepatic or Renal failure and metabolic bone disease were not included in the current study.']	N/A	N/A	[('UBERON_0022293', 'reproductive gland secretion', 85, 'intrauterine'), ('UBERON_0000995', 'uterus', 131, 'uterine'), ('GO_0007565', 'female pregnancy', 152, 'gestational'), ('UBERON_0002046', 'thyroid gland', 260, 'thyroid'), ('UBERON_0001132', 'parathyroid gland', 269, 'parathyroid'), ('UBERON_0002369', 'adrenal gland', 284, 'adrenal'), ('UBERON_0002107', 'liver', 302, 'hepatic'), ('UBERON_0002113', 'kidney', 313, 'renal')]
PMC4064785	9/2013	S30-PMC4064785	["eligibility criteria included < 24 wk Gestational age at first interview, singleton Pregnancy, no prior history of hypertension, chronic Renal disease, diabetes, premature labor, ruptured membrane & during this Pregnancy they shouldn't have Placenta previa, need for complete bed rest, ruptured membrane or bleeding."]	N/A	N/A	[('GO_0007565', 'female pregnancy', 38, 'gestational'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('UBERON_0002113', 'kidney', 137, 'renal'), ('GO_0007565', 'female pregnancy', 211, 'pregnancy'), ('UBERON_0001987', 'placenta', 241, 'placenta')]
PMC4089555	5/2014	S11-PMC4089555	['Iodide is absorbed in the Stomach and Duodenum and cleared by the Kidney and the Thyroid.']	N/A	N/A	[('CHEBI_5859', 'Icacine', 0, 'Iodide'), ('UBERON_0000945', 'stomach', 26, 'stomach'), ('UBERON_0002114', 'duodenum', 38, 'duodenum'), ('UBERON_0002113', 'kidney', 66, 'kidney'), ('UBERON_0002046', 'thyroid gland', 81, 'thyroid')]
PMC4089555	5/2014	S22-PMC4089555	['Iodide is rapidly cleared from the circulation by the Thyroid Gland and Kidneys.']	N/A	N/A	[('CHEBI_5859', 'Icacine', 0, 'Iodide'), ('UBERON_0002046', 'thyroid gland', 54, 'thyroid gland'), ('UBERON_0002113', 'kidney', 72, 'kidneys')]
PMC4113768	7/2014	S291-PMC4113768	['Liver or Renal failure was considered exclusion criteria.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0002113', 'kidney', 9, 'renal')]
PMC4113768	7/2014	S703-PMC4113768	['performance evaluation of 25-Hydroxy Vitamin D assays with chronic Kidney disease patients\n\nvogl, c.; roth, h.j.']	N/A	N/A	[('CHEBI_43141', '3-hydroxypropoxy group', 26, '25-Hydroxy'), ('CHEBI_28384', 'vitamin K', 37, 'Vitamin D'), ('UBERON_0002113', 'kidney', 67, 'Kidney')]
PMC4113768	7/2014	S705-PMC4113768	['the highly Regulated interplay of Metabolism and catabolism of Vitamin D is disrupted in patients with chronic Kidney disease (ckd) resulting in a decreased concentration of 1,25(Oh)2D.']	N/A	N/A	[('GO_0065007', 'biological regulation', 11, 'regulated'), ('GO_0008152', 'metabolic process', 34, 'metabolism'), ('CHEBI_28384', 'vitamin K', 63, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 63, 'Vitamin'), ('UBERON_0002113', 'kidney', 111, 'kidney'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 176, '25(OH)2D')]
PMC4113768	7/2014	S727-PMC4113768	['Vitamin D3Is mainly Metabolized in the Liver and Kidney.']	N/A	N/A	[('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D3is'), ('GO_0008152', 'metabolic process', 20, 'metabolized'), ('UBERON_0002107', 'liver', 39, 'liver'), ('UBERON_0002113', 'kidney', 49, 'kidney')]
PMC4113768	7/2014	S729-PMC4113768	['Serum levels of 1,25-(Oh)2-Vitamin D3Regulate the Expression of Cyp24A1 in the Kidney.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_68974', 'squamostatin-D', 16, '1,25-(OH)2-'), ('CHEBI_72754', 'bisphenol AF', 27, 'vitamin D3regulate'), ('GO_0010467', 'gene expression', 50, 'expression'), ('PR_000006101', 'cytochrome P450 1A1', 64, 'CYP24A1'), ('UBERON_0002113', 'kidney', 79, 'kidney')]
PMC4113768	7/2014	S1091-PMC4113768	['exclusion criteria: previous hypocalcaemic seizure or an underlying condition causing secondary vdd (e.g., Renal & Liver disease).']	N/A	N/A	[('UBERON_0002113', 'kidney', 107, 'renal'), ('UBERON_0002107', 'liver', 115, 'liver')]
PMC4113768	7/2014	S1697-PMC4113768	['Renal and Liver function test was done for screening any pseudo cause of hypovitaminosis.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Renal'), ('UBERON_0002107', 'liver', 10, 'liver')]
PMC4113768	7/2014	S2101-PMC4113768	['compared to participants in the highest 25(Oh)D quartile (>53.7 nmol/l), participants in the lowest quartile (<24.5 nmol/l) had twice the risk of any stroke (hazard ratio 2.0, 95% ci 1.4–2.9) and a 70% higher risk of ischemic stroke (1.7, 1.1–2.6) in cox proportional hazards models adjusting for age, sex, education, smoking status, body mass index, Renal function, and prior stroke.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 40, '25(OH)D'), ('UBERON_0002113', 'kidney', 351, 'renal')]
PMC4113768	7/2014	S2971-PMC4113768	['having end stage Renal disease (esrd) since 2002 she was initially managed on Peritoneal dialysis and transferred to haemodialysis in 2004.']	N/A	N/A	[('UBERON_0002113', 'kidney', 17, 'renal'), ('UBERON_0001179', 'peritoneal cavity', 78, 'peritoneal')]
PMC4113768	7/2014	S2994-PMC4113768	['Vitamin D deficiency in advanced chronic Kidney disease is not corrected after Kidney transplantation\n\nparker, s.; ting, s.m.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('UBERON_0002113', 'kidney', 41, 'Kidney'), ('UBERON_0002113', 'kidney', 79, 'Kidney')]
PMC4113768	7/2014	S2995-PMC4113768	['; petchey, m.; higgins, r.; fletcher, s.; zehnder, d.; bland, r.\nbackground: supplementation with Calcitriol (1,25-Dihydroxy Vitamin D; or analogue) is used routinely in patients with chronic Kidney disease (ckd).']	N/A	N/A	[('CHEBI_17823', 'calcitriol', 98, 'calcitriol'), ('CHEBI_50050', 'cystinyl group', 114, '-dihydroxy'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D'), ('UBERON_0002113', 'kidney', 192, 'kidney')]
PMC4113768	7/2014	S3005-PMC4113768	['32 who received a Kidney transplant (mean age 45.2 ± 2.59 years; male 59%; bmi 24.7 ± 0.62 kg/m2), 33 patients with ckd (mean age 47.6 ± 2.34 years; male 73%; bmi 27.4 ± 1.00 kg/m2) and 34 in the hypertensive group (mean age 55.2 ± 1.24 years; male 44%; bmi 28.0 ± 0.58 kg/m2).']	N/A	N/A	[('UBERON_0002113', 'kidney', 18, 'kidney')]
PMC4160672	7/2014	S46-PMC4160672	['those previously or currently treated for Pulmonary tuberculosis, Upper and Lower Respiratory Tract infections, Medications that alter Lung function (e.g., bronchodilators and constrictors), acute malaria in Pregnancy, Preeclampsia, diabetes in Pregnancy, febrile conditions, multiple Pregnancy, chronic Renal disease, Sickle Cell anemia, hiv positive patients, and other Pregnancy complications (threatened abortion, antepartum hemorrhage, etc.)']	N/A	N/A	[('UBERON_0002048', 'lung', 42, 'pulmonary'), ('UBERON_0002027', 'stratum corneum of epidermis', 66, 'upper ...'), ('UBERON_0004905', 'articulation', 76, 'lower respiratory tract'), ('CHEBI_25441', 'mycothiols', 112, 'medications'), ('UBERON_0002048', 'lung', 135, 'lung'), ('GO_0007565', 'female pregnancy', 208, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 219, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 245, 'pregnancy'), ('GO_0007565', 'female pregnancy', 285, 'pregnancy'), ('UBERON_0002113', 'kidney', 304, 'renal'), ('CL_0000129', 'microglial cell', 319, 'sickle cell'), ('GO_0007565', 'female pregnancy', 372, 'pregnancy')]
PMC4161944	9/2014	S160-PMC4161944	['in utero exposure to famine resulted in lower Birth weights, later increased rates of mental illness (schizophrenia and antisocial personality disorder), congenital neural defects, obstructive Airway disease, Coronary Heart disease, altered Renal function, fivefold increases in Breast cancer risk among women and reduced Glucose and Insulin tolerance (124).']	N/A	N/A	[('GO_0007567', 'parturition', 46, 'birth'), ('UBERON_0001005', 'respiratory airway', 193, 'airway'), ('UBERON_0004151', 'cardiac chamber', 209, 'coronary heart'), ('UBERON_0002113', 'kidney', 241, 'renal'), ('UBERON_0000310', 'breast', 279, 'breast'), ('CHEBI_17234', 'glucose', 322, 'glucose'), ('PR_000045358', 'insulin family protein', 334, 'insulin')]
PMC4166817	10/2014	S23-PMC4166817	['[9] Perinatal supplementation with Citrulline in drinking Water (l-Citrulline, 2.5 g/l) increased Renal No at 2 weeks and persistently ameliorated the development Of Hypertension in females and until 20 weeks in males.']	N/A	N/A	[('GO_0036268', 'swimming', 4, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 4, 'Perinatal'), ('CHEBI_18211', 'citrulline', 35, 'citrulline'), ('CHEBI_15377', 'water', 58, 'water'), ('CHEBI_18211', 'citrulline', 67, 'citrulline'), ('UBERON_0002113', 'kidney', 98, 'renal'), ('CHEBI_16382', 'iodide', 104, 'NO'), ('GO_0007608', 'sensory perception of smell', 163, 'of hypertension')]
PMC4169453	9/2014	S38-PMC4169453	['the exclusion criteria were: maternal and neonatal Endocrine disorders (e.g., diabetes mellitus, Thyroid disease, disturbed Calcium-Phosphorus Homeostasis), Renal and Hepatic insufficiency, Anticonvulsant treatment, and congenital malformations of the newborn infant.']	N/A	N/A	[('GO_0006397', 'mRNA processing', 51, 'endocrine'), ('UBERON_0002046', 'thyroid gland', 97, 'thyroid'), ('CHEBI_22313', 'alkaline earth metal atom', 124, 'calcium'), ('GO_0055073', 'cadmium ion homeostasis', 124, 'calcium- ... homeostasis'), ('CHEBI_35885', 'secondary phosphine', 132, 'phosphorus'), ('UBERON_0002113', 'kidney', 157, 'renal'), ('UBERON_0002107', 'liver', 167, 'hepatic'), ('CHEBI_35624', 'azaspiro compound', 190, 'anticonvulsant')]
PMC4188019	1/2010	S15-PMC4188019	['in the Liver, Vitamin D is hydroxylated to 25-Hydroxyvitamin D. subsequent hydroxylation in the Kidney forms the active Metabolite, 1,25-Oh vitamin D.\nin Pregnancy, there is a 2-fold higher concentration of 1,25-Oh Vitamin D in maternal Serum due to activity of Placental 1-α-hydroxylase (novakovic et al., 2009).']	N/A	N/A	[('UBERON_0002107', 'liver', 7, 'liver'), ('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 43, '25-hydroxyvitamin D'), ('UBERON_0002113', 'kidney', 96, 'kidney'), ('CHEBI_39382', 'flufenoxuron', 120, 'metabolite'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 134, '25-OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 148, 'D'), ('GO_0007565', 'female pregnancy', 154, 'pregnancy'), ('CHEBI_72639', '13-HODE', 207, '1,25-OH'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('UBERON_0001977', 'blood serum', 237, 'serum'), ('UBERON_0001987', 'placenta', 262, 'placental')]
PMC4210909	10/2014	S17-PMC4210909	['Absorption Of Iron is primarily Regulated within the Intestine, and once iron has been absorbed, there is no mechanism of Excretion from the Kidneys or Liver [9].']	N/A	N/A	[('GO_0006754', 'ATP biosynthetic process', 0, 'Absorption of iron'), ('GO_0065007', 'biological regulation', 32, 'regulated'), ('UBERON_0000160', 'intestine', 53, 'intestine'), ('GO_0007588', 'excretion', 122, 'excretion'), ('UBERON_0002113', 'kidney', 141, 'kidneys'), ('UBERON_0002107', 'liver', 152, 'liver')]
PMC4224012	11/2014	S3-PMC4224012	['methods\nfor this follow-up study, we identified children from the original trial and measured anthropometry, body composition with bioelectrical impedance (with population-specific isotope calibration), Blood pressure, and Renal dimensions by ultrasound.']	N/A	N/A	[('UBERON_0000178', 'blood', 203, 'blood'), ('UBERON_0002113', 'kidney', 223, 'renal')]
PMC4224012	11/2014	S59-PMC4224012	['we recorded maximum Renal length and anteroposterior dimensions, after visualising Sinus and Parenchyma using predefined landmarks.']	N/A	N/A	[('UBERON_0002113', 'kidney', 20, 'renal'), ('UBERON_0001825', 'paranasal sinus', 83, 'sinus'), ('UBERON_0000353', 'parenchyma', 93, 'parenchyma')]
PMC4224261	9/2014	S83-PMC4224261	['Iodine Metabolism in the Pregnant versus the non-Pregnant state\nInorganic Iodine is almost completely absorbed from the Gastrointestinal Tract [15], and Plasma inorganic Iodine is primarily balanced by Iodine Intake, Transfer Of Iodine into the Thyroid Gland and Renal Excretion Of Iodine.']	N/A	N/A	[('CHEBI_31719', 'ipriflavone', 0, 'Iodine'), ('GO_0046102', 'inosine metabolic process', 0, 'Iodine Metabolism'), ('GO_0007565', 'female pregnancy', 25, 'Pregnant'), ('GO_0007565', 'female pregnancy', 49, 'Pregnant'), ('CHEBI_5939', 'Interferon gamma-1b', 64, 'Inorganic'), ('CHEBI_24859', 'iodine atom', 74, 'iodine'), ('UBERON_0001555', 'digestive tract', 120, 'gastrointestinal tract'), ('UBERON_0001969', 'blood plasma', 153, 'plasma'), ('CHEBI_24859', 'iodine atom', 170, 'iodine'), ('CHEBI_24859', 'iodine atom', 202, 'iodine'), ('GO_0007631', 'feeding behavior', 209, 'intake'), ('GO_0009294', 'DNA mediated transformation', 217, 'transfer of iodine'), ('CHEBI_24859', 'iodine atom', 229, 'iodine'), ('UBERON_0002046', 'thyroid gland', 245, 'thyroid gland'), ('GO_0006281', 'DNA repair', 263, 'renal'), ('UBERON_0002113', 'kidney', 263, 'renal'), ('GO_0008386', 'cholesterol monooxygenase (side-chain-cleaving) activity', 269, 'excretion of iodine'), ('CHEBI_24859', 'iodine atom', 282, 'iodine')]
PMC4249952	12/2014	S15-PMC4249952	['lead is absorbed and spread through the Blood, resulting in long-term accumulation in the Liver, Kidney, Spleen, Lung, and Brain.']	N/A	N/A	[('UBERON_0000178', 'blood', 40, 'blood'), ('UBERON_0002107', 'liver', 90, 'liver'), ('UBERON_0002113', 'kidney', 97, 'kidney'), ('UBERON_0002106', 'spleen', 105, 'spleen'), ('UBERON_0002048', 'lung', 113, 'lung'), ('UBERON_0000955', 'brain', 123, 'brain')]
PMC4251419	12/2014	S18-PMC4251419	['the Synthesis Of Vitamin D following uvb irradiation Of The Skin\nuvb Photons are absorbed by 7-Dehydrocholestrol in the Epidermis and are converted into pre-Vitamin D which undergoes a thermal isomerisation to Formvitamin D. this then undergoes two Hydroxylation reactions, first in the Liver to form 25-Hydroxyvitamin D (25(Oh)D) and then in the Kidney to form the active Metabolite, 1,25-Dihydroxyvitamin D (1,25(Oh)2D).']	N/A	N/A	[('GO_0030474', 'spindle pole body duplication', 4, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0001554', 'luteolysis', 53, 'of     skin'), ('CHEBI_30212', 'photon', 69, 'photons'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 93, '7-dehydrocholestrol'), ('UBERON_0007376', 'outer epithelium', 120, 'epidermis'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('CHEBI_72459', 'Dig-Cy5', 210, 'formvitamin D'), ('GO_0044444', 'cytoplasmic part', 249, 'hydroxylation'), ('UBERON_0002107', 'liver', 287, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 301, '25-hydroxyvitamin D'), ('CHEBI_63056', 'zinc cation', 322, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 328, 'D'), ('UBERON_0002113', 'kidney', 347, 'kidney'), ('CHEBI_39382', 'flufenoxuron', 373, 'metabolite'), ('CHEBI_67472', '15-epi-lupulin B', 385, '1,25-dihydroxyvitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 410, '1,25(OH)2D')]
PMC4271720	12/2014	S203-PMC4271720	['other clinical manifestations involve Parenchymal Organs such as the Kidney, Lung, and Liver (mavragani and moutsopoulos, 2014).']	N/A	N/A	[('UBERON_0001804', 'capsule of lens', 38, 'parenchymal'), ('UBERON_0000062', 'organ', 50, 'organs'), ('UBERON_0002113', 'kidney', 69, 'kidney'), ('UBERON_0002048', 'lung', 77, 'lung'), ('UBERON_0002107', 'liver', 87, 'liver')]
PMC4284764	12/2014	S27-PMC4284764	['male pup mortality rates, body weight (bw), Kidney weight, and Heart weight were not different among the three groups (table 1).']	N/A	N/A	[('UBERON_0002113', 'kidney', 44, 'kidney'), ('UBERON_0000948', 'heart', 63, 'heart')]
PMC4284764	12/2014	S29-PMC4284764	['note that weights and bp data from three-month-old offspring, which in part was published previously [4], is included in this study for the sake of comparison.ijms-15-23255-t001_table 1\n\ncaption (table-wrap): table 1\n\nweights and functional parameters in Rats at three months of age.groupscontroll-Namel-Name + citmortality0%0%0%body weight (bw) (g)524 ± 30478 ± 15469 ± 9left kidney weight (g)2.08 ± 0.161.87 ± 0.101.95 ± 0.04left Kidney weight/100 g bw0.39 ± 0.010.39 ± 0.010.42 ± 0.01heart weight (g)1.56 ± 0.101.61 ± 0.041.62 ± 0.04heart weight/100 g bw0.30 ± 0.010.34 ± 0.020.35 ± 0.01systolic Blood pressure (mmhg)149 ± 2165 ± 1a152 ± 2bdiastolic Blood pressure (mmhg)102 ± 4107 ± 487 ± 2a,bmean Arterial pressure (mmhg)117 ± 2126 ± 3a109 ± 1b\nn = 6/group,ap< 0.05 vs. control;bp<0.05 vs. L-Name.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 255, 'rats'), ('CHEBI_32875', 'methyl group', 298, 'NAMEl'), ('CHEBI_13389', 'NAD', 304, 'NAME'), ('UBERON_0002113', 'kidney', 432, 'kidney'), ('UBERON_0000178', 'blood', 599, 'blood'), ('UBERON_0000178', 'blood', 653, 'blood'), ('UBERON_0001637', 'artery', 702, 'arterial'), ('CHEBI_75819', '8-oxo-ETE', 795, 'l-NAME')]
PMC4284764	12/2014	S31-PMC4284764	['the effects ofl-name andl-name + cit on Renal transcriptome\nwe next analyzed differential Gene Expression induced byl-name andl-Name + cit in 3-month-old offspring Kidney.']	N/A	N/A	[('UBERON_0002113', 'kidney', 40, 'Renal'), ('GO_0010467', 'gene expression', 90, 'gene expression'), ('SO_0000704', 'gene', 90, 'gene'), ('CHEBI_13389', 'NAD', 128, 'NAME'), ('UBERON_0002113', 'kidney', 164, 'kidney')]
PMC4284764	12/2014	S38-PMC4284764	['we validated five Renal Transcripts predicted to change significantly in the rna-seq dataset by quantitative real-time polymerase chain reaction (qpcr).']	N/A	N/A	[('UBERON_0002113', 'kidney', 18, 'renal'), ('SO_0000673', 'transcript', 24, 'transcripts')]
PMC4284764	12/2014	S40-PMC4284764	['caption (fig): figure 1\n\n( a ) venn diagram depicting unique and shared (over-lapping circles) sets of differentially Expressed Genes (degs) in the Kidney between maternall-name therapy (black circle) andl-name plusl-Citrulline therapy (white circle) at 12 weeks of age; ( b ) confirmatory analysis of Kidney Gene Expression by qpcr.']	N/A	N/A	[('GO_0010467', 'gene expression', 118, 'expressed'), ('SO_0000704', 'gene', 128, 'genes'), ('UBERON_0002113', 'kidney', 148, 'kidney'), ('CHEBI_18211', 'citrulline', 217, 'citrulline'), ('UBERON_0002113', 'kidney', 302, 'kidney'), ('GO_0010467', 'gene expression', 309, 'gene expression'), ('SO_0000704', 'gene', 309, 'gene')]
PMC4284764	12/2014	S48-PMC4284764	['we identified two Genes above the chosen threshold, namely Dnmt3L and Hdac9 (table 4).ijms-15-23255-t004_table 4\n\ncaption (table-wrap): table 4\n\nchanges in Genes involved in epigenetic Regulation in the Kidney of offspring at three months of age to maternall-name and/or cit vs. control.Gene idgene symboldescriptionfold changesl-Name/controlfold changesl-Name + cit/Control dna methyltransferases ensrnog00000039859 Dnmt1 dna methyltransferase 11.011.04ensrnog00000026132 Dnmt2 dna methyltransferase 20.970.96ensrnog00000026649 Dnmt3A dna methyltransferase 3a0.740.87ensrnog00000010625 dnmt3b dna methyltransferase 3b0.780.90ensrnog00000001212 Dnmt3L Dna Methyltransferase 3-like0.61 0.40histone deacetylases ensrnog00000009568 Hdac1 Histone deacetylase 10.891.00ensrnog00000000604 Hdac2 Histone Deacetylase 21.041.13ensrnog00000019618 Hdac3 Histone Deacetylase 30.890.99ensrnog00000020372 Hdac4 Histone deacetylase 40.871.21ensrnog00000020905 Hdac5 Histone Deacetylase 51.131.07ensrnog00000006791 Hdac6 Histone Deacetylase 60.920.89ensrnog00000008308 Hdac7 Histone Deacetylase 71.041.03ensrnog00000003122 Hdac8 Histone Deacetylase 81.071.01ensrnog00000004158 Hdac9 Histone Deacetylase 9 0.46 ndensrnog00000031915 Hdac10 Histone Deacetylase 100.961.17ensrnog00000006824 Hdac11 Histone Deacetylase 110.850.76 chromodomain-containing proteins ensrnog00000014434 chd1 chromodomain Helicase Dna Binding Protein 10.981.22ensrnog00000012716 chd2 chromodomain Helicase Dna Binding Protein 21.111.17ensrnog00000009722 chd3 Chromodomain Helicase Dna Binding Protein 31.010.97ensrnog00000018309 chd4 chromodomain Helicase Dna Binding Protein 40.891.24ensrnog00000011268 chd5 chromodomain Helicase Dna Binding Protein 50.770.89ensrnog00000025011 chd8 chromodomain Helicase Dna Binding Protein 60.941.10 bromodomain-containing proteins ensrnog00000004538 Brd1 bromodomain containing 10.931.16ensrnog00000000461 Brd2 bromodomain containing 20.750.95ensrnog00000006770 brd4 bromodomain containing 40.610.94ensrnog00000014419 brd7 bromodomain containing 71.011.15ensrnog00000020340 brd8 bromodomain containing 81.121.08ensrnog00000015676 brd9 bromodomain containing 90.961.05ensrnog00000028641 Brpf3 bromodomain and phd finger containing 30.950.58ensrnog00000001453 Baz1B bromodomain adjacent to zinc finger Domain, 1b1.081.25ensrnog00000028816 Baz2A bromodomain adjacent to zinc finger Domain, 2a0.81.14ensrnog00000025148 Baz2B bromodomain adjacent to zinc finger Domain, 2b0.881.23ensrnog00000002073 brdt bromodomain, Testis-specific0.641.3ensrnog00000001632 brwd1 bromodomain and wd repeat Domain containing 10.981.23ensrnog00000002291 brwd3 bromodomain and wd repeat Domain containing 31.111.20 Histone Methyl- and acetyl-transferase ensrnog00000019585 Myst1 k (lysine) acetyltransferase 80.800.71ensrnog00000022664 Myst2 k (lysine) acetyltransferase 71.071.32ensrnog00000025174 myst3 k(lysine) acetyltransferase 6a0.921.20ensrnog00000007242 ehmt1 euchromatic Histone-lysine n -methyltransferase 10.951.12ensrnog00000030630 ehmt2 euchromatic Histone-lysine n -methyltransferase 20.840.79ensrnog00000001524 Hat1 Histone acetyltransferase 11.351.14\nquantification for Gene Expression was calculated as reads per kilobase of Exon per million mapped reads (rpkm).']	N/A	N/A	[('SO_0000704', 'gene', 18, 'genes'), ('PR_000006603', 'dynamin-2', 59, 'Dnmt3l'), ('PR_000008454', 'hepatitis A virus cellular receptor 2', 70, 'Hdac9'), ('SO_0000704', 'gene', 156, 'genes'), ('GO_0065007', 'biological regulation', 185, 'regulation'), ('UBERON_0002113', 'kidney', 203, 'kidney'), ('SO_0000704', 'gene', 287, 'Gene'), ('CHEBI_13389', 'NAD', 330, 'NAME'), ('CHEBI_13389', 'NAD', 356, 'NAME'), ('GO_0065007', 'biological regulation', 367, 'Control'), ('PR_000006543', 'doublesex- and mab-3-related transcription factor 2', 417, 'Dnmt1'), ('PR_000006549', 'doublesex- and mab-3-related transcription factor C2', 473, 'Dnmt2'), ('PR_000006564', 'dynein heavy chain 5, axonemal', 529, 'Dnmt3a'), ('PR_000006603', 'dynamin-2', 645, 'Dnmt3l'), ('PR_000012973', 'DNA polymerase subunit gamma-1', 652, 'DNA methyltransferase 3'), ('PR_000008532', 'hemojuvelin', 729, 'Hdac1'), ('CHEBI_15358', 'histone', 735, 'Histone'), ('PR_000027594', 'histone H3', 735, 'Histone'), ('PR_000008594', 'histone H2B type 1-O', 783, 'Hdac2'), ('CHEBI_15358', 'histone', 789, 'Histone'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 789, 'Histone deacetylase'), ('PR_000008443', 'huntingtin-associated protein 1', 837, 'Hdac3'), ('CHEBI_15358', 'histone', 843, 'Histone'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 843, 'Histone deacetylase'), ('PR_000008532', 'hemojuvelin', 891, 'Hdac4'), ('CHEBI_15358', 'histone', 897, 'Histone'), ('PR_000027594', 'histone H3', 897, 'Histone'), ('PR_000008532', 'hemojuvelin', 945, 'Hdac5'), ('CHEBI_15358', 'histone', 951, 'Histone'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 951, 'Histone deacetylase'), ('PR_000008532', 'hemojuvelin', 999, 'Hdac6'), ('CHEBI_15358', 'histone', 1005, 'Histone'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 1005, 'Histone deacetylase'), ('PR_000008532', 'hemojuvelin', 1053, 'Hdac7'), ('CHEBI_15358', 'histone', 1059, 'Histone'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 1059, 'Histone deacetylase'), ('PR_000008532', 'hemojuvelin', 1107, 'Hdac8'), ('CHEBI_15358', 'histone', 1113, 'Histone'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 1113, 'Histone deacetylase'), ('PR_000008454', 'hepatitis A virus cellular receptor 2', 1161, 'Hdac9'), ('CHEBI_15358', 'histone', 1167, 'Histone'), ('PR_000008476', 'orexin', 1167, 'Histone deacetylase 9'), ('PR_000008443', 'huntingtin-associated protein 1', 1215, 'Hdac10'), ('CHEBI_15358', 'histone', 1222, 'Histone'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 1222, 'Histone deacetylase'), ('PR_000008532', 'hemojuvelin', 1271, 'Hdac11'), ('CHEBI_15358', 'histone', 1278, 'Histone'), ('PR_000008776', 'very-long-chain 3-oxoacyl-CoA reductase', 1278, 'Histone deacetylase 110'), ('PR_000014411', 'protein S100-A4', 1379, 'helicase DNA binding protein 10'), ('PR_000008443', 'huntingtin-associated protein 1', 1454, 'helicase DNA binding protein 21'), ('PR_000005090', 'protein chibby homolog 1', 1516, 'Chromodomain helicase DNA binding protein 31'), ('PR_000014741', 'protein SFI1', 1604, 'helicase DNA binding protein 40'), ('PR_000017341', 'vacuolar protein sorting-associated protein 45', 1679, 'helicase DNA binding protein 50'), ('PR_000008433', 'trifunctional enzyme subunit alpha, mitochondrial', 1754, 'helicase DNA binding protein'), ('PR_000004803', 'breast cancer type 1 susceptibility protein', 1844, 'Brd1'), ('PR_000004803', 'breast cancer type 1 susceptibility protein', 1900, 'Brd2'), ('PR_000013043', 'POU domain, class 4, transcription factor 3', 2180, 'Brpf3'), ('PR_000004803', 'breast cancer type 1 susceptibility protein', 2252, 'Baz1b'), ('SO_0000417', 'polypeptide_domain', 2294, 'domain'), ('PR_000004693', 'Bcl-2-like protein 10', 2331, 'Baz2a'), ('SO_0000417', 'polypeptide_domain', 2373, 'domain'), ('PR_000004803', 'breast cancer type 1 susceptibility protein', 2409, 'Baz2b'), ('SO_0000417', 'polypeptide_domain', 2451, 'domain'), ('UBERON_0000473', 'testis', 2506, 'testis'), ('SO_0000417', 'polypeptide_domain', 2579, 'domain'), ('SO_0000417', 'polypeptide_domain', 2657, 'domain'), ('CHEBI_15358', 'histone', 2685, 'Histone'), ('PR_000027594', 'histone H3', 2685, 'Histone'), ('CHEBI_32875', 'methyl group', 2693, 'methyl'), ('PR_000010911', 'lens fiber major intrinsic protein', 2743, 'Myst1'), ('PR_000010911', 'lens fiber major intrinsic protein', 2806, 'Myst2'), ('CHEBI_15358', 'histone', 2950, 'histone'), ('PR_000043452', 'core histone', 2950, 'histone'), ('CHEBI_15358', 'histone', 3032, 'histone'), ('PR_000043452', 'core histone', 3032, 'histone'), ('PR_000008443', 'huntingtin-associated protein 1', 3096, 'Hat1'), ('CHEBI_15358', 'histone', 3101, 'Histone'), ('GO_0010467', 'gene expression', 3156, 'gene expression'), ('SO_0000704', 'gene', 3156, 'gene'), ('SO_0000147', 'exon', 3212, 'exon')]
PMC4284764	12/2014	S116-PMC4284764	['Kidneys were harvested after perfusion with phosphate buffered saline (pbs), decapsulated, divided into Cortex and Medulla, and stored at −80 °c for further analysis.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidneys'), ('UBERON_0001851', 'cortex', 104, 'cortex'), ('UBERON_0000958', 'medulla of organ', 115, 'medulla')]
PMC4284764	12/2014	S118-PMC4284764	['next-generation sequencing and analysis\nKidneys of control,l-Name, andl-Name + cit group were isolated and snap-frozen for whole-Genome rna next-generation sequencing (rna-seq), performed by welgene biotech co., ltd. (taipei, taiwan).']	N/A	N/A	[('UBERON_0002113', 'kidney', 40, 'Kidneys'), ('CHEBI_13389', 'NAD', 61, 'NAME'), ('PR_000010990', 'N-alpha-acetyltransferase 16, NatA auxiliary subunit', 61, 'NAME'), ('1', 'A1BG (human)', 71, '-'), ('CHEBI_13389', 'NAD', 72, 'NAME'), ('SO_0001026', 'genome', 129, 'genome')]
PMC4284764	12/2014	S128-PMC4284764	['go term enrichment and fold enrichment or depletion for Gene lists of significantly up- and downregulated Genes in Kidney were determined.']	N/A	N/A	[('SO_0000704', 'gene', 56, 'gene'), ('SO_0000704', 'gene', 106, 'genes'), ('UBERON_0002113', 'kidney', 115, 'kidney')]
PMC4289552	12/2014	S15-PMC4289552	['maternal Calcium Homeostasis is maintained by hormonal adaptive mechanisms that Control Intestinal Calcium Absorption, Renal Calcium Excretion, and mobilization of Skeletal Mineral stores [3,4].']	N/A	N/A	[('GO_0055073', 'cadmium ion homeostasis', 9, 'calcium homeostasis'), ('GO_0065007', 'biological regulation', 80, 'control'), ('UBERON_0000160', 'intestine', 88, 'intestinal'), ('GO_0051304', 'chromosome separation', 99, 'calcium absorption'), ('GO_0006281', 'DNA repair', 119, 'renal'), ('UBERON_0002113', 'kidney', 119, 'renal'), ('GO_0036161', 'calcitonin secretion', 125, 'calcium excretion'), ('UBERON_0004288', 'skeleton', 164, 'skeletal'), ('CHEBI_46662', 'mineral', 173, 'mineral')]
PMC4289552	12/2014	S32-PMC4289552	['when Pregnant women were screened for initial recruitment, they were excluded if they exhibited any of the following conditions: any factor that could interfere with maternal calcium Metabolism, intention not to Breastfeed, Preeclampsia, Kidney or Cardiac diseases, Gestational diabetes, history of Urinary infections, family or personal history of Kidney stone formation, seizure disorder requiring daily medications, or ingestion of Corticosteroids.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 5, 'pregnant'), ('GO_0008152', 'metabolic process', 183, 'metabolism'), ('GO_0007596', 'blood coagulation', 212, 'breastfeed'), ('GO_0007128', 'meiotic prophase I', 224, 'preeclampsia'), ('UBERON_0002113', 'kidney', 238, 'kidney'), ('UBERON_0000948', 'heart', 248, 'cardiac'), ('GO_0007565', 'female pregnancy', 266, 'gestational'), ('UBERON_0001088', 'urine', 299, 'urinary'), ('UBERON_0002113', 'kidney', 349, 'kidney'), ('CHEBI_50850', 'etabonate ester', 435, 'corticosteroids')]
PMC4303849	1/2015	S40-PMC4303849	['Regulation of the vd-Metabolizing enzymes\nRenal Cyp27B1, which is responsible for the most part of circulating Calcitriol, is mainly Regulated by Parathyroid hormone (pth) -as a signal of calcium status-, Fibroblast Growth Factor 23 (Fgf23) -as a signal of Serum Phosphate levels- and Calcitriol itself -as a negative feedback Regulatory loop- [26].']	N/A	N/A	[('GO_0065007', 'biological regulation', 0, 'Regulation'), ('GO_0008152', 'metabolic process', 21, 'Metabolizing'), ('UBERON_0002113', 'kidney', 42, 'Renal'), ('PR_000006101', 'cytochrome P450 1A1', 48, 'CYP27B1'), ('CHEBI_17823', 'calcitriol', 111, 'calcitriol'), ('GO_0065007', 'biological regulation', 133, 'regulated'), ('UBERON_0001132', 'parathyroid gland', 146, 'parathyroid'), ('CL_0000057', 'fibroblast', 205, 'fibroblast'), ('PR_000007481', 'fibroblast growth factor 11', 205, 'fibroblast growth factor 23'), ('PR_000007483', 'fibroblast growth factor 13', 234, 'FGF23'), ('UBERON_0001977', 'blood serum', 257, 'serum'), ('CHEBI_18367', 'phosphate(3-)', 263, 'phosphate'), ('CHEBI_17823', 'calcitriol', 285, 'calcitriol'), ('GO_0065007', 'biological regulation', 327, 'regulatory')]
PMC4303849	1/2015	S41-PMC4303849	['when Serum calcium levels are low, pth is Secreted by the Parathyroid Gland in order to stimulate Renal Cyp27B1 by a Cyclic Amp (Camp)-dependent mechanism [27].']	N/A	N/A	[('UBERON_0001977', 'blood serum', 5, 'serum'), ('GO_0046903', 'secretion', 42, 'secreted'), ('UBERON_0001132', 'parathyroid gland', 58, 'parathyroid gland'), ('UBERON_0002113', 'kidney', 98, 'renal'), ('PR_000006101', 'cytochrome P450 1A1', 104, 'CYP27B1'), ('CHEBI_27840', '2,4-dimethylaniline', 117, 'cyclic AMP'), ('CHEBI_17489', "3',5'-cyclic AMP", 129, 'cAMP')]
PMC4303849	1/2015	S42-PMC4303849	['pth also causes Cyp24A1 Mrna Degradation in the Kidney [28].']	N/A	N/A	[('PR_000006101', 'cytochrome P450 1A1', 16, 'CYP24A1'), ('GO_0006402', 'mRNA catabolic process', 24, 'mRNA degradation'), ('UBERON_0002113', 'kidney', 48, 'kidney')]
PMC4303849	1/2015	S74-PMC4303849	['collectively, these changes include increased maternal Serum Calcitriol, dbp, Placental vdr and Renal and Placental Cyp27B1 activity, without changes in Serum 25Ohd or calcium levels.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_17823', 'calcitriol', 61, 'calcitriol'), ('UBERON_0001987', 'placenta', 78, 'placental'), ('UBERON_0002113', 'kidney', 96, 'renal'), ('UBERON_0001987', 'placenta', 106, 'placental'), ('PR_000006101', 'cytochrome P450 1A1', 116, 'CYP27B1'), ('UBERON_0001977', 'blood serum', 153, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 159, '25OHD')]
PMC4329745	10/2014	S20-PMC4329745	['exclusion criteria included chronic illness, history of cancer, Pregnancy or Lactation, malabsorption syndrome or gastric disorders, Metabolic bone disease, Renal or Hepatic failure, recent history of therapeutic Vitamin D consumption or osteoporosis treatment.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007595', 'lactation', 77, 'lactation'), ('GO_0008152', 'metabolic process', 133, 'metabolic'), ('UBERON_0002113', 'kidney', 157, 'renal'), ('UBERON_0002107', 'liver', 166, 'hepatic'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC4341080	3/2015	S51-PMC4341080	['Animal measurements\nbody condition scores were determined by palpating the Lumbar Region, specifically on and around the Backbone (Spinous and Transverse Processes) in the Loin area, immediately behind the Last Rib and above the Kidneys to examine the degree of sharpness or roundness (jefferies 1961;kenyon et al., 2014, scale 0 to 5.0 including half units).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('UBERON_0008337', 'inguinal part of abdomen', 75, 'lumbar region'), ('UBERON_0001447', 'tarsal bone', 121, 'backbone'), ('UBERON_0002061', 'truncus arteriosus', 131, 'spinous ...'), ('UBERON_0001077', 'transverse process of vertebra', 143, 'transverse processes'), ('GO_0042995', 'cell projection', 154, 'processes'), ('UBERON_0001751', 'dentine', 172, 'loin'), ('UBERON_0000088', 'trophoblast', 206, 'last'), ('UBERON_0002228', 'rib', 211, 'rib'), ('UBERON_0002113', 'kidney', 229, 'kidneys')]
PMC4349447	3/2015	S85-PMC4349447	['Eating offal —the Eating of Liver, Heart, Kidney or Liver pate with five responses ranging from never or rarely to more than once per day .']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Eating'), ('GO_0051318', 'G1 phase', 18, 'eating'), ('UBERON_0002107', 'liver', 28, 'liver'), ('UBERON_0000948', 'heart', 35, 'heart'), ('UBERON_0002113', 'kidney', 42, 'kidney'), ('UBERON_0002107', 'liver', 52, 'liver')]
PMC4363193	3/2015	S103-PMC4363193	['cold Carcass weight was estimated as the weight of the hot eviscerated Carcass, (minus Tongue, Bristles, Genital Organs, Kidneys, flare fat and Diaphragm) 45\xa0min after harvest x 0.98.']	N/A	N/A	[('UBERON_0008979', 'carcass', 5, 'carcass'), ('UBERON_0008979', 'carcass', 71, 'carcass'), ('UBERON_0001723', 'tongue', 87, 'tongue'), ('UBERON_0004361', 'stylohyoid ligament', 95, 'bristles'), ('UBERON_0003133', 'reproductive organ', 105, 'genital organs'), ('UBERON_0002113', 'kidney', 121, 'kidneys'), ('UBERON_0001103', 'diaphragm', 144, 'diaphragm')]
PMC4377888	3/2015	S3-PMC4377888	['this then predisposes these offspring to Cardiovascular disease and Renal dysfunction in Adulthood.']	N/A	N/A	[('UBERON_0004535', 'cardiovascular system', 41, 'cardiovascular'), ('UBERON_0002113', 'kidney', 68, 'renal'), ('UBERON_0000113', 'post-juvenile adult stage', 89, 'adulthood')]
PMC4377888	3/2015	S55-PMC4377888	['[50] report greater mean Arterial pressure (6 mmhg), Heart rate (13 bpm) and Renal Sympathetic Nerve activity (1.3 nu) compared with controls.']	N/A	N/A	[('UBERON_0001637', 'artery', 25, 'arterial'), ('UBERON_0000948', 'heart', 53, 'heart'), ('UBERON_0002113', 'kidney', 77, 'renal'), ('UBERON_0034729', 'sympathetic nerve', 83, 'sympathetic nerve')]
PMC4377888	3/2015	S77-PMC4377888	['Kidney Development\n\n2.1.']	N/A	N/A	[('GO_0060132', 'prolactin secreting cell development', 0, 'Kidney Development'), ('UBERON_0002113', 'kidney', 0, 'Kidney')]
PMC4377888	3/2015	S79-PMC4377888	['in Mammals, the Kidney develops through three successive stages (figure 1):\nthe Pronephros, a rudimentary structure that develops from the Lateral Plate and intermediate Mesoderm and continues to develop into the Mesonephros [59].']	N/A	N/A	[('NCBITaxon_40674', 'Mammalia', 3, 'mammals'), ('UBERON_0002113', 'kidney', 16, 'kidney'), ('UBERON_0002120', 'pronephros', 80, 'Pronephros'), ('UBERON_0003081', 'lateral plate mesoderm', 139, 'lateral plate'), ('UBERON_0000926', 'mesoderm', 170, 'mesoderm'), ('UBERON_0000080', 'mesonephros', 213, 'mesonephros')]
PMC4377888	3/2015	S82-PMC4377888	['caption (fig): figure 1\n\nKidney Development.']	N/A	N/A	[('GO_0000162', 'tryptophan biosynthetic process', 25, 'Kidney development'), ('UBERON_0002113', 'kidney', 25, 'Kidney')]
PMC4377888	3/2015	S83-PMC4377888	['the Mammalian Kidney develops through three stages (Pronephros, Mesonephros and Metanephros).']	N/A	N/A	[('NCBITaxon_40674', 'Mammalia', 4, 'mammalian'), ('UBERON_0002113', 'kidney', 14, 'kidney'), ('UBERON_0002120', 'pronephros', 52, 'pronephros'), ('UBERON_0000080', 'mesonephros', 64, 'mesonephros'), ('UBERON_0000081', 'metanephros', 80, 'metanephros')]
PMC4377888	3/2015	S92-PMC4377888	['Genetic Control Of Kidney Development\n\n2.2.1.']	N/A	N/A	[('GO_0007268', 'chemical synaptic transmission', 0, 'Genetic'), ('SO_0000704', 'gene', 0, 'Genetic'), ('GO_0061314', 'Notch signaling involved in heart development', 8, 'Control of Kidney Development'), ('UBERON_0002113', 'kidney', 19, 'Kidney')]
PMC4377888	3/2015	S96-PMC4377888	['caption (fig): figure 2\n\nmolecular Control of early Kidney Development.']	N/A	N/A	[('GO_0065007', 'biological regulation', 35, 'control'), ('GO_0001822', 'kidney development', 52, 'kidney development'), ('UBERON_0002113', 'kidney', 52, 'kidney')]
PMC4377888	3/2015	S97-PMC4377888	['early Development Of the Metanephros, the permanent Mammalian Kidney, is under tight molecular Control.']	N/A	N/A	[('GO_0042742', 'defense response to bacterium', 6, 'development of ... metanephros'), ('UBERON_0000081', 'metanephros', 25, 'metanephros'), ('NCBITaxon_40674', 'Mammalia', 52, 'mammalian'), ('GO_0016255', 'attachment of GPI anchor to protein', 62, 'kidney'), ('UBERON_0002113', 'kidney', 62, 'kidney'), ('GO_0065007', 'biological regulation', 95, 'control')]
PMC4377888	3/2015	S99-PMC4377888	['Production Of Gdnf is under the influence of Pax2 , together these factors stimulate Branching Morphogenesis Of the Kidney.']	N/A	N/A	[('GO_0008283', 'cell proliferation', 0, 'Production of'), ('PR_000007859', 'transcription factor GATA-4', 14, 'Gdnf'), ('PR_000012318', 'paired box protein Pax-6', 45, 'Pax2'), ('GO_0002412', 'antigen transcytosis by M cells in mucosal-associated lymphoid tissue', 85, 'branching morphogenesis of ... kidney'), ('UBERON_0002113', 'kidney', 116, 'kidney')]
PMC4377888	3/2015	S102-PMC4377888	['the Formation Of Renal Vesicles (from the Cap Mesenchyme) is Controlled by the number of Six2 positive cells (denoting Renal Stem Cells).']	N/A	N/A	[('GO_0048468', 'cell development', 4, 'formation of ... vesicles'), ('UBERON_0004209', 'renal vesicle', 17, 'renal vesicles'), ('UBERON_0005107', 'metanephric cap', 42, 'cap mesenchyme'), ('GO_0065007', 'biological regulation', 61, 'controlled'), ('PR_000014740', 'splicing factor 4', 89, 'Six2'), ('CL_0002518', 'kidney epithelial cell', 119, 'renal stem cells'), ('UBERON_0002113', 'kidney', 119, 'renal')]
PMC4377888	3/2015	S111-PMC4377888	['under influence of the Genes Pax2 , Wnt4 and Hnf4Α [76,77,78,79] the induced Mesenchyme undergoes Epithelialisation and differentiates successively into Renal Vesicles, Comma-Shaped Bodies, S-Shaped Bodies before the Glomerular Vascular Tuft develops and attaches to the Proximal Tubule to finally form mature Nephrons, the functional units of the Kidney.']	N/A	N/A	[('SO_0000704', 'gene', 23, 'genes'), ('PR_000012318', 'paired box protein Pax-6', 29, 'Pax2'), ('PR_000017444', 'protein Wnt-4', 36, 'Wnt4'), ('PR_000008593', 'histone H2B type 1-M', 45, 'Hnf4α'), ('UBERON_0003104', 'mesenchyme', 77, 'mesenchyme'), ('UBERON_0000397', 'colonic epithelium', 98, 'epithelialisation'), ('UBERON_0004209', 'renal vesicle', 153, 'renal vesicles'), ('UBERON_0004198', 'comma-shaped body', 169, 'comma-shaped bodies'), ('UBERON_0004199', 'S-shaped body', 190, 'S-shaped bodies'), ('UBERON_0005749', 'glomerular tuft', 217, 'glomerular vascular tuft'), ('UBERON_0004134', 'proximal tubule', 271, 'proximal tubule'), ('UBERON_0001285', 'nephron', 310, 'nephrons'), ('UBERON_0002113', 'kidney', 348, 'kidney')]
PMC4377888	3/2015	S132-PMC4377888	['after 20–22 weeks of Gestation in Humans, and by the very end of Kidney Development in Rodent, Nephrons are attached individually and directly along the entire length of the Collecting Duct and are not incorporated in the arcade [63,65].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 21, 'gestation'), ('NCBITaxon_9606', 'Homo sapiens', 34, 'humans'), ('GO_0001822', 'kidney development', 65, 'kidney development'), ('UBERON_0002113', 'kidney', 65, 'kidney'), ('NCBITaxon_33208', 'Metazoa', 87, 'rodent'), ('UBERON_0001285', 'nephron', 95, 'nephrons'), ('UBERON_0001232', 'collecting duct of renal tubule', 174, 'collecting duct')]
PMC4377888	3/2015	S212-PMC4377888	['[129] report Renal abnormalities including hydronephrosis and cyst formation.']	N/A	N/A	[('UBERON_0002113', 'kidney', 13, 'renal')]
PMC4377888	3/2015	S213-PMC4377888	['furthermore, offspring had increased Renal Apoptosis combined with reduced Glomerular number.']	N/A	N/A	[('GO_0006281', 'DNA repair', 37, 'renal'), ('UBERON_0002113', 'kidney', 37, 'renal'), ('GO_0006915', 'apoptotic process', 43, 'apoptosis'), ('UBERON_0000074', 'renal glomerulus', 75, 'glomerular')]
PMC4377888	3/2015	S242-PMC4377888	['[101] that the Kidneys of australian aboriginals contain 30% fewer Nephrons than those of non-indigenous australians.']	N/A	N/A	[('UBERON_0002113', 'kidney', 15, 'kidneys'), ('UBERON_0001285', 'nephron', 67, 'nephrons')]
PMC4377888	3/2015	S307-PMC4377888	['assessing the maturity of preterm Kidneys, sutherland et al.']	N/A	N/A	[('UBERON_0002113', 'kidney', 34, 'kidneys')]
PMC4379362	3/2015	S125-PMC4379362	['caption (table-wrap): table ii\n\ndiagnosis and treatment of asymptomatic bacteriuria (asb) and acute cystitis/Urethritis (doses for normal Renal function)asymptomatic bacteriuriaacute cystitis/Urethritis screening (obligatory) 1stprenatal visit or 12–16 hbd first line treatment Amoxicillin 500 mg every 8–12 h – for 3–7 daysfor 7 dayscephalexin 500 mg every 12/6 h – for 3–7 daysfor 7 days fda cat.']	N/A	N/A	[('UBERON_0000084', 'ureteric bud', 109, 'urethritis'), ('UBERON_0002113', 'kidney', 138, 'renal'), ('UBERON_0000084', 'ureteric bud', 192, 'urethritis'), ('CHEBI_2676', 'amoxicillin', 278, 'Amoxicillin')]
PMC4379362	3/2015	S164-PMC4379362	['complications included: anemia (23%), septicemia (17%), transient Renal dysfunction (2%), and Pulmonary insufficiency (7%).']	N/A	N/A	[('UBERON_0002113', 'kidney', 66, 'renal'), ('UBERON_0002048', 'lung', 94, 'pulmonary')]
PMC4379362	3/2015	S173-PMC4379362	['Renal abscess, Ureter obstruction, other Abdominal infections).']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'renal'), ('UBERON_0000056', 'ureter', 15, 'ureter'), ('UBERON_0000916', 'abdomen', 41, 'abdominal')]
PMC4379362	3/2015	S174-PMC4379362	['caption (table-wrap): table iii\n\ndiagnosis and treatment of acute pyelonephritis (doses for normal Renal function)diagnosis symptoms+Urine culture:fever > 38°c, Lumbar pain, Skeletal and Joint pains, nausea/vomiting with or without accompanying dysuria, polyuria≥ 105cfu/ml in mid-stream Urine specimen mild or moderate acute pyelonephritis ceftriaxone 1 g every 24 Hcefepime 1 g every 24 hamoxicillin with Clavulanic Acid 1.2 g every 12 haztreonam 1 g every 8–12 h severe acute pyelonephritis/immunosuppression/Urinary stasis Ticarcillin with Clavulanic Acid 3.1 g every 6 hpiperacillin with Tazobactam 3.375 g every 6 hmeropenem 0.5 g every 8 hertapenem 1 g every 24 hdoripenem 1 g every 8 h\nin case of allergy to Β -Lactams.']	N/A	N/A	[('UBERON_0002113', 'kidney', 99, 'renal'), ('UBERON_0001088', 'urine', 133, 'urine'), ('UBERON_0005462', 'lower back', 161, 'lumbar'), ('UBERON_0004288', 'skeleton', 174, 'skeletal'), ('UBERON_0004905', 'articulation', 187, 'joint'), ('UBERON_0001088', 'urine', 288, 'urine'), ('CHEBI_5660', 'hentriacontane-14,16-dione', 366, 'hCefepime'), ('CHEBI_23357', 'cofactor', 407, 'clavulanic acid'), ('UBERON_0001088', 'urine', 512, 'urinary'), ('CHEBI_9594', 'Tiglyl tiglate', 527, 'Ticarcillin'), ('CHEBI_23357', 'cofactor', 544, 'clavulanic acid'), ('CHEBI_9421', 'tazobactam', 593, 'tazobactam'), ('CHEBI_35425', 'D-ribose 1-phosphate', 716, 'β -lactams')]
PMC4383437	3/2015	S52-PMC4383437	['medical and obstetric history variables relevant to the tested outcomes were combined into an obstetric/fetal risk factor variable, which included history of Kidney disease; hypertension; anemia; Heart disease; seizures; diabetes; hiv; Rh negative status; asthma; Sexually Transmitted infections; abnormal Blood Clotting; Thyroid disorders; Vaginal, Cervical, or Urinary Tract infections; Endocrine disorders; abnormal Pregnancy weight gain (<4\u2009kg or >18\u2009kg); Preeclampsia; or abnormal bleeding during Pregnancy.']	N/A	N/A	[('UBERON_0002113', 'kidney', 158, 'kidney'), ('UBERON_0000948', 'heart', 196, 'heart'), ('PR_000013773', 'retinoblastoma-associated protein', 236, 'Rh'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 264, 'sexually transmitted'), ('GO_0007596', 'blood coagulation', 306, 'blood clotting'), ('UBERON_0000178', 'blood', 306, 'blood'), ('UBERON_0002046', 'thyroid gland', 322, 'thyroid'), ('UBERON_0001987', 'placenta', 341, 'vaginal'), ('UBERON_0005434', 'cervical region', 350, 'cervical'), ('UBERON_0001553', 'medial tarsal artery', 363, 'urinary tract'), ('GO_0006397', 'mRNA processing', 389, 'endocrine'), ('UBERON_0002049', 'vasculature', 389, 'endocrine'), ('GO_0007565', 'female pregnancy', 419, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 460, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 502, 'pregnancy')]
PMC4392553	3/2015	S92-PMC4392553	['[98139140]\nsprague-dawley Rats Fed a Mn-deficient diet had significantly reduced concentrations of Mn in Liver, Kidney, Heart, and Pancreas, compared with controls.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 26, 'rats'), ('GO_0007631', 'feeding behavior', 31, 'fed'), ('CHEBI_25614', 'nylons', 37, 'Mn'), ('CHEBI_25614', 'nylons', 99, 'Mn'), ('UBERON_0002107', 'liver', 105, 'liver'), ('UBERON_0002113', 'kidney', 112, 'kidney'), ('UBERON_0000948', 'heart', 120, 'heart'), ('UBERON_0001264', 'pancreas', 131, 'pancreas')]
PMC4392553	3/2015	S232-PMC4392553	['[174] several Metabolites were measured from the Liver, Kidney, and Brain.']	N/A	N/A	[('CHEBI_25212', 'metabolite', 14, 'metabolites'), ('UBERON_0002107', 'liver', 49, 'liver'), ('UBERON_0002113', 'kidney', 56, 'kidney'), ('UBERON_0000955', 'brain', 68, 'brain')]
PMC4392553	3/2015	S599-PMC4392553	['these include autism, ad, pd, anxiety disorder, osteoporosis, Inflammatory Bowel disease, Renal lithiasis, osteomalacia, cholestasis, Thyroid dysfunction, and infertility.']	N/A	N/A	[('UBERON_0001782', 'pigmented layer of retina', 62, 'inflammatory bowel'), ('UBERON_0002113', 'kidney', 90, 'renal'), ('UBERON_0002046', 'thyroid gland', 134, 'thyroid')]
PMC4393585	4/2015	S96-PMC4393585	['+ malformation – harelip *malformation – Renal dysplasia.']	N/A	N/A	[('UBERON_0002113', 'kidney', 41, 'renal')]
PMC4404267	4/2015	S27-PMC4404267	['during Mouse Gestation, increased Slc13A1 Gene Expression in the maternal Kidneys leads to increased Renal Sulfate reabsorption and a two-fold increase in circulating Sulfate levels in the Pregnant Mouse [25].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 7, 'mouse'), ('GO_0007565', 'female pregnancy', 13, 'gestation'), ('PR_000014968', 'vesicular acetylcholine transporter', 34, 'Slc13a1'), ('GO_0010467', 'gene expression', 42, 'gene expression'), ('SO_0000704', 'gene', 42, 'gene'), ('UBERON_0002113', 'kidney', 74, 'kidneys'), ('UBERON_0002113', 'kidney', 101, 'renal'), ('CHEBI_16189', 'sulfate', 107, 'sulfate'), ('CHEBI_16189', 'sulfate', 167, 'sulfate'), ('GO_0007565', 'female pregnancy', 189, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 198, 'mouse')]
PMC4404267	4/2015	S29-PMC4404267	['targeted disruption of the Slc13A1 Gene in Pregnant female Mice leads to maternal Renal Sulfate wasting and hyposulfatemia, as well as fetal hyposulfatemia and mid-Gestational Miscarriage [25].']	N/A	N/A	[('PR_000014968', 'vesicular acetylcholine transporter', 27, 'Slc13a1'), ('SO_0000704', 'gene', 35, 'gene'), ('GO_0007565', 'female pregnancy', 43, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 59, 'mice'), ('UBERON_0002113', 'kidney', 82, 'renal'), ('CHEBI_16189', 'sulfate', 88, 'sulfate'), ('GO_0007565', 'female pregnancy', 164, 'gestational'), ('GO_0046660', 'female sex differentiation', 176, 'miscarriage')]
PMC4404267	4/2015	S103-PMC4404267	['increasing Renal Sulfate Reabsorption) with gravidity and parity at 30-37 weeks Gestation, with a steeper decline occurring in female babies when compared to male babies.']	N/A	N/A	[('GO_0070294', 'renal sodium ion absorption', 11, 'renal sulfate reabsorption'), ('UBERON_0002113', 'kidney', 11, 'renal'), ('CHEBI_16189', 'sulfate', 17, 'sulfate'), ('GO_0007565', 'female pregnancy', 80, 'gestation')]
PMC4404267	4/2015	S109-PMC4404267	['the increased Sulfatemia in Pregnant Mice is due to increased Expression of the Renal Slc13A1 Sulfate transporter, which mediates Sulfate reabsorption in the maternal Kidneys [25].']	N/A	N/A	[('CHEBI_9322', 'sulbenicillin', 14, 'sulfatemia'), ('GO_0007565', 'female pregnancy', 28, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 37, 'mice'), ('GO_0010467', 'gene expression', 62, 'expression'), ('UBERON_0002113', 'kidney', 80, 'renal'), ('PR_000014968', 'vesicular acetylcholine transporter', 86, 'Slc13a1'), ('CHEBI_16189', 'sulfate', 94, 'sulfate'), ('CHEBI_16189', 'sulfate', 130, 'sulfate'), ('UBERON_0002113', 'kidney', 167, 'kidneys')]
PMC4404267	4/2015	S125-PMC4404267	['increasing Renal Sulfate Reabsorption) during Pregnancy when the fetus is female.']	N/A	N/A	[('UBERON_0002113', 'kidney', 11, 'renal'), ('CHEBI_16189', 'sulfate', 17, 'sulfate'), ('GO_0001171', 'reverse transcription', 25, 'reabsorption'), ('GO_0007565', 'female pregnancy', 46, 'pregnancy')]
PMC4410178	4/2015	S112-PMC4410178	['Renal function\nUrinary albumin-to-creatinine ratio did not differ significantly between the groups (table 1).']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Renal'), ('UBERON_0001088', 'urine', 15, 'Urinary')]
PMC4413804	5/2015	S31-PMC4413804	['weight was 2.45\u2005kg (5\u2005lbs 6\u2005oz—considered “low weight”) and 49\u2005cm (19.3 inch)the physician attributes hernia to the fact that the child was Born “by his Foot” and was pulled out during the Delivery3Ectopic Kidney, agenesis, Renal dysgenesis, obstructive congenital abnormalities to the Renal Pelvis and Ureter1Male36Term delivery4spina bifida, hydrocephalus and clubfeet1male29the patient was primiparous.']	N/A	N/A	[('GO_0007567', 'parturition', 140, 'born'), ('UBERON_0002387', 'pes', 153, 'foot'), ('GO_0060318', 'definitive erythrocyte differentiation', 189, 'delivery3Ectopic'), ('UBERON_0002113', 'kidney', 206, 'kidney'), ('GO_0006281', 'DNA repair', 224, 'renal'), ('UBERON_0002113', 'kidney', 224, 'renal'), ('UBERON_0001224', 'renal pelvis', 286, 'renal pelvis'), ('UBERON_0012242', 'internal urethral orifice', 303, 'ureter1Male36Term')]
PMC4417995	4/2015	S17-PMC4417995	['25(Oh)D is released into the circulation and is transported to the Kidney where it undergoes further hydroxylation to 1,25-Dihydroxyvitamin D (1,25(Oh)D).']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 0, '25(OH)D'), ('UBERON_0002113', 'kidney', 67, 'kidney'), ('CHEBI_67472', '15-epi-lupulin B', 118, '1,25-dihydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 145, '25(OH)D')]
PMC4425955	4/2015	S13-PMC4425955	['Expression of Angiotensin Receptor Type 2 (Agtr2) is upregulated in response to Renal injury (mcgrath and welham1999; vazquez et\xa0al.2005), promoting Tissue Remodeling via Proliferation and Apoptosis.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000001185', 'alpha-1D adrenergic receptor', 14, 'angiotensin receptor type 2'), ('PR_000001180', 'opsin-5', 43, 'AGTR2'), ('UBERON_0002113', 'kidney', 80, 'renal'), ('GO_0048771', 'tissue remodeling', 149, 'tissue remodeling'), ('UBERON_0000479', 'tissue', 149, 'tissue'), ('GO_0008283', 'cell proliferation', 171, 'proliferation'), ('GO_0006915', 'apoptotic process', 189, 'apoptosis')]
PMC4425955	4/2015	S20-PMC4425955	['in Humans, Blood pressure is higher in men than in women (baylis et\xa0al.1988; august and oparil1999) and the incidence of hypertension is greater in men until women reach their seventh decade (wyndham et\xa0al.1987; joles et\xa0al.2010b), with men exhibiting a more rapid decline in Renal function than women (everitt et\xa0al.1983).']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('UBERON_0000178', 'blood', 11, 'blood'), ('UBERON_0002113', 'kidney', 276, 'renal')]
PMC4425955	4/2015	S51-PMC4425955	['all major Organs were dissected from the Carcass, with Kidneys separated into Cortex and Medulla.']	N/A	N/A	[('UBERON_0000062', 'organ', 10, 'organs'), ('UBERON_0008979', 'carcass', 41, 'carcass'), ('UBERON_0002113', 'kidney', 55, 'kidneys'), ('UBERON_0001851', 'cortex', 78, 'cortex'), ('UBERON_0000958', 'medulla of organ', 89, 'medulla')]
PMC4425955	4/2015	S54-PMC4425955	['biochemical assays\n\nPlasma and Urinary markers of Renal function\nall assays were performed using a microplate reader (model 680 microplate reader, bio-rad laboratories ltd, hemel hempstead, uk).']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 20, 'Plasma'), ('UBERON_0001088', 'urine', 31, 'urinary'), ('UBERON_0002113', 'kidney', 50, 'renal')]
PMC4425955	4/2015	S60-PMC4425955	['Renal Carbonyls\nKidney Carbonyls were determined using the method described previously (langley-evans and sculley2005).']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Renal'), ('CHEBI_33607', 'dihydridoboron(.)', 6, 'carbonyls'), ('UBERON_0002113', 'kidney', 16, 'Kidney'), ('CHEBI_33607', 'dihydridoboron(.)', 23, 'carbonyls')]
PMC4425955	4/2015	S61-PMC4425955	['crushed, frozen Kidney was homogenized in 50\xa0mmol/l potassium phosphate buffer, 5\xa0mmol/l edta, ph 7.4.']	N/A	N/A	[('UBERON_0002113', 'kidney', 16, 'kidney')]
PMC4425955	4/2015	S89-PMC4425955	['fixed Kidney samples were processed and embedded in paraffin using a Tissue processor (histokinette benchtop).']	N/A	N/A	[('UBERON_0002113', 'kidney', 6, 'kidney'), ('UBERON_0000479', 'tissue', 69, 'tissue')]
PMC4425955	4/2015	S94-PMC4425955	['Ed1 and cd3 positive cells were counted in left Kidney.']	N/A	N/A	[('PR_000006880', 'extracellular matrix protein 2', 0, 'ED1'), ('UBERON_0002113', 'kidney', 48, 'kidney')]
PMC4425955	4/2015	S95-PMC4425955	['in Kidney sections, positive cells in 50 Glomeruli and 20 Peritubular areas were counted (magnification 400×) (fig.2).']	N/A	N/A	[('UBERON_0002113', 'kidney', 3, 'kidney'), ('UBERON_0000074', 'renal glomerulus', 41, 'glomeruli'), ('UBERON_0005105', 'posterior mesonephric tubule', 58, 'peritubular')]
PMC4425955	4/2015	S96-PMC4425955	['caption (fig): figure 2\n\nrepresentative images of cd3 and Ed1 positive cells in left Kidney.']	N/A	N/A	[('PR_000006880', 'extracellular matrix protein 2', 58, 'ED1'), ('UBERON_0002113', 'kidney', 85, 'kidney')]
PMC4425955	4/2015	S109-PMC4425955	['caption (table-wrap): table 1\n\nbody and Organ weights of female offspring at 6, 12, and 18\xa0months of ageoffspring weightsdiet6\xa0months12\xa0months18\xa0monthsthree-way anovasham mean\xa0±\xa0semovx mean\xa0±\xa0semsham mean\xa0±\xa0semovx mean\xa0±\xa0semsham mean\xa0±\xa0semovx mean\xa0±\xa0sembody weight (bw, g)con264.7\xa0±\xa07.8287.8\xa0±\xa08.4295.9\xa0±\xa015.1350.6\xa0±\xa015.1372.4\xa0±\xa013.8422.1\xa0±\xa013.86\xa0<\xa012\xa0<\xa018 p \xa0<\xa00.001sham<ovx p \xa0<\xa00.001mlp273.3\xa0±\xa07.8330.2\xa0±\xa07.8290.5\xa0±\xa013.1370.9\xa0±\xa013.1366.5\xa0±\xa013.8429.6\xa0±\xa013.8gonadal fat (% of bw)con2.43\xa0±\xa00.293.11\xa0±\xa00.313.14\xa0±\xa00.323.84\xa0±\xa00.353.97\xa0±\xa00.353.92\xa0±\xa00.356\xa0<\xa012, 18 p \xa0<\xa00.001sham<ovx p \xa0<\xa00.001age*surgery p \xa0<\xa00.01Mlp2.41\xa0±\xa00.292.83\xa0±\xa00.292.57\xa0±\xa00.304.37\xa0±\xa00.284.25\xa0±\xa00.354.03\xa0±\xa00.35perirenal (fat % of bw)con1.99\xa0±\xa00.222.70\xa0±\xa00.242.50\xa0±\xa00.453.78\xa0±\xa00.392.93\xa0±\xa00.333.72\xa0±\xa00.336\xa0<\xa012\xa0<\xa018 p \xa0<\xa00.001sham<ovx p \xa0<\xa00.001mlp1.54\xa0±\xa00.242.31\xa0±\xa00.241.81\xa0±\xa00.343.46\xa0±\xa00.342.62\xa0±\xa00.334.61\xa0±\xa00.33left Kidney (% of bw)con0.30\xa0±\xa00.010.24\xa0±\xa00.010.33\xa0±\xa00.010.27\xa0±\xa00.010.28\xa0±\xa00.010.22\xa0±\xa00.016, 12\xa0<\xa018 p \xa0<\xa00.001 Sham>ovx p \xa0<\xa00.001mlp0.29\xa0±\xa00.010.26\xa0±\xa00.010.31\xa0±\xa00.010.22\xa0±\xa00.010.27\xa0±\xa00.010.22\xa0±\xa00.01right Kidney (% of bw)con0.33\xa0±\xa00.020.24\xa0±\xa00.020.36\xa0±\xa00.020.26\xa0±\xa00.010.28\xa0±\xa00.010.23\xa0±\xa00.016, 12\xa0<\xa018 p \xa0<\xa00.001sham>ovx p \xa0<\xa00.001mlp0.29\xa0±\xa00.020.25\xa0±\xa00.020.36\xa0±\xa00.010.23\xa0±\xa00.010.28\xa0±\xa00.010.23\xa0±\xa00.01liver (% of bw)con3.61\xa0±\xa00.132.51\xa0±\xa00.133.16\xa0±\xa00.112.43\xa0±\xa00.122.85\xa0±\xa00.122.21\xa0±\xa00.126\xa0>\xa012\xa0>\xa018 p \xa0<\xa00.001sham>ovx p \xa0<\xa00.001mlp3.51\xa0±\xa00.132.89\xa0±\xa00.133.31\xa0±\xa00.092.40\xa0±\xa00.092.65\xa0±\xa00.122.30\xa0±\xa00.12lungs (% of bw)con0.54\xa0±\xa00.030.46\xa0±\xa00.030.57\xa0±\xa00.030.48\xa0±\xa00.030.56\xa0±\xa00.060.41\xa0±\xa00.06sham>ovx p \xa0<\xa00.001mlp0.59\xa0±\xa00.030.54\xa0±\xa00.030.56\xa0±\xa00.020.45\xa0±\xa00.020.53\xa0±\xa00.060.55\xa0±\xa00.06heart (% of bw)con0.41\xa0±\xa00.020.31\xa0±\xa00.020.32\xa0±\xa00.020.26\xa0±\xa00.020.30\xa0±\xa00.010.25\xa0±\xa00.016\xa0>\xa012, 18 p \xa0<\xa00.001sham>ovx p \xa0<\xa00.001diet*surgery p\xa0<\xa00.05mlp0.34\xa0±\xa00.020.33\xa0±\xa00.020.32\xa0±\xa00.010.27\xa0±\xa00.010.30\xa0±\xa00.010.26\xa0±\xa00.01\nAnimals were exposed to a Prenatal control (con) or low-protein (mlp) diet, with sham or ovariectomy (ovx) surgery at 10\xa0weeks of Postnatal age.']	N/A	N/A	[('UBERON_0000062', 'organ', 40, 'organ'), ('PR_000012774', 'polycystic kidney disease 2-like 1 protein', 608, '01MLP2'), ('UBERON_0002113', 'kidney', 886, 'kidney'), ('PR_000014833', 'SH3 and multiple ankyrin repeat domains protein 3', 993, 'SHAM'), ('UBERON_0002113', 'kidney', 1087, 'kidney'), ('NCBITaxon_33208', 'Metazoa', 1862, 'Animals'), ('GO_0007565', 'female pregnancy', 1888, 'prenatal'), ('GO_0007567', 'parturition', 1992, 'postnatal')]
PMC4425955	4/2015	S116-PMC4425955	['ovariectomy resulted in decrease of absolute weight of right (Sham 0.97\xa0±\xa00.02 vs. ovx 0.88\xa0±\xa00.02) and left (Sham 0.91\xa0±\xa00.02 vs. ovx 0.85\xa0±\xa00.02) Kidneys and the Liver (Sham 9.6\xa0±\xa00.2 vs. ovx 8.8\xa0±\xa00.2), p \xa0<\xa00.001.']	N/A	N/A	[('PR_000014833', 'SH3 and multiple ankyrin repeat domains protein 3', 62, 'SHAM'), ('PR_000014833', 'SH3 and multiple ankyrin repeat domains protein 3', 110, 'SHAM'), ('UBERON_0002113', 'kidney', 148, 'kidneys'), ('UBERON_0002107', 'liver', 164, 'liver'), ('PR_000014833', 'SH3 and multiple ankyrin repeat domains protein 3', 171, 'SHAM')]
PMC4425955	4/2015	S123-PMC4425955	['caption (table-wrap): table 2\n\nmarkers of Renal function in female offspring at 6, 12, and 18\xa0months of agemarkerdiet6\xa0months12\xa0months18\xa0monthsthree-way anovasham mean\xa0±\xa0semovx mean\xa0±\xa0semsham mean\xa0±\xa0semovx mean\xa0±\xa0semsham mean\xa0±\xa0semovx mean\xa0±\xa0semplasma Urea (mmol/l)con7.2\xa0±\xa00.47.7\xa0±\xa00.48.5\xa0±\xa00.58.5\xa0±\xa00.58.2\xa0±\xa00.37.2\xa0±\xa00.312\xa0>\xa018 p \xa0<\xa00.05age*diet p\xa0<\xa0 0.05Mlp9.0\xa0±\xa00.47.7\xa0±\xa00.48.4\xa0±\xa00.58.5\xa0±\xa00.57.1\xa0±\xa00.37.0\xa0±\xa00.3urine protein (mg/24\xa0h)con75.9\xa0±\xa04.371.5\xa0±\xa04.163.2\xa0±\xa05.164.4\xa0±\xa05.679.5\xa0±\xa06.163.7\xa0±\xa06.16\xa0>\xa012\xa0<\xa018 p \xa0<\xa00.001con<mlp p \xa0<\xa00.001mlp76.5\xa0±\xa04.182.7\xa0±\xa04.173.2\xa0±\xa04.466.5\xa0±\xa04.497.1\xa0±\xa06.185.7\xa0±\xa06.1urine volume (ml/24\xa0h)con11.4\xa0±\xa01.610.0\xa0±\xa01.514.6\xa0±\xa01.99.1\xa0±\xa02.111.4\xa0±\xa01.37.4\xa0±\xa01.1con<mlp p \xa0<\xa00.01sham>ovx p \xa0<\xa00.05mlp13.2\xa0±\xa01.413.9\xa0±\xa01.815.8\xa0±\xa01.87.4\xa0±\xa01.914.3\xa0±\xa01.212.0\xa0±\xa01.2water Intake (ml/24\xa0h)con27.5\xa0±\xa02.718.3\xa0±\xa02.926.1\xa0±\xa02.820.9\xa0±\xa02.524.9\xa0±\xa01.818.9\xa0±\xa01.8con<mlp p \xa0<\xa00.05sham>ovx p \xa0<\xa00.001mlp27.8\xa0±\xa02.725.9\xa0±\xa02.732.3\xa0±\xa01.919.9\xa0±\xa02.125.0\xa0±\xa01.925.1\xa0±\xa01.8food Intake (g/24\xa0h)con22.1\xa0±\xa01.519.6\xa0±\xa01.521.7\xa0±\xa01.620.4\xa0±\xa01.621.1\xa0±\xa01.515.4\xa0±\xa01.5nsmlp20.7\xa0±\xa01.522.7\xa0±\xa01.520.6\xa0±\xa01.420.8\xa0±\xa01.422.0\xa0±\xa01.519.9\xa0±\xa01.5\nAnimals were exposed to a Prenatal control (con) or low-protein (mlp) diet, with sham or ovariectomy (ovx) surgery at 10\xa0weeks of Postnatal age.']	N/A	N/A	[('UBERON_0002113', 'kidney', 42, 'renal'), ('CHEBI_16199', 'urea', 252, 'urea'), ('PR_000029679', 'pleckstrin homology domain-containing family M member 3', 355, '05MLP9'), ('GO_0007631', 'feeding behavior', 789, 'intake'), ('GO_0007631', 'feeding behavior', 972, 'intake'), ('NCBITaxon_33208', 'Metazoa', 1116, 'Animals'), ('GO_0007565', 'female pregnancy', 1142, 'prenatal'), ('GO_0007567', 'parturition', 1246, 'postnatal')]
PMC4425955	4/2015	S150-PMC4425955	['Nf- Κ B protein Expression and inflammatory changes in the Kidney\nExpression of Nf- Κ B protein, which is a transcription factor for proinflammatory Genes including cytokines, chemokines, and adhesion Molecules (fig.6) has been measured in the Renal Cortex.']	N/A	N/A	[('GO_0005883', 'neurofilament', 0, 'NF-'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 0, 'NF- κ B'), ('GO_0010467', 'gene expression', 16, 'expression'), ('UBERON_0002113', 'kidney', 59, 'kidney'), ('GO_0010467', 'gene expression', 66, 'Expression'), ('GO_0005883', 'neurofilament', 80, 'NF'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 80, 'NF- κ B'), ('SO_0000704', 'gene', 149, 'genes'), ('CHEBI_36357', 'polyatomic entity', 201, 'molecules'), ('UBERON_0001225', 'cortex of kidney', 244, 'renal cortex')]
PMC4425955	4/2015	S154-PMC4425955	['histochemical analysis of sectioned Kidneys showed that Glomerular infiltration by cd3+cells (fig.6) and Ed1+cells was higher at 6\xa0months of age compared to 12 and 18\xa0months (6\xa0months: 1.20\xa0±\xa00.05, 12\xa0months: 0.48\xa0±\xa00.06, 18\xa0months: 0.52\xa0±\xa00.06; p \xa0<\xa00.001).']	N/A	N/A	[('UBERON_0002113', 'kidney', 36, 'kidneys'), ('UBERON_0000074', 'renal glomerulus', 56, 'glomerular'), ('PR_000006880', 'extracellular matrix protein 2', 105, 'ED1')]
PMC4427001	4/2015	S30-PMC4427001	['25(Oh)D is further hydroxylated to the active 1,25-Dihydroxyvitamin D (1,25(Oh)2D) almost exclusively in the Kidney upon Regulation by parathormon [17].']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 0, '25(OH)D'), ('CHEBI_67472', '15-epi-lupulin B', 46, '1,25-dihydroxyvitamin D'), ('CHEBI_37958', 'dye', 71, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 73, '25(OH)2D'), ('UBERON_0002113', 'kidney', 109, 'kidney'), ('GO_0065007', 'biological regulation', 121, 'regulation')]
PMC4441812	6/2015	S100-PMC4441812	['none of the women reported having chronic Renal disease.']	N/A	N/A	[('UBERON_0002113', 'kidney', 42, 'renal')]
PMC4448820	5/2015	S383-PMC4448820	['the Promoter region of Cyp27B1 , the enzyme responsible for 1,25(Oh)2D generation, is demethylated, and Histones associated with the Promoter deacetylated in response to Vitamin D treatment in Mouse Kidney Proximal Tubule-derived Mouse Cortical Tubular Cells and the Human Embryonic Kidney–derived cell line 293f (222).']	N/A	N/A	[('SO_0000167', 'promoter', 4, 'promoter'), ('PR_000006101', 'cytochrome P450 1A1', 23, 'CYP27B1'), ('CHEBI_37958', 'dye', 60, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 62, '25(OH)2D'), ('CHEBI_15358', 'histone', 104, 'histones'), ('PR_000043452', 'core histone', 104, 'histones'), ('SO_0000167', 'promoter', 133, 'promoter'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 193, 'mouse'), ('UBERON_0004134', 'proximal tubule', 199, 'kidney proximal tubule'), ('NCBITaxon_10088', 'Mus <genus>', 230, 'mouse'), ('CL_0002364', 'cortical thymic epithelial cell', 236, 'cortical tubular cells'), ('UBERON_0004106', 'crus of ear', 236, 'cortical tubular'), ('NCBITaxon_9606', 'Homo sapiens', 267, 'human'), ('CL_0002321', 'embryonic cell (metazoa)', 273, 'embryonic ...'), ('UBERON_0000922', 'embryo', 273, 'embryonic'), ('UBERON_0002113', 'kidney', 283, 'kidney')]
PMC4466139	6/2015	S24-PMC4466139	['maternal exclusion criteria were: Gestational diabetes, presence of any psychiatric or organic disease (Renal failure, Liver failure, other endocrine diseases) and any particular Pharmacological treatment (Corticosteroids, Antiepileptic Drugs, immunosuppressants) (s1 strobe checklist).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 34, 'gestational'), ('UBERON_0002113', 'kidney', 104, 'renal'), ('UBERON_0002107', 'liver', 119, 'liver'), ('CHEBI_52217', 'pharmaceutical', 179, 'pharmacological'), ('CHEBI_50850', 'etabonate ester', 206, 'corticosteroids'), ('CHEBI_35473', 'tranquilizing drug', 223, 'antiepileptic drugs')]
PMC4488777	5/2015	S38-PMC4488777	['in the Kidneys, 25[Oh] D is decomposed by 1-α-hydroxylase (by Cyp27B1) to an active form of 1,25-Dihydroxyvitamin D [13].']	N/A	N/A	[('UBERON_0002113', 'kidney', 7, 'kidneys'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 16, '25[OH] D'), ('PR_000006101', 'cytochrome P450 1A1', 62, 'CYP27B1'), ('CHEBI_37983', 'sulfur-35 atom', 93, ',25'), ('CHEBI_27481', 'rhodexin A', 97, 'dihydroxyvitamin D')]
PMC4499266	4/2015	S77-PMC4499266	['Pendrin functions as an Anion exchanger and is Expressed in the Kidney, Thyroid and Inner Ear.']	N/A	N/A	[('PR_000015039', 'pendrin', 0, 'Pendrin'), ('CHEBI_22563', 'anion', 24, 'anion'), ('GO_0010467', 'gene expression', 47, 'expressed'), ('UBERON_0002113', 'kidney', 64, 'kidney'), ('UBERON_0002046', 'thyroid gland', 72, 'thyroid'), ('UBERON_0001846', 'internal ear', 84, 'inner ear')]
PMC4499946	7/2015	S275-PMC4499946	['participants with persistent symptoms of Renal colic or hypercalciuria will be referred for Renal ultrasound to assess for the presence of urolithiasis or nephrolithiasis.']	N/A	N/A	[('UBERON_0002113', 'kidney', 41, 'renal'), ('UBERON_0002113', 'kidney', 92, 'renal')]
PMC4539876	7/2015	S213-PMC4539876	['additionally, the authors also reported 11 retrospectively identified cases, in which major malformations in the form of dysplastic Kidney (1 case) and down syndrome (1 case) was found.']	N/A	N/A	[('UBERON_0002113', 'kidney', 132, 'kidney')]
PMC4539876	7/2015	S219-PMC4539876	['various malformations which had been recorded include Renal malformation ( n = 5), additional Thumb Digit ( n = 2) and one case each of bilateral Talipes, spontaneous Abortion of severe deformed fetus, pretragus fibrochondroma, clubfoot, anencephaly, absent Heart, cleft palate, Ventricular Septum defect, albino infant, Esophageal atresia, myelomeningocele plus hydrocephalus, and absent Fingers.']	N/A	N/A	[('UBERON_0002113', 'kidney', 54, 'renal'), ('UBERON_0006052', 'digit 5', 94, 'thumb digit'), ('UBERON_0009578', 'myelencephalon sulcus limitans', 146, 'talipes'), ('GO_0007569', 'cell aging', 167, 'abortion'), ('UBERON_0000948', 'heart', 258, 'heart'), ('UBERON_0005956', 'outflow part of left ventricle', 279, 'ventricular septum'), ('UBERON_0011358', 'infundibular organ', 321, 'esophageal'), ('UBERON_0002389', 'manual digit', 389, 'fingers')]
PMC4539881	7/2015	S24-PMC4539881	['Glomerular filtration rate and Renal Blood flow are increased.']	N/A	N/A	[('UBERON_0000074', 'renal glomerulus', 0, 'Glomerular'), ('UBERON_0002113', 'kidney', 31, 'renal'), ('UBERON_0000178', 'blood', 37, 'blood')]
PMC4588865	8/2015	S216-PMC4588865	['funding\nthis work was supported by themrc integrative epidemiology unitand theuniversity of bristol(mc_uu_12013_2,mc_uu_12013_5andmc_uu_12013_8) and theunited states national institute of diabetes and Digestive and Kidney diseases(r01 dk10324).']	N/A	N/A	[('GO_0007586', 'digestion', 201, 'Digestive'), ('UBERON_0002113', 'kidney', 215, 'Kidney')]
PMC4613350	9/2015	S87-PMC4613350	['exclusion: spontaneous Miscarriage prior to 20 weeks, loss to follow-up or fetal anomalies diagnosed in the second Trimester;28exclusion: high risk Pregnancies;29definition controls: randomly selected women without reported Pregnancy-associated hypertension;30definition controls: had Blood collected and stored on the same day, which did not develop any Pregnancy complications and resulted in the Live Birth of phenotypically normal neonates;31unknown in- and exclusion criteria;32inclusion: singleton Pregnancies;33,34gestational age matched controls;35exclusion: multiparity, chronic hypertension, diabetes, multiple Gestation, Connective Tissue disorder, any long-term use of Medicine other than Prenatal Vitamins, and Miscarriage before viability;36exclusion: diabetes, Connective Tissue disease, Renal disorders, essential hypertension;37exclusion: previous systemic disorders or Drug use, chronic hypertension, diabetes, Renal disorders, recent or present fever or infectious disease, malignancies, Autoimmune diseases and multiple Pregnancies;38exclusion: early-onset pe, multiple Gestations, Pregnancies with fetal chromosomal or major structural anomaly, Miscarriages;39unknown inclusion/exclusion criteria;40exclusion: cases showing Intrahepatic Cholestasis of Pregnancy, abortion, peripartum cardiomyopathy, and other complications.']	N/A	N/A	[('GO_0046660', 'female sex differentiation', 23, 'miscarriage'), ('GO_0009294', 'DNA mediated transformation', 115, 'trimester'), ('GO_0007565', 'female pregnancy', 148, 'pregnancies'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('UBERON_0000178', 'blood', 285, 'blood'), ('GO_0007565', 'female pregnancy', 355, 'pregnancy'), ('GO_0006266', 'DNA ligation', 399, 'live'), ('GO_0007567', 'parturition', 404, 'birth'), ('GO_0007565', 'female pregnancy', 504, 'pregnancies'), ('GO_0007565', 'female pregnancy', 621, 'gestation'), ('UBERON_0002384', 'connective tissue', 632, 'connective tissue'), ('CHEBI_6807', 'methadone', 681, 'medicine'), ('GO_0007565', 'female pregnancy', 701, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 710, 'vitamins'), ('GO_0046660', 'female sex differentiation', 724, 'miscarriage'), ('UBERON_0002384', 'connective tissue', 776, 'connective tissue'), ('UBERON_0002113', 'kidney', 803, 'renal'), ('CHEBI_23888', 'drug', 887, 'drug'), ('UBERON_0002113', 'kidney', 929, 'renal'), ('UBERON_0001442', 'skeleton of manus', 1007, 'autoimmune'), ('GO_0007565', 'female pregnancy', 1040, 'pregnancies'), ('GO_0007565', 'female pregnancy', 1090, 'gestations'), ('GO_0007565', 'female pregnancy', 1102, 'pregnancies'), ('GO_0042706', 'eye photoreceptor cell fate commitment', 1166, 'miscarriages'), ('UBERON_0001226', 'major calyx', 1245, 'intrahepatic'), ('GO_0000075', 'cell cycle checkpoint signaling', 1258, 'cholestasis'), ('GO_0007565', 'female pregnancy', 1273, 'pregnancy')]
PMC4644058	9/2015	S14-PMC4644058	['a bedside ultrasound assessment was performed that showed normal-appearing Kidneys, and was negative for free Abdominal Fluid or Pericardial effusion.']	N/A	N/A	[('UBERON_0002113', 'kidney', 75, 'kidneys'), ('UBERON_0007808', 'adipose tissue of abdominal region', 110, 'abdominal fluid'), ('UBERON_3000714', 'perichordal', 129, 'pericardial')]
PMC4661480	10/2015	S3-PMC4661480	['he had no significant family history and no Renal, vertebral, Gastrointestinal, or Cardiac malformations.']	N/A	N/A	[('UBERON_0002113', 'kidney', 44, 'renal'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 62, 'gastrointestinal'), ('UBERON_0000948', 'heart', 83, 'cardiac')]
PMC4661480	10/2015	S17-PMC4661480	['1aandb) and Kidneys (fig.']	N/A	N/A	[('UBERON_0002113', 'kidney', 12, 'kidneys')]
PMC4661500	11/2014	S398-PMC4661500	['in the experiments with magnesium deficiency, Cardiac muscle was more sensitive than Kidney and Liver showing a decrease in oxphos.']	N/A	N/A	[('UBERON_0000948', 'heart', 46, 'cardiac'), ('UBERON_0002113', 'kidney', 85, 'kidney'), ('UBERON_0002107', 'liver', 96, 'liver')]
PMC4663588	11/2015	S460-PMC4663588	['a post-weaning low protein diet reduced the growth rate in male offspring and presented with lower Liver, Pancreas and Kidney weight.']	N/A	N/A	[('UBERON_0002107', 'liver', 99, 'liver'), ('UBERON_0001264', 'pancreas', 106, 'pancreas'), ('UBERON_0002113', 'kidney', 119, 'kidney')]
PMC4666222	11/2015	S89-PMC4666222	['she was started on continuous Renal replacement therapy, and required this for the next 5\xa0days.']	N/A	N/A	[('UBERON_0002113', 'kidney', 30, 'renal')]
PMC4673623	11/2015	S79-PMC4673623	['caption (table-wrap): table 1\n\nPlacental and fetal morphometric characteristics at cesarean section (0.9\xa0Gestation) in control ( n \xa0=\xa020–22) and hf-hed ( n \xa0=\xa05) group*controlhf-hedplacenta measures\u2003weight (g)210\xa0±\xa09214\xa0±\xa09\u2003efficiency (g fetus/g Placenta)3.9\xa0±\xa00.13.2\xa0±\xa00.2†\u2003volume (cm3)159\xa0±\xa018111\xa0±\xa026fetal measures\u2003body weight (g)806\xa0±\xa024675\xa0±\xa036†\u2003length (cm)38\xa0±\xa00.637\xa0±\xa01\u2003bmi (kg/m2)5.7\xa0±\xa00.15.1\xa0±\xa00.4‡\u2003ponderal index (kg/m3)15\xa0±\xa00.514\xa0±\xa01\u2003Brain (g)82\xa0±\xa0280\xa0±\xa02\u2003Heart (g)4.9\xa0±\xa00.24.2\xa0±\xa00.2\u2003Kidneys (g)4.5\xa0±\xa00.24.0\xa0±\xa00.2\u2003Liver (g)24\xa0±\xa00.920\xa0±\xa01.2‡\u2003Lung (g)17\xa0±\xa00.617\xa0±\xa01.5\u2003Pancreas (g)0.56\xa0±\xa00.060.44\xa0±\xa00.05\u2003Thymus (g)3.4\xa0±\xa00.203.4\xa0±\xa00.46fetal measures as percent fetal weight\u2003Placenta26\xa0±\xa00.832\xa0±\xa02.5†\u2003Brain11\xa0±\xa00.312\xa0±\xa00.6†\u2003Heart0.61\xa0±\xa00.020.63\xa0±\xa00.04\u2003Kidneys0.56\xa0±\xa00.020.59\xa0±\xa00.03\u2003Liver3.0\xa0±\xa00.063.0\xa0±\xa00.125\u2003Lungs2.2\xa0±\xa00.072.4\xa0±\xa00.12‡\u2003Pancreas0.07\xa0±\xa00.010.07\xa0±\xa00.01\u2003Thymus0.42\xa0±\xa00.020.52\xa0±\xa00.05†fetal measures as percent maternal weight\u2003fetal weight4.3\xa0±\xa00.13.5\xa0±\xa00.2†\u2003Placenta1.13\xa0±\xa00.041.09\xa0±\xa00.05\ndata are mean\xa0±\xa0sem.']	N/A	N/A	[('UBERON_0001987', 'placenta', 31, 'Placental'), ('GO_0007565', 'female pregnancy', 105, 'gestation'), ('UBERON_0001987', 'placenta', 246, 'placenta'), ('UBERON_0000955', 'brain', 445, 'Brain'), ('UBERON_0000948', 'heart', 467, 'Heart'), ('UBERON_0002113', 'kidney', 495, 'Kidneys'), ('UBERON_0002107', 'liver', 525, 'Liver'), ('UBERON_0002048', 'lung', 552, 'Lung'), ('UBERON_0001264', 'pancreas', 577, 'Pancreas'), ('UBERON_0002370', 'thymus', 612, 'Thymus'), ('UBERON_0001950', 'neocortex', 681, 'Placenta26'), ('UBERON_0009747', 'tail fold of embryonic disc', 707, 'Brain11'), ('UBERON_0000948', 'heart', 730, 'Heart0'), ('UBERON_0000975', 'sternum', 758, 'Kidneys0'), ('UBERON_0006009', 'cusp of cardiac valve', 788, 'Liver3'), ('UBERON_0000170', 'pair of lungs', 815, 'Lungs2'), ('UBERON_0001272', 'innominate bone', 842, 'Pancreas0'), ('UBERON_0002370', 'thymus', 873, 'Thymus0'), ('UBERON_0001987', 'placenta', 976, 'Placenta1')]
PMC4682815	12/2015	S83-PMC4682815	['all mrna levels are presented relative to the geometric mean of the three control Genes, Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide ( ywhaz ), ubiquitin c ( ubc ) and topoisomerase ( Top1 ) [27].10.1371/journal.pone.0143653.t001\n\ncaption (table-Wrap): table 1\ninformation on amino acid transporter Genes, Primers and probes.amino acid transportergenegene idgenebank accession no.Primersroche universal probe library no.lat1slc7a58140nm_003486.5f-5′-gtggaaaaacaagcccaagt-3’r-5′-gcatgagcttctgacacagg-3’25lat2slc7a823428nm_182728.1nm_012244.2f-5′-ttgccaatgtcgcttatgtc-3’r-5′-ggagcttctctccaaaagtcac-3’17asct1slc1a46509nm_003038.2f-5′-tttgcgacagcatttgctac-3’r-5′-gcacttcatcatagagggaagg-3’78asct2slc1a56510nm_005628.2nm_001145145.1f-5′-gaggaatatcaccggaacca-3’r-5′-aggatgttcatcccctcca-3’43y+lat1slc7a79056nm_001126106.1nm_003982.3f-5′-acactgccgtgagaacctg-3’r-5′-aggagaggaaacccttcacc-3’72y+lat2slc7a69057nm_001076785.1nm_003983.4f-5′-gctgtgatcccccatacct-3’r-5′-ggcacagttcacaaatgtcag-3’664f2hcslc3a26520nm_001012661.1f-5′-tggttctccactcaggttga-3’r-5′-cagccaaaactccagagcat-3’49eaat1slc1a36507nm_004172.4f-5′-ttgaactgaacttcggacaaatta-3’r-5′-attccagctgccccaatact-3’76eaat2slc1a26506nm_004171.3f-5′-aaaatgctcattctccctctaatc-3’r-5′-gccactagccttagcatcca-3’78eaat3slc1a16505nm_004170.4f-5′-agttgaatgacctggacttgg-3’r-5′-gcagatgtggccgtgatac-3’9eaat4slc1a66511nm_005071.1f-5′-tgcagatgctggtgttacct-3’r-5′-gttgtccagggatgccata-3’19eaat5slc1a76512nm_006671.4f-5′-cgcccaggtcaacaactac-3’r-5′-gctgcagtggctgtgatact-5’9snat1slc38a181539nm_030674.3nm_001077484.1f-5′-attttgggactcgcctttg-3’r-5′-agcaatgtcactgaagtcaaaagt-3’47snat2slc38a254407nm_018976.3f-5′-cctatgaaatctgtacaaaagattgg-3’F-5′-ttgtgtacccaatccaaaacaa-3’9snat4slc38a455089nm_018018.4nm_001143824.1f-5′-tgttctggtcatccttgtgc-3’r-5′-aaaactgctggaagaataaaaatcag-3’29tat1slc16a10117247nm_018593.4f-5′-ggtgtgaagaaggtttatctacagg-3′R-5′-agggccccaaagatgcta-3′6lat3slc43a18501nm_003627.5nm_001198810.1f-5′-gccctcatgattggctctta-3’r-5′-ccggcatcgtagatcagc-3’29lat4slc42a2124935nm_001284498.1nm_152346.2f-5′-acaagtatggcccgaggaa-3’r-5′-gcaatcagcaagcaggaaa-3’3\nslc, solute carrier; F, Forward; R, Reverse; 4f2hc, type-ii Membrane Glycoprotein heavy chain.10.1371/journal.pone.0143653.t002\n\ncaption (table-wrap): table 2\ninformation on Metabolic Genes, Primers and probes.Metabolic Genesgene idgenebank accession no.Primersroche universal probe library no.branched chain aminotransferase 1mitochondrial (bcatm) 587nm_001190.2f-5′-aaaatgggcctgagctgat-3’r-5′-gtgggctctgattccgtact-3’17branched chain aminotransferase 2cytosolic (bcatc) 586nm_005504.5f-5′-gatgtttggctctggtacagc-3’r-5′-ggaccattctccatagttggaa-3’61glutaminase (gls1) Kidney Isoform2744Nm_014905.3f-5′-tgcagagggtcatgttgaag-3’f-5′-catccatgggagtgttattcc-3’11glutamine synthetase (glul) 2752nm_002065.4nm_001033044.1nm_001033056.1f-5′-ccataccaacttcagcacca-3’r-5′-caatggcctcctcgatgta-3’52glutamate dehydrogenase (glud) mitochondrial2746nm_005271.2nm_012084.3f-5′-cactctggcttggcatacac-3’r-5′-tcaggtccaatcccaggtta-3’76alanine Aminotransferase 1 (Gpt1) 2875nm_005309.2f-5′-catagtgcagcgagccttg-3’r-5′-ggatgacctcggtgaaagg-3’15Alanine Aminotransferase 2 (Gpt2) 84706nm_133443.1f-5′-ggatcttcattcctgccaaa-3’r-5′-acatgtctggagccatttga-3’75aspartate Aminotransferase 1 (Got1 ) Cytosolic2805Nm_002079.1f-5′-caactgggattgacccaact-3’r-5′-ggaacagaaaccggtgctt-3’38aspartate Aminotransferase 2 (Got2) mitochondrial2806nm_002080.2f-5′-ccattctgaacaccccagat-3’r-5′-ggtcagccatgactttcactt-3’46\nf, Forward; r, Reverse\n\nprobe and Primer design\noligonucleotide probes and Primers were designed using the roche probefinder version 2.45 for Human.']	N/A	N/A	[('SO_0000704', 'gene', 82, 'genes'), ('PR_000028799', 'tubulin', 89, 'tyrosine'), ('PR_000016523', 'tensin-4', 229, 'TOP1'), ('PR_000017453', 'protein Wnt-9b', 291, 'WRAP'), ('SO_0000704', 'gene', 344, 'genes'), ('SO_0000112', 'primer', 351, 'primers'), ('SO_0000112', 'primer', 425, 'PrimersRoche'), ('SO_0001030', 'forward', 1701, 'F'), ('SO_0001031', 'reverse', 1900, 'R'), ('SO_0001030', 'forward', 2142, 'F'), ('SO_0001030', 'forward', 2145, 'forward'), ('SO_0001031', 'reverse', 2154, 'R'), ('SO_0001031', 'reverse', 2157, 'reverse'), ('GO_0016020', 'membrane', 2181, 'membrane'), ('CHEBI_17089', 'glycoprotein', 2190, 'glycoprotein'), ('GO_0008152', 'metabolic process', 2295, 'metabolic'), ('SO_0000704', 'gene', 2305, 'genes'), ('SO_0000112', 'primer', 2312, 'primers'), ('GO_0008152', 'metabolic process', 2331, 'Metabolic'), ('SO_0000704', 'gene', 2341, 'GenesGene'), ('SO_0000112', 'primer', 2375, 'PrimersRoche'), ('UBERON_0002113', 'kidney', 2686, 'kidney'), ('SO_0000810', 'chimeric_cDNA_clone', 2693, 'isoform2744NM_014905'), ('PR_000003611', 'acetyl-CoA acetyltransferase, cytosolic', 3038, 'aminotransferase 1'), ('PR_000008160', 'glycerol-3-phosphate acyltransferase 2, mitochondrial', 3058, 'GPT1'), ('CHEBI_64808', 'tetrahydro-4-hydroxyphenylpyruvic acid', 3133, '15Alanine'), ('PR_000003611', 'acetyl-CoA acetyltransferase, cytosolic', 3143, 'aminotransferase 2'), ('PR_000008190', 'adhesion G-protein coupled receptor G2', 3163, 'GPT2'), ('PR_000003611', 'acetyl-CoA acetyltransferase, cytosolic', 3253, 'aminotransferase 1'), ('PR_000008166', 'glypican-4', 3273, 'GOT1'), ('GO_0005835', 'fatty acid synthase complex', 3280, 'cytosolic2805NM_002079'), ('PR_000003611', 'acetyl-CoA acetyltransferase, cytosolic', 3371, 'aminotransferase 2'), ('PR_000008160', 'glycerol-3-phosphate acyltransferase 2, mitochondrial', 3391, 'GOT2'), ('SO_0001030', 'forward', 3488, 'forward'), ('SO_0001031', 'reverse', 3500, 'reverse'), ('SO_0000112', 'primer', 3519, 'primer'), ('SO_0000112', 'primer', 3560, 'primers'), ('NCBITaxon_9606', 'Homo sapiens', 3627, 'human')]
PMC4699824	12/2015	S146-PMC4699824	['offspring of Rats whose mothers were Fed a low protein diet had comparable Renal angiotensin i and Angiotensin Ii levels at 28 days of age to offspring of Rats Fed a control diet [39].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 13, 'rats'), ('GO_0007631', 'feeding behavior', 37, 'fed'), ('UBERON_0002113', 'kidney', 75, 'renal'), ('PR_000002200', 'cytoplasmic tyrosine-protein kinase BMX', 99, 'angiotensin II'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 155, 'rats'), ('GO_0007631', 'feeding behavior', 160, 'fed')]
PMC4714725	1/2016	S272-PMC4714725	['diabetic Kidney disease\n\nrecommendations\n\nassess Urinary albumin (e.g., spot Urinary albumin–to–creatinine ratio [uacr]) and egfr at least annually in patients with type 1 diabetes with duration of ≥5 years, in all patients with type 2 diabetes, and in all patients with comorbid hypertension.']	N/A	N/A	[('UBERON_0002113', 'kidney', 9, 'Kidney'), ('UBERON_0001088', 'urine', 49, 'urinary'), ('UBERON_0001088', 'urine', 77, 'urinary')]
PMC4714725	1/2016	S355-PMC4714725	['factors include cost, Coexisting conditions (e.g., Renal status), and hypoglycemia.']	N/A	N/A	[('GO_0000279', 'M phase', 22, 'coexisting'), ('UBERON_0002113', 'kidney', 51, 'renal')]
PMC4728659	1/2016	S114-PMC4728659	['Kidney weight was greater in hp1 than hf1 and c1 ( p = 0.037).nutrients-08-00046-t002_table 2\n\ncaption (table-wrap): table 2\n\nphysical characteristics of offspring at 28 weeks.diet groupsexhp1hf1c1rhliver (g)m16.1 ± 0.515.5 ± 0.717.3 ± 0.718.8 ± 0.919.0 ± 1.0f9.5 ± 0.68.9 ± 0.49.8 ± 0.89.0 ± 1.210.2 ± 1.1stomach (g)m2.7 ± 0.12.6 ± 0.12.8 ± 0.1a3.3 ± 0.1b3.1 ± 0.2bf2.0 ± 0.12.0 ± 0.11.9 ± 0.1a1.9 ± 0.2b2.4 ± 0.3bsmall Intestine length (cm)m130.5 ± 1.5x143.8 ± 2.7y125.7 ± 2.4x,a134.8 ± 2.2b133.8 ± 1.3a,bf115.0 ± 3.4x122.8 ± 2.5y116.8 ± 3.7x,a104.6 ± 2.2b122 ± 5.5a,bsmall Intestine weight (g)m8.1 ± 0.48.7 ± 0.47.9 ± 0.28.2 ± 0.248.6 ± 0.13f6.1 ± 0.46.1 ± 0.46.8 ± 0.35.4 ± 0.646.3 ± 0.41cecum (g)m1.07 ± 0.1x3.2 ± 0.3y1.01 ± 0.1x,a1.5 ± 0.04b0.63 ± 0.36af0.74 ± 0.06x2.3 ± 0.3y0.8 ± 0.1x,a1.0 ± 0.19b0.88 ± 0.29acolon length (cm)m23.5 ± 0.7x26.1 ± 0.9y21.6 ± 0.7x21.1 ± 0.4323.3 ± 0.85f19.6 ± 0.3x24.8 ± 0.4y20.0 ± 0.7x16.4 ± 1.920.5 ± 1.3colon weight (g)m2.1 ± 0.1y2.4 ± 0.2z1.8 ± 0.1x1.6 ± 0.051.9 ± 0.1f1.5 ± 0.1y2.0 ± 0.1z1.3 ± 0.05x1.1 ± 0.131.3 ± 0.06kidneys (g)m4.0 ± 0.1y3.4 ± 0.1x3.6 ± 0.1x3.5 ± 0.13.8 ± 0.2f2.4 ± 0.1y2.1 ± 0.1x2.3 ± 0.1x1.9 ± 0.22.4 ± 0.3nasoanal length (cm)m28.9 ± 0.1628.6 ± 0.3428.5 ± 0.1928.4 ± 0.1628.8 ± 0.32f24.0 ± 0.4123.5 ± 0.1924.0 ± 0.1723.6 ± 0.2723.8 ± 0.32\nhp1, offspring of high protein (hp) dams re-matched to hp in Adulthood; hf1, offspring of high prebiotic fiber (hf) dams re-matched to hf in Adulthood; c1, offspring of control dams re-matched to control in Adulthood; r, reference group no high fat/Sucrose (hfs) Consumed; h, continued on hfs after other groups re-matched; m, male; f, female.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidney'), ('UBERON_0000160', 'intestine', 421, 'Intestine'), ('UBERON_0000160', 'intestine', 576, 'Intestine'), ('UBERON_0000113', 'post-juvenile adult stage', 1365, 'adulthood'), ('UBERON_0000113', 'post-juvenile adult stage', 1445, 'adulthood'), ('UBERON_0000113', 'post-juvenile adult stage', 1511, 'adulthood'), ('CHEBI_17992', 'sucrose', 1553, 'sucrose'), ('GO_0007631', 'feeding behavior', 1567, 'consumed')]
PMC4729160	1/2016	S36-PMC4729160	['we excluded participants with a history of Kidney disease or chronic Liver disease.']	N/A	N/A	[('UBERON_0002113', 'kidney', 43, 'kidney'), ('UBERON_0002107', 'liver', 69, 'liver')]
PMC4730270	12/2015	S49-PMC4730270	['normalized edvd14 to 16 weeks of age[29]50% caloric restriction during Pregnancywistar Rats.↑ bp Lbw Endothelial dysfunction impaired Renal function ↓ Glomerular numbermicronutrients Mix: vit.']	N/A	N/A	[('GO_0006412', 'translation', 71, 'pregnancyWistar'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 87, 'rats'), ('UBERON_0005414', 'zone of polarizing activity', 97, 'LBW'), ('UBERON_0001986', 'endothelium', 101, 'Endothelial'), ('UBERON_0002113', 'kidney', 134, 'renal'), ('UBERON_0000074', 'renal glomerulus', 151, 'Glomerular'), ('CHEBI_60004', 'mixture', 183, 'mix')]
PMC4730270	12/2015	S54-PMC4730270	['c, e and Taurine)2 weeks before until 8 weeks after Birth↓ hypertension and Rvr rbf Autoregulation shifted towards wky patternat 9 week old[32]Genetic hypertension, Renal injuryfhh ratshypertension progressive Renal injuryl-arginine plus antioxidants (vit.']	N/A	N/A	[('CHEBI_15891', 'taurine', 9, 'taurine'), ('GO_0007567', 'parturition', 52, 'birth'), ('GO_0007567', 'parturition', 57, '↓'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 76, 'RVR'), ('GO_0051458', 'corticotropin secretion', 84, 'autoregulation'), ('SO_0000704', 'gene', 143, 'Genetic'), ('UBERON_0002113', 'kidney', 165, 'renal'), ('UBERON_0002113', 'kidney', 210, 'renal')]
PMC4730270	12/2015	S56-PMC4730270	['↓ proteinuria ↓ glomerulosclerosis in femalesuntil 36 weeks of age[33]50% caloric restriction during Pregnancy and lactationsprague-dawley ratslbw, impaired Renal function, Renal injurycitrullineduring Pregnancy and Lactation↑ bp ↓ Renal injury ↑ Nephron numberuntil 12 weeks of age[34]Genetic hypertension.shr and wky ratshypertension.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 101, 'pregnancy'), ('UBERON_0002113', 'kidney', 157, 'renal'), ('UBERON_0002113', 'kidney', 173, 'renal'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy'), ('GO_0007595', 'lactation', 216, 'lactation'), ('UBERON_0002113', 'kidney', 232, 'Renal'), ('UBERON_0001285', 'nephron', 247, 'Nephron'), ('SO_0000704', 'gene', 286, 'Genetic')]
PMC4730270	12/2015	S57-PMC4730270	['↓ Renal No at 2 weeks.']	N/A	N/A	[('UBERON_0002113', 'kidney', 2, 'Renal'), ('CHEBI_16382', 'iodide', 8, 'NO')]
PMC4730270	12/2015	S58-PMC4730270	['↓ Renal Gene Expression of Ass and Asl at 2 weekscitrulline2 weeks before until 6 weeks after Birth↓ hypertension in females and until 20 weeks in males ↑ Renal No at 2 weeksuntil 50 weeks of age[35]diabetes (stz) during Pregnancy and lactationsprague-dawley ratshypertension, Renal injurycitrullineduring Pregnancy and Lactation↓ bp ↓ Renal injuryuntil 12 weeks of age[36]dexamethasone during Pregnancysprague-dawley ratshypertensioncitrullineduring Pregnancy and Lactation↓ bpuntil 12 weeks of age[37]l-Name during Pregnancysprague-dawley ratshypertensioncitrullineduring Pregnancy and Lactation↓ bp ↓ admauntil 12 weeks of age[38,39]Genetic hypertension, Renal injuryfhh ratshypertension progressive Renal injurymolsidomine (No Donor)2 weeks before until 4 weeks after Birthprevented hypertension.']	N/A	N/A	[('UBERON_0002113', 'kidney', 2, 'Renal'), ('GO_0010467', 'gene expression', 8, 'gene expression'), ('SO_0000704', 'gene', 8, 'gene'), ('PR_000004376', 'ATPase GET3', 27, 'ASS'), ('PR_000004376', 'ATPase GET3', 35, 'ASL'), ('GO_0007567', 'parturition', 94, 'birth'), ('GO_0007567', 'parturition', 99, '↓'), ('UBERON_0002113', 'kidney', 155, 'Renal'), ('CHEBI_16382', 'iodide', 161, 'NO'), ('GO_0007565', 'female pregnancy', 221, 'pregnancy'), ('UBERON_0002113', 'kidney', 277, 'renal'), ('GO_0007565', 'female pregnancy', 306, 'pregnancy'), ('GO_0007595', 'lactation', 320, 'lactation'), ('GO_0007567', 'parturition', 329, '↓'), ('UBERON_0002113', 'kidney', 336, 'Renal'), ('GO_0012501', 'programmed cell death', 394, 'pregnancySprague'), ('GO_0007565', 'female pregnancy', 451, 'pregnancy'), ('GO_0007595', 'lactation', 465, 'lactation'), ('GO_0007567', 'parturition', 474, '↓'), ('CHEBI_13389', 'NAD', 505, 'NAME'), ('GO_0012501', 'programmed cell death', 517, 'pregnancySprague'), ('GO_0007565', 'female pregnancy', 574, 'pregnancy'), ('GO_0007595', 'lactation', 588, 'lactation'), ('GO_0007567', 'parturition', 597, '↓'), ('SO_0000704', 'gene', 636, 'Genetic'), ('UBERON_0002113', 'kidney', 658, 'renal'), ('UBERON_0002113', 'kidney', 703, 'renal'), ('CHEBI_7570', 'nigerose', 728, 'NO donor'), ('GO_0007596', 'blood coagulation', 772, 'birthPrevented')]
PMC4730270	12/2015	S62-PMC4730270	['↓ oxidative stress.until 12 weeks of age[47]Genetic hypertensionshr and wky ratshypertensionpyrrolidine Di-Thio-Carbamate (Nf-Κb inhibitor)2 weeks before until 4 weeks after Birth↓ bp ↑ natriuresis at 4 weeks ↓ oxidative stress markersuntil 28 weeks of age[48]Genetic hypertensionfhh ratshypertension progressive Renal injurypyrrolidine Di-Thio-Carbamate (Nf-Κb Inhibitor)2 weeks before until 4 weeks after Birthprevented hypertension ↓ glomerulosclerosisuntil 36 and 42 weeks of age[49]\n\n4.']	N/A	N/A	[('SO_0000704', 'gene', 44, 'Genetic'), ('CHEBI_35694', 'cyclobutane-1,1-dicarboxylate(1-)', 104, 'di-thio-carbamate'), ('GO_0071159', 'NF-kappaB complex', 123, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 123, 'NF-κB'), ('GO_0007567', 'parturition', 174, 'birth'), ('GO_0007567', 'parturition', 179, '↓'), ('SO_0000704', 'gene', 260, 'Genetic'), ('UBERON_0002113', 'kidney', 313, 'renal'), ('CHEBI_35694', 'cyclobutane-1,1-dicarboxylate(1-)', 337, 'di-thio-carbamate'), ('GO_0071159', 'NF-kappaB complex', 356, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 356, 'NF-κB'), ('CHEBI_35222', 'inhibitor', 362, 'inhibitor'), ('GO_0007596', 'blood coagulation', 407, 'birthPrevented')]
PMC4730270	12/2015	S89-PMC4730270	['the Renal transcriptome is profoundly altered in Adult offspring in the presence of hypertension [26,42,67,68,69,70].']	N/A	N/A	[('UBERON_0002113', 'kidney', 4, 'renal'), ('UBERON_0007023', 'adult organism', 49, 'adult')]
PMC4752899	11/2015	S79-PMC4752899	['safety outcomes included toxicity to maternal Bone Marrow, Kidney, and Liver as measured by laboratory parameters collected just before, and 24 hours after dosing, maternal seizures, immediate toxicity to the fetus as assessed by abortion (fetal demise before 20 weeks Gestation), Live Birth rate, and newborn congenital anomalies.']	N/A	N/A	[('UBERON_0002371', 'bone marrow', 46, 'bone marrow'), ('UBERON_0002113', 'kidney', 59, 'kidney'), ('UBERON_0002107', 'liver', 71, 'liver'), ('GO_0007565', 'female pregnancy', 269, 'gestation'), ('GO_0008610', 'lipid biosynthetic process', 281, 'live birth')]
PMC4763449	2/2016	S2-PMC4763449	['circulating Angiogenic factors are helpful for prognostication of Pregnant patients with chronic Kidney disease who are not on dialysis.']	N/A	N/A	[('GO_0001525', 'angiogenesis', 12, 'angiogenic'), ('GO_0007565', 'female pregnancy', 66, 'pregnant'), ('UBERON_0002113', 'kidney', 97, 'kidney')]
PMC4763449	2/2016	S4-PMC4763449	['case presentation\nwe report the case of a patient with a history of Interstitial nephritis who had a Kidney transplant that failed after 8 years due to membranous nephropathy.']	N/A	N/A	[('UBERON_0005169', 'interstitial tissue', 68, 'interstitial'), ('UBERON_0002113', 'kidney', 101, 'kidney')]
PMC4763449	2/2016	S20-PMC4763449	['we measured Pigf and S-Flt-1 in a Pregnant patient with end-stage Renal disease secondary to Interstitial nephritis whose Renal transplant failed because of de novo membranous nephropathy, and she was started on Hemodialysis therapy.']	N/A	N/A	[('PR_000012702', 'GPI ethanolamine phosphate transferase 3', 12, 'PIGF'), ('PR_000014740', 'splicing factor 4', 21, 's-FLT-1'), ('GO_0007565', 'female pregnancy', 34, 'pregnant'), ('UBERON_0002113', 'kidney', 66, 'renal'), ('UBERON_0005169', 'interstitial tissue', 93, 'interstitial'), ('UBERON_0002113', 'kidney', 122, 'renal'), ('GO_0030097', 'hemopoiesis', 212, 'hemodialysis')]
PMC4763449	2/2016	S21-PMC4763449	['case presentation\na 33-year-old female with a history of esrd secondary to Interstitial nephritis had a preemptive Kidney transplant which failed after 8\xa0years, secondary to biopsy-proven de novo membranous nephropathy.']	N/A	N/A	[('UBERON_0005169', 'interstitial tissue', 75, 'interstitial'), ('UBERON_0002113', 'kidney', 115, 'kidney')]
PMC4763449	2/2016	S22-PMC4763449	['she had had a history of unprovoked Pulmonary embolism 4\xa0years after the Renal transplant and had been treated with oral Anticoagulation for 2\xa0years.']	N/A	N/A	[('UBERON_0002048', 'lung', 36, 'pulmonary'), ('UBERON_0002113', 'kidney', 73, 'renal'), ('GO_0051648', 'vesicle localization', 121, 'anticoagulation')]
PMC4764298	2/2016	S39-PMC4764298	['pe was defined as a Blood pressure greater than 140/90 mmhg on two occasions six hours apart and proteinuria greater than 2+ on dipstick or greater than 300 mg in 24 hour Urine collection, supplemented by clinical symptoms and lab test results such as hellp (hemolysis, elevated Liver enzymes, and low Platelet count), thrombocytopenia, Renal insufficiency, impaired Liver function, Pulmonary edema, Cerebral or Visual symptoms, and elevated Uric Acid levels, in the absence of proteinuria.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood'), ('UBERON_0001088', 'urine', 171, 'urine'), ('UBERON_0002107', 'liver', 279, 'liver'), ('CL_0000233', 'platelet', 302, 'platelet'), ('UBERON_0002113', 'kidney', 337, 'renal'), ('UBERON_0002107', 'liver', 367, 'liver'), ('UBERON_0002048', 'lung', 383, 'pulmonary'), ('UBERON_0001893', 'telencephalon', 400, 'cerebral'), ('GO_0007601', 'visual perception', 412, 'visual'), ('CHEBI_27226', 'uric acid', 442, 'uric acid')]
PMC4770602	1/2016	S28-PMC4770602	['Pregnant women at less than 16 week Gestation from outpatient clinics at “shahid beheshti” hospital were eligible if they did not have any sign of Vitamin D deficiency, did not using Aspirin and had no diagnosis of chronic hypertension, Gestational diabetes, Renal disease or systemic lupus erythematus.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('GO_0007565', 'female pregnancy', 36, 'gestation'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_2904', 'atenolol', 183, 'aspirin'), ('GO_0007565', 'female pregnancy', 237, 'gestational'), ('UBERON_0002113', 'kidney', 259, 'renal')]
PMC4785305	3/2016	S90-PMC4785305	['Renal stones.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Renal')]
PMC4789467	3/2016	S201-PMC4789467	['Uterine Artery ligation also reduces Nephron number in male and female offspring (wlodek et al.,2008; moritz et al.,2009), with female offspring developing compensatory Glomerular hypertrophy and Renal dysfunction later in Life (moritz et al.,2009).']	N/A	N/A	[('UBERON_0002493', 'uterine artery', 0, 'Uterine artery'), ('UBERON_0001285', 'nephron', 37, 'nephron'), ('UBERON_0000074', 'renal glomerulus', 169, 'glomerular'), ('UBERON_0002113', 'kidney', 196, 'renal'), ('UBERON_0000104', 'life cycle', 223, 'life')]
PMC4811441	3/2016	S20-PMC4811441	['Pulmonary edema, eclampsia, Renal or Liver failure and stroke [3].']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'pulmonary'), ('UBERON_0002113', 'kidney', 28, 'renal'), ('UBERON_0002107', 'liver', 37, 'liver')]
PMC4811441	3/2016	S73-PMC4811441	['preexisting medical conditions relevant to this study were Heart disease, Coagulations disorders including previous Thrombosis, Autoimmune disease (diabetes, multiple sclerosis, systemic lupus erythematosus and reumatoid arthritis) and Kidney disease.']	N/A	N/A	[('UBERON_0000948', 'heart', 59, 'heart'), ('GO_0050817', 'coagulation', 74, 'coagulations'), ('GO_0007596', 'blood coagulation', 116, 'thrombosis'), ('UBERON_0001442', 'skeleton of manus', 128, 'autoimmune'), ('UBERON_0002113', 'kidney', 236, 'kidney')]
PMC4811441	3/2016	S108-PMC4811441	['gwg calculated from t1 up until Gestational week 37.\nc.preexisting Heart disease, Coagulation disorder, Kidney disease, diabetes, systemic lupus erythematosus, reumatoid arthritis.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 32, 'gestational'), ('UBERON_0000948', 'heart', 67, 'heart'), ('GO_0050817', 'coagulation', 82, 'coagulation'), ('UBERON_0002113', 'kidney', 104, 'kidney')]
PMC4829940	5/2016	S13-PMC4829940	['25(Oh)D is activated in a second hydroxylation step, by 1α-hydroxylase (encoded by Cyp27B1 ), primarily in the Kidneys, but also in other Tissues Expressing Cyp27B1 including Lymphocytes[1],[2].']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 0, '25(OH)D'), ('PR_000006101', 'cytochrome P450 1A1', 83, 'CYP27B1'), ('UBERON_0002113', 'kidney', 111, 'kidneys'), ('UBERON_0000479', 'tissue', 138, 'tissues'), ('GO_0010467', 'gene expression', 146, 'expressing'), ('PR_000006101', 'cytochrome P450 1A1', 157, 'CYP27B1'), ('CL_0000542', 'lymphocyte', 175, 'lymphocytes')]
PMC4843009	4/2016	S10-PMC4843009	['klotho is Expressed mainly in the Kidney, but is highly Expressed as well in Choroid Plexus Of the Brain1.']	N/A	N/A	[('GO_0010467', 'gene expression', 10, 'expressed'), ('UBERON_0002113', 'kidney', 34, 'kidney'), ('GO_0010467', 'gene expression', 56, 'expressed'), ('UBERON_0002890', 'anterior amygdaloid area', 77, 'choroid plexus of ... brain1')]
PMC4846845	4/2016	S161-PMC4846845	['this is typically accomplished in the Kidneys, but the Placenta is also capable of synthesizing 1,25(Oh)2D [126].']	N/A	N/A	[('UBERON_0002113', 'kidney', 38, 'kidneys'), ('UBERON_0001987', 'placenta', 55, 'placenta'), ('CHEBI_37958', 'dye', 96, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 98, '25(OH)2D')]
PMC4892656	6/2016	S184-PMC4892656	['the low-hchf Sheep in addition to hypercholesterolaemia also developed hyperuraemia, hypercreatinaemia and hyperlactaemia, of which the two first were indicators of alterations in Hepatic and/or Renal function.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 13, 'sheep'), ('UBERON_0002107', 'liver', 180, 'hepatic'), ('UBERON_0002113', 'kidney', 195, 'renal')]
PMC4896250	4/2016	S516-PMC4896250	['Renal function tests, Complement-4 (C4), C3 levels were within normal ranges.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Renal'), ('PR_000004090', 'AP-1 complex subunit beta-1', 22, 'complement-4'), ('PR_000004904', 'complement C5', 36, 'C4'), ('PR_000004904', 'complement C5', 41, 'C3')]
PMC4896250	4/2016	S807-PMC4896250	['Blood chemistries, Liver and Kidney function tests, inflammatory markers (esr and crp) and Immunoglobulin levels were within the normal ranges in all patients.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002107', 'liver', 19, 'liver'), ('UBERON_0002113', 'kidney', 29, 'kidney'), ('GO_0019814', 'immunoglobulin complex', 91, 'immunoglobulin')]
PMC4896250	4/2016	S1171-PMC4896250	['it was compared among the total time of Abdominal pain, pain relief, hospitalization, fasting and Kidney injury case in the groups.']	N/A	N/A	[('UBERON_0000916', 'abdomen', 40, 'abdominal'), ('UBERON_0002113', 'kidney', 98, 'kidney')]
PMC4896250	4/2016	S1179-PMC4896250	['there was no significant difference (p> 0.05) in the incidence of Kidney injury between two groups of children during hospitalization.']	N/A	N/A	[('UBERON_0002113', 'kidney', 66, 'kidney')]
PMC4896250	4/2016	S1327-PMC4896250	['co-morbidities consisted of hypertension (29.5%), Renal insufficiency (13.6%), diabetes (9.1%), dyslipidemia (5.7%), Cardiac diseases (4.5%) and Liver diseases (4.5%).']	N/A	N/A	[('UBERON_0002113', 'kidney', 50, 'renal'), ('UBERON_0000948', 'heart', 117, 'cardiac'), ('UBERON_0002107', 'liver', 145, 'liver')]
PMC4896250	4/2016	S2236-PMC4896250	['Kidney biopsy and skin biopsy were performed, and histological examination showed acute necrotizing crescentic glomerulonephritis and leukoclastic vasculitis in skin, which led to the diagnosis of churg-strauss syndrome (Eosinophilic granulomatosis with polyangiitis, egpa) combined with rapidly progressive glomerulonephritis (rpgn).']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidney'), ('CL_0000771', 'eosinophil', 221, 'eosinophilic')]
PMC4896250	4/2016	S6363-PMC4896250	['however, deterioration of his Renal function occurred on day 8 of admission.']	N/A	N/A	[('UBERON_0002113', 'kidney', 30, 'renal')]
PMC4896250	4/2016	S6365-PMC4896250	['ultrasonography showed diffuse Renal enlargement.']	N/A	N/A	[('UBERON_0002113', 'kidney', 31, 'renal')]
PMC4896250	4/2016	S6368-PMC4896250	['after hemodialysis, his Renal function recovered completely within 2 weeks without administration of systemic Corticosteroid.']	N/A	N/A	[('UBERON_0002113', 'kidney', 24, 'renal'), ('CHEBI_36916', 'cation', 110, 'corticosteroid')]
PMC4896250	4/2016	S7343-PMC4896250	['in these diseases, affected Vessels have changed with focal necrosis in pathologic findings and patients suffer from Pulmonary, Cerebral, Gastrointestinal, other hemorrhagic complication and also Renal dysfunction represented by crescentic glomerulonephritis.']	N/A	N/A	[('UBERON_0000055', 'vessel', 28, 'vessels'), ('UBERON_0002048', 'lung', 117, 'pulmonary'), ('UBERON_0001893', 'telencephalon', 128, 'cerebral'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 138, 'gastrointestinal'), ('UBERON_0002113', 'kidney', 196, 'renal')]
PMC4896250	4/2016	S7479-PMC4896250	['from the laboratory examination, there were anaemia, with a small increased of the Erythrocyte sedimentation rate (esr), but C-Reactive Protein (Crp), Liver and Kidney function were within normal limits.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 83, 'erythrocyte'), ('PR_000005890', 'crooked neck-like protein 1', 125, 'C-reactive protein'), ('PR_000005890', 'crooked neck-like protein 1', 145, 'CRP'), ('UBERON_0002107', 'liver', 151, 'liver'), ('UBERON_0002113', 'kidney', 161, 'kidney')]
PMC4910255	6/2016	S156-PMC4910255	['[46]compared to 30\xa0mg iron control adjusted for iron intervention dummy and Food intervention variables: systolic, 0.05 (–0.71 to 0.81); Diastolic, 0.55 (–0.10 to 1.20)no difference in Kidney volumes compared to 30\xa0mg ironburkina fasoroberfroid et al.']	N/A	N/A	[('CHEBI_33290', 'food', 76, 'food'), ('GO_0006281', 'DNA repair', 137, 'Diastolic'), ('UBERON_0002113', 'kidney', 185, 'kidney')]
PMC4910255	6/2016	S162-PMC4910255	['[39]0.05 (–0.09 to 0.19)not recorded by trial group0.02 (–0.10 to 0.15)not recorded by trial groupbmi for age 0.04 (–0.09 to 0.18)not recorded by trial grouplean mass, –0.05\xa0kg (–0.43 to 0.34\xa0kg); fat mass, –0.07\xa0kg (–0.32 to 0.18\xa0kg); no difference in Biceps, Triceps, Subscapular and Suprailiac Skinfold thicknesseshead, 0.18\xa0cm (–0.02 to 0.38); muac, 0.04 (–0.15 to 0.23\xa0cm)systolic, 0.02\xa0mmhg (–1.02 to 1.05\xa0mmhg); diastolic, 0.13\xa0mmhg (–0.93 to 1.19\xa0mmhg)no difference in Kidney dimensions; exclusion of children with chronic or major illness made no differencenepal sarlahistewart et al.']	N/A	N/A	[('UBERON_0004347', 'limb bud', 253, 'biceps'), ('UBERON_0001509', 'triceps brachii', 261, 'triceps'), ('UBERON_0001161', 'body of stomach', 270, 'subscapular'), ('UBERON_0010402', 'epidermis suprabasal layer', 286, 'suprailiac'), ('UBERON_0009007', 'superficial inguinal lymph node', 297, 'skinfold'), ('UBERON_0002113', 'kidney', 477, 'kidney')]
PMC4912994	6/2016	S64-PMC4912994	['at this time, she presented with a complaint of Flank pain, and a Renal sonogram was performed that also documented a normal sized Spleen.']	N/A	N/A	[('UBERON_0000180', 'lateral lumbar region of abdomen', 48, 'flank'), ('UBERON_0002113', 'kidney', 66, 'renal'), ('UBERON_0002106', 'spleen', 131, 'spleen')]
PMC4919374	6/2016	S72-PMC4919374	['nephropathy\nKidney disease increases the risk of hypertension, Preterm Delivery, preeclampsia, iugr, neonatal jaundice, and mechanical ventilation of the infant.']	N/A	N/A	[('UBERON_0002113', 'kidney', 12, 'Kidney'), ('GO_0007565', 'female pregnancy', 63, 'preterm'), ('GO_0007567', 'parturition', 71, 'delivery')]
PMC4919374	6/2016	S158-PMC4919374	['age and Renal function determine the incidence of cvd in non-Pregnant women with t1dm [99•].']	N/A	N/A	[('UBERON_0002113', 'kidney', 8, 'renal'), ('GO_0007565', 'female pregnancy', 61, 'pregnant')]
PMC4934634	11/2015	S27-PMC4934634	['Vitamin D binding protein transports the 25(Oh)D to the Kidneys where hydroxylation by 1-α-hydroxylase to the active form, 1,25-Dihydroxyvitamin D3(1,25(Oh)2D) occurs.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 41, '25(OH)D'), ('UBERON_0002113', 'kidney', 56, 'kidneys'), ('CHEBI_33229', 'vitamin (role)', 128, 'dihydroxyvitamin D3'), ('CHEBI_17996', 'chloride', 149, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 150, '25(OH)2D')]
PMC4939564	8/2015	S106-PMC4939564	['additionally, those exposed in mid-Pregnancy demonstrated reduced Renal function [61,62].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 35, 'pregnancy'), ('UBERON_0002113', 'kidney', 66, 'renal')]
PMC4939564	8/2015	S121-PMC4939564	['Oxidation Of Fatty Acids generates Ketones that can be used as fuel by Skeletal and Cardiac Muscle, Liver, Kidney, and Adipose Tissue, thus sparing Glucose for continued utilization by Brain and Erythrocytes [64].']	N/A	N/A	[('GO_0035193', 'larval central nervous system remodeling', 0, 'Oxidation of fatty acids'), ('CHEBI_35366', 'fatty acid', 13, 'fatty acids'), ('CHEBI_17087', 'ketone', 35, 'ketones'), ('UBERON_0001442', 'skeleton of manus', 71, 'skeletal ...'), ('UBERON_0001133', 'cardiac muscle tissue', 84, 'cardiac muscle'), ('UBERON_0002107', 'liver', 100, 'liver'), ('UBERON_0002113', 'kidney', 107, 'kidney'), ('UBERON_0001013', 'adipose tissue', 119, 'adipose tissue'), ('CHEBI_17234', 'glucose', 148, 'glucose'), ('UBERON_0000955', 'brain', 185, 'brain'), ('CL_0000232', 'erythrocyte', 195, 'erythrocytes')]
PMC4944244	7/2016	S38-PMC4944244	['the exclusion criteria were mothers with pre-existing type i or type ii diabetes, pre-existing hypertension, pre-existing Parathyroid disease or uncontrolled Thyroid disease, rheumatoid arthritis, Metabolic bone disease, malabsorption, Kidney disease, Liver disease or treatment with Antiepileptic Drugs or Antituberculous.']	N/A	N/A	[('UBERON_0001132', 'parathyroid gland', 122, 'parathyroid'), ('UBERON_0002046', 'thyroid gland', 158, 'thyroid'), ('GO_0008152', 'metabolic process', 197, 'metabolic'), ('UBERON_0002113', 'kidney', 236, 'kidney'), ('UBERON_0002107', 'liver', 252, 'liver'), ('CHEBI_35473', 'tranquilizing drug', 284, 'antiepileptic drugs'), ('CHEBI_35494', 'D-cystine', 307, 'antituberculous')]
PMC4975765	1/2016	S35-PMC4975765	['the exclusion criteria for the study were maternal diseases (Preeclampsia, hypertension, diabetes mellitus, active hepatitis, Renal and Cardiovascular diseases, and inflammatory conditions), multiple Pregnancy, Birth defects detected during Pregnancy, Alcohol drinking, and assisted reproduction.']	N/A	N/A	[('GO_0007128', 'meiotic prophase I', 61, 'preeclampsia'), ('UBERON_0002113', 'kidney', 126, 'renal'), ('UBERON_0004535', 'cardiovascular system', 136, 'cardiovascular'), ('GO_0007565', 'female pregnancy', 200, 'pregnancy'), ('GO_0007567', 'parturition', 211, 'birth'), ('GO_0007565', 'female pregnancy', 241, 'pregnancy'), ('CHEBI_30879', 'alcohol', 252, 'alcohol')]
PMC4989298	8/2016	S255-PMC4989298	['the biological activities of Eicosanoids are varied: for example, Prostaglandin E2 (Pge2) acts on Blood Vessels, Airways, the Stomach, the Kidneys, Neutrophil function, Lymphocytes and pain receptors.']	N/A	N/A	[('CHEBI_36744', 'guaiane sesquiterpenoid', 29, 'eicosanoids'), ('CHEBI_15551', 'prostaglandin E2', 66, 'prostaglandin E2'), ('PR_000013393', 'proteasome activator complex subunit 2', 66, 'prostaglandin E2'), ('CHEBI_7998', 'Peptide(-Leu)', 84, 'PGE2'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 84, 'PGE2'), ('UBERON_0001981', 'blood vessel', 98, 'blood vessels'), ('UBERON_0001005', 'respiratory airway', 113, 'airways'), ('UBERON_0000945', 'stomach', 126, 'stomach'), ('UBERON_0002113', 'kidney', 139, 'kidneys'), ('CL_0000775', 'neutrophil', 148, 'neutrophil'), ('CL_0000542', 'lymphocyte', 169, 'lymphocytes')]
PMC4989298	8/2016	S340-PMC4989298	['pth then Regulates the hydroxylation of 25 [Oh] D to its biologically active form (1,25[Oh]2D3) in the Kidney.']	N/A	N/A	[('GO_0065007', 'biological regulation', 9, 'regulates'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 40, '25 [OH] D'), ('CHEBI_64115', '(1S,2R)-5-methoxy-1-methyl-2-(propylamino)tetralin hydrochloride', 85, '25[OH]2D3'), ('UBERON_0002113', 'kidney', 103, 'kidney')]
PMC4992225	8/2016	S34-PMC4992225	['however, 25-Hydroxyvitamin D requires an additional hydroxylation in the Kidneys to form the biologically active form of Vitamin D, 1, 25(Oh) 2D.']	N/A	N/A	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 9, '25-hydroxyvitamin D'), ('UBERON_0002113', 'kidney', 73, 'kidneys'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 135, '25(OH) 2D')]
PMC4992225	8/2016	S67-PMC4992225	['the inclusion criteria were: being 18\xa0years or older, healthy women means; any one with no history of mental illness and internal diseases such as hyper/hypothyroidism, Parathyroid, Renal, diabetes and Heart diseases, no addiction to any kind of Narcotic Drugs, living with a husband, a singleton live fetus, without any Pregnancy complications such as Preeclampsia, Gestational diabetes, ruptured membranes and suspicion of Preterm Birth, no previous cesarean sections, Gestational age of 26–28 weeks based on ultrasound results, and the epds baseline scores of 0 to 13.']	N/A	N/A	[('UBERON_0001132', 'parathyroid gland', 169, 'parathyroid'), ('UBERON_0002113', 'kidney', 182, 'renal'), ('UBERON_0000948', 'heart', 202, 'heart'), ('CHEBI_49103', 'drug metabolite', 246, 'narcotic'), ('CHEBI_23888', 'drug', 255, 'drugs'), ('GO_0007565', 'female pregnancy', 321, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 353, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 367, 'gestational'), ('GO_0007565', 'female pregnancy', 425, 'preterm birth'), ('GO_0007565', 'female pregnancy', 471, 'gestational')]
PMC4996908	5/2016	S19-PMC4996908	['Genetic testing did not reveal an abnormality, but given her constellation of Spinal segmentation and Rib anomalies, a diagnosis of scdo was made, along with Pulmonary hypoplasia, congenital Heart disease with a Ventricular Septal defect, Bicuspid Aortic Valve, Transverse Aortic Arch hypoplasia and severe Aortic coarctation, Pelvic horseshoe Kidney, Uterine didelphys, and Inguinal hernia (with subsequent obstruction).']	N/A	N/A	[('SO_0000704', 'gene', 0, 'Genetic'), ('UBERON_0001130', 'vertebral column', 78, 'spinal'), ('UBERON_0002228', 'rib', 102, 'rib'), ('UBERON_0002048', 'lung', 158, 'pulmonary'), ('UBERON_0000948', 'heart', 191, 'heart'), ('UBERON_0002094', 'interventricular septum', 212, 'ventricular septal'), ('UBERON_0003674', 'cuspid', 239, 'bicuspid'), ('UBERON_0002137', 'aortic valve', 248, 'aortic valve'), ('UBERON_0002201', 'vasculature of trunk', 262, 'transverse'), ('UBERON_0001508', 'arch of aorta', 273, 'aortic arch'), ('UBERON_0000947', 'aorta', 307, 'aortic'), ('UBERON_0002108', 'small intestine', 327, 'pelvic'), ('UBERON_0002113', 'kidney', 344, 'kidney'), ('UBERON_0000995', 'uterus', 352, 'uterine'), ('UBERON_0008337', 'inguinal part of abdomen', 375, 'inguinal')]
PMC4997567	8/2016	S19-PMC4997567	['inclusion criteria\nthe cases were children between 2 - 4 years of age with history, clinical, laboratory, and radiographic findings of Vitamin D deficiency rickets causing bow Legs or Genu Varus, not receiving therapeutic doses of Vitamin D, with no history of prematurity, and not suffering any form of Renal, Liver, Cardiac, bone (excluding rickets) disease or any form of chronic infection.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('UBERON_0000978', 'leg', 176, 'legs'), ('UBERON_0004084', 'genital labium', 184, 'genu varus'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('UBERON_0002113', 'kidney', 304, 'renal'), ('UBERON_0002107', 'liver', 311, 'liver'), ('UBERON_0000948', 'heart', 318, 'cardiac')]
PMC4997567	8/2016	S21-PMC4997567	['exclusion criteria\nchildren younger than 2 years and older than 4 years of age, with no history, clinical, laboratory, and radiographic findings of Vitamin D deficiency rickets, or rachitic but with no Bow Legs or Genu varus, receiving therapeutic doses of Vitamin D, history of prematurity, and suffering any form of Renal, Liver, Cardiac, bone (excluding rickets) disease or any form of chronic infection were rejected.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('UBERON_0000160', 'intestine', 202, 'bow legs'), ('UBERON_2001304', 'vagal ganglion 3', 214, 'genu'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin D'), ('UBERON_0002113', 'kidney', 318, 'renal'), ('UBERON_0002107', 'liver', 325, 'liver'), ('UBERON_0000948', 'heart', 332, 'cardiac')]
PMC4997567	8/2016	S31-PMC4997567	['1,25(Oh)2D is the product of both Liver and Renal Hydroxylation of Vitamin D3Which is the most active Metabolite of Vitamin D. its standard Serum level ranges from 20 - 60 ng/dl.']	N/A	N/A	[('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 2, '25(OH)2D'), ('UBERON_0002107', 'liver', 34, 'liver'), ('UBERON_0002113', 'kidney', 44, 'renal'), ('GO_0044444', 'cytoplasmic part', 50, 'hydroxylation'), ('CHEBI_83360', 'N-lignoceroylsphingosine-1-phosphocholine', 67, 'vitamin D3which'), ('CHEBI_39382', 'flufenoxuron', 102, 'metabolite'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('UBERON_0001977', 'blood serum', 140, 'serum')]
PMC4999234	8/2016	S5-PMC4999234	['results\nno differences between groups were observed in total Renal volume, volume of Renal compartments or number of Glomeruli.']	N/A	N/A	[('UBERON_0002113', 'kidney', 61, 'renal'), ('UBERON_0002113', 'kidney', 85, 'renal'), ('UBERON_0000074', 'renal glomerulus', 117, 'glomeruli')]
PMC4999234	8/2016	S8-PMC4999234	['protein Expression of the At2Receptor was lower in the Kidneys of the ls males and females than in those of the ns males and females.']	N/A	N/A	[('GO_0010467', 'gene expression', 8, 'expression'), ('PR_000004455', 'ATP synthase subunit gamma, mitochondrial', 26, 'AT2receptor'), ('UBERON_0002113', 'kidney', 55, 'kidneys')]
PMC4999234	8/2016	S10-PMC4999234	['Salt restriction during Pregnancy reduced the Expression of Renal Angiotensin Ii Receptors in newborns.']	N/A	N/A	[('CHEBI_17418', 'valeric acid', 0, 'Salt'), ('GO_0007565', 'female pregnancy', 24, 'pregnancy'), ('GO_0010467', 'gene expression', 46, 'expression'), ('PR_000001658', 'prostaglandin E2 receptor EP2 subtype', 60, 'renal angiotensin II receptors'), ('UBERON_0002113', 'kidney', 60, 'renal')]
PMC4999234	8/2016	S30-PMC4999234	['Kidneys and Hearts were collected immediately and weighed.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidneys'), ('UBERON_0000948', 'heart', 12, 'hearts')]
PMC4999234	8/2016	S33-PMC4999234	['stereological analysis\nKidneys and Hearts were routinely processed for paraffin embedding.']	N/A	N/A	[('UBERON_0002113', 'kidney', 23, 'Kidneys'), ('UBERON_0000948', 'heart', 35, 'hearts')]
PMC4999234	8/2016	S34-PMC4999234	['we embedded the entire Kidney and produced sections parallel to its major axis.']	N/A	N/A	[('UBERON_0002113', 'kidney', 23, 'kidney')]
PMC4999234	8/2016	S36-PMC4999234	['blocks containing Kidneys and Hearts were exhaustively sectioned at 5 μm using a microtome.']	N/A	N/A	[('UBERON_0002113', 'kidney', 18, 'kidneys'), ('UBERON_0000948', 'heart', 30, 'hearts')]
PMC4999234	8/2016	S37-PMC4999234	['every 60th(Kidney) and 70th(Heart) slice was collected onto a glass slide until the end of both blocks was reached.']	N/A	N/A	[('UBERON_0002113', 'kidney', 11, 'kidney'), ('UBERON_0000948', 'heart', 28, 'heart')]
PMC4999234	8/2016	S38-PMC4999234	['we also collected random intervals of 10 pairs of Kidney sections (d = 15 μm) to estimate the number of Glomeruli.']	N/A	N/A	[('UBERON_0002113', 'kidney', 50, 'kidney'), ('UBERON_0000074', 'renal glomerulus', 104, 'glomeruli')]
PMC4999234	8/2016	S41-PMC4999234	['total volumes of the Kidney and the Heart\nwe obtained the total volumes of the Hearts and the Kidneys using the cavalieri principle [6].']	N/A	N/A	[('UBERON_0002113', 'kidney', 21, 'kidney'), ('UBERON_0000948', 'heart', 36, 'heart'), ('UBERON_0000948', 'heart', 79, 'hearts'), ('UBERON_0002113', 'kidney', 94, 'kidneys')]
PMC4999234	8/2016	S42-PMC4999234	['volume fractions and total volumes of Kidney and Heart compartments\nwe used the method of point counting to estimate the volume fraction (vv comp) of each major compartment of the Kidney (Cortex, Medulla and Pelvis) and Heart (Septum, Left Ventricle, Right Ventricle and respective Cavities) [7].']	N/A	N/A	[('UBERON_0002113', 'kidney', 38, 'kidney'), ('UBERON_0000948', 'heart', 49, 'heart'), ('UBERON_0002113', 'kidney', 180, 'kidney'), ('UBERON_0001851', 'cortex', 188, 'cortex'), ('UBERON_0000958', 'medulla of organ', 196, 'medulla'), ('UBERON_0002355', 'pelvic region of trunk', 208, 'pelvis'), ('UBERON_0000948', 'heart', 220, 'heart'), ('UBERON_0003037', 'septum', 227, 'septum'), ('UBERON_0002084', 'heart left ventricle', 235, 'left ventricle'), ('UBERON_0002080', 'heart right ventricle', 251, 'right ventricle'), ('UBERON_0001450', 'calcaneus', 282, 'cavities')]
PMC4999234	8/2016	S44-PMC4999234	['we performed differential counts of points falling on the structures of interest and used the following formula: (1) we estimated the vv comp and multiplied the vv comp by the total volume (2) of the Organ (Kidney or Heart) to obtain the total volume (v comp) of the compartment.vvcomp=∑ptcomp∑pt(struct)vcomp=vvcompxvorganwhere ∑pt (comp) is the sum of points falling in a defined compartment in the series of sections analyzed, and ∑pt (struct) is the sum of points falling in the other structures (compartments) of the Organ.']	N/A	N/A	[('UBERON_0000062', 'organ', 200, 'organ'), ('UBERON_0002113', 'kidney', 207, 'kidney'), ('UBERON_0000948', 'heart', 217, 'heart'), ('UBERON_0000062', 'organ', 522, 'organ')]
PMC4999234	8/2016	S57-PMC4999234	['elisa\nwhole Kidneys and Hearts from eight Animals from each experimental group of male and female newborns were homogenized (ika ultra-turrax t10 basic, wilmington, north carolina, usa) in 500 μl of buffer (50 mm Tris-Cl, 1 mm edta + 10% Sucrose, ph 7.4), 5 μl of a Cocktail of protease inhibitors (sigma, st. louis, missouri, usa) and 100 mm Sodium Fluoride for each Tissue.']	N/A	N/A	[('UBERON_0002113', 'kidney', 12, 'kidneys'), ('UBERON_0000948', 'heart', 24, 'hearts'), ('NCBITaxon_33208', 'Metazoa', 42, 'animals'), ('CHEBI_9754', 'tris', 213, 'Tris'), ('CHEBI_17996', 'chloride', 218, 'Cl'), ('CHEBI_17992', 'sucrose', 238, 'sucrose'), ('CHEBI_60004', 'mixture', 266, 'cocktail'), ('CHEBI_26710', 'sodium chloride', 343, 'sodium fluoride'), ('UBERON_0000479', 'tissue', 368, 'tissue')]
PMC4999234	8/2016	S78-PMC4999234	['no differences in litter size, sex ratio, Cardiac mass or Renal mass were observed between the experimental groups (table 1).10.1371/journal.pone.0161598.t001\n\ncaption (table-wrap): table 1\neffect of low-, normal- and high-Salt diet during Pregnancy on mothers and offspring.lsnnsnhsndamsbody weight—third week of Gestation (g)351±23#8377±367386±428food Intake (g/dam/day)seventh day of Gestation21±1721±1720±17fourteenth day of Gestation21±1722±1722±17twenty first day of Gestation19±1*#722±1722±17neonateslitter size13.6±0.8814±0.6714±0.59m6.9±1.087.6±0.876.7±0.89f6.7±0.686.4±0.777.4±0.89body weight (g)m5.4±0.09*#556.4±0.07536.4±0.0860f5.1±0.07*#536.0±0.09456.0±0.0867sex ratiom6.9±1.087.6±0.876.7±0.89f6.7±0.686.4±0.777.4±0.89heart mass/ body weight (mg/10 g)m59±22363±22860±226f0.061±0.002250.062±0.001240.059±0.00232kidney mass/body weight (mg/10 g)m94±32399±22892±0.00426f102±325100±22497±232\ndata are reported as the means±sem.']	N/A	N/A	[('UBERON_0000948', 'heart', 42, 'cardiac'), ('UBERON_0002113', 'kidney', 58, 'renal'), ('CHEBI_24866', 'salt', 223, 'salt'), ('GO_0007565', 'female pregnancy', 240, 'pregnancy'), ('GO_0007565', 'female pregnancy', 314, 'gestation'), ('GO_0007631', 'feeding behavior', 354, 'intake'), ('GO_0007565', 'female pregnancy', 387, 'gestation21'), ('GO_0007565', 'female pregnancy', 429, 'gestation21'), ('GO_0007565', 'female pregnancy', 473, 'gestation19')]
PMC4999234	8/2016	S86-PMC4999234	['volumes of offspring Kidneys and compartments and Glomeruli number\ntotal Kidney volume and compartment volumes (Cortex, Medulla and Pelvis) were not different between the three experimental groups in newborn males and females.']	N/A	N/A	[('UBERON_0002113', 'kidney', 21, 'kidneys'), ('UBERON_0000074', 'renal glomerulus', 50, 'glomeruli'), ('UBERON_0002113', 'kidney', 73, 'kidney'), ('UBERON_0001851', 'cortex', 112, 'cortex'), ('UBERON_0000958', 'medulla of organ', 120, 'medulla'), ('UBERON_0002355', 'pelvic region of trunk', 132, 'pelvis')]
PMC4999234	8/2016	S87-PMC4999234	['the number of Glomeruli was also not different between the experimental groups, but female neonates exhibited a higher number of Glomeruli than males in the three experimental groups (table 3).10.1371/journal.pone.0161598.t003\n\ncaption (table-wrap): table 3\nvolumes of whole Kidneys and compartments in newborns.lsnshskidney total volume (mm3)m7.04±0.477.44±0.228.20±0.46f6.73±0.615.84±0.447.25±0.98cortex (mm3)m4.97±0.345.40±0.165.86±0.27f4.74±0.484.19±0.284.99±0.61medulla (mm3)m1.89±0.161.87±0.072.16±0.16f1.76±0.151.51±0.162.08±0.36pelvis (mm3)m0.18±0.040.17±0.020.18±0.06f0.22±0.030.14±0.040.18±0.04cortex (%)m0.71±0.010.73±0.000.72±0.01f0.70±0.010.72±0.020.70±0.01medulla (%)m0.27±0.010.25±0.010.26±0.01f0.26±0.010.26±0.020.28±0.01pelvis (%)m0.03±0.010.02±0.000.02±0.01f0.04±0.010.02±0.000.03±0.01glomeruli numberm16286±135116318±108514405±1499f24095±2431*25770±3096*24112±2938*\ndata are reported as the means±sem.']	N/A	N/A	[('UBERON_0000074', 'renal glomerulus', 14, 'glomeruli'), ('UBERON_0000074', 'renal glomerulus', 129, 'glomeruli'), ('UBERON_0002113', 'kidney', 275, 'kidneys')]
PMC4999234	8/2016	S90-PMC4999234	['protein Expression of at1and at2receptors in Kidney and Heart\nprotein Expression of the At1Receptor in Kidneys was lower (p > 0.05) in male newborns of the ls group than the ns and hs groups.']	N/A	N/A	[('GO_0010467', 'gene expression', 8, 'Expression'), ('UBERON_0002113', 'kidney', 45, 'kidney'), ('UBERON_0000948', 'heart', 56, 'heart'), ('GO_0010467', 'gene expression', 70, 'expression'), ('PR_000004455', 'ATP synthase subunit gamma, mitochondrial', 88, 'AT1receptor'), ('UBERON_0002113', 'kidney', 103, 'kidneys')]
PMC4999234	8/2016	S91-PMC4999234	['At1Receptor protein Expression in the Kidneys of females did not differ between the experimental groups.']	N/A	N/A	[('PR_000004455', 'ATP synthase subunit gamma, mitochondrial', 0, 'AT1receptor'), ('GO_0010467', 'gene expression', 20, 'expression'), ('UBERON_0002113', 'kidney', 38, 'kidneys')]
PMC4999234	8/2016	S95-PMC4999234	['At2Receptor protein Expression did not differ between the experimental groups in neonatal males and females (fig 1).10.1371/journal.pone.0161598.g001\n\ncaption (fig): fig 1\nprotein Expression in the Kidney and Heart of newborn offspring.']	N/A	N/A	[('PR_000004455', 'ATP synthase subunit gamma, mitochondrial', 0, 'AT2receptor'), ('GO_0010467', 'gene expression', 20, 'expression'), ('GO_0010467', 'gene expression', 180, 'expression'), ('UBERON_0002113', 'kidney', 198, 'kidney'), ('UBERON_0000948', 'heart', 209, 'heart')]
PMC4999234	8/2016	S96-PMC4999234	['(a) At1In male Kidneys; (b) At2In male Kidneys; (c) at1in male Heart; (d) At2In male Heart; (e) At1In female Kidneys; (f) At2In female Kidneys; (g) at1in female Heart; (h) at2in female Heart.']	N/A	N/A	[('PR_000029299', 'B-cell CLL/lymphoma 7 protein family member A', 4, 'AT1in'), ('UBERON_0002113', 'kidney', 15, 'kidneys'), ('PR_000029299', 'B-cell CLL/lymphoma 7 protein family member A', 28, 'AT2in'), ('UBERON_0002113', 'kidney', 39, 'kidneys'), ('UBERON_0000948', 'heart', 63, 'heart'), ('PR_000029299', 'B-cell CLL/lymphoma 7 protein family member A', 74, 'AT2in'), ('UBERON_0000948', 'heart', 85, 'heart'), ('PR_000029299', 'B-cell CLL/lymphoma 7 protein family member A', 96, 'AT1in'), ('UBERON_0002113', 'kidney', 109, 'kidneys'), ('PR_000029299', 'B-cell CLL/lymphoma 7 protein family member A', 122, 'AT2in'), ('UBERON_0002113', 'kidney', 135, 'kidneys'), ('UBERON_0000948', 'heart', 161, 'heart'), ('UBERON_0000948', 'heart', 185, 'heart')]
PMC4999234	8/2016	S159-PMC4999234	['lower and absent At1 Receptor protein Expression in ls neonates was observed in the Kidneys and Hearts, respectively, in males but not females.']	N/A	N/A	[('PR_000004455', 'ATP synthase subunit gamma, mitochondrial', 17, 'AT1 receptor'), ('GO_0010467', 'gene expression', 38, 'expression'), ('UBERON_0002113', 'kidney', 84, 'kidneys'), ('UBERON_0000948', 'heart', 96, 'hearts')]
PMC4999234	8/2016	S163-PMC4999234	['the lower Renal At2Receptor protein Expression in male and female offspring of dams Fed a low-Salt diet during Pregnancy is a primary interest.']	N/A	N/A	[('UBERON_0002113', 'kidney', 10, 'renal'), ('PR_000004455', 'ATP synthase subunit gamma, mitochondrial', 16, 'AT2receptor'), ('GO_0010467', 'gene expression', 36, 'expression'), ('GO_0007631', 'feeding behavior', 84, 'fed'), ('CHEBI_24866', 'salt', 94, 'salt'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy')]
PMC4999234	8/2016	S189-PMC4999234	['Renal and Cardiac At1Receptor protein Expression was lower in newborns from dams Fed a low-Salt diet during Gestation.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Renal'), ('UBERON_0000948', 'heart', 10, 'cardiac'), ('PR_000004455', 'ATP synthase subunit gamma, mitochondrial', 18, 'AT1receptor'), ('GO_0010467', 'gene expression', 38, 'expression'), ('GO_0007631', 'feeding behavior', 81, 'fed'), ('CHEBI_24866', 'salt', 91, 'salt'), ('GO_0007565', 'female pregnancy', 108, 'gestation')]
PMC4999234	8/2016	S191-PMC4999234	['limitations of the study\nit would relevant to obtain more details about Angiotensin Ii Receptors protein Expression, such as the identity of the Renal structure that contained lower at2 protein Expression in the ls offspring.']	N/A	N/A	[('PR_000001185', 'alpha-1D adrenergic receptor', 72, 'angiotensin II receptors'), ('GO_0010467', 'gene expression', 105, 'expression'), ('UBERON_0002113', 'kidney', 145, 'renal'), ('GO_0010467', 'gene expression', 194, 'expression')]
PMC4999868	8/2016	S29-PMC4999868	['acute Folate over supplementation results in a significant decrease in Intestinal and Renal Folate Uptake due to down-regulation of the Expression of fr, Rfc and Pcft, mediated by post-transcriptional or Translational mechanisms1920.']	N/A	N/A	[('CHEBI_30863', '5-azaorotic acid', 6, 'folate'), ('UBERON_0000160', 'intestine', 71, 'intestinal'), ('GO_0006281', 'DNA repair', 86, 'renal'), ('UBERON_0002113', 'kidney', 86, 'renal'), ('CHEBI_30863', '5-azaorotic acid', 92, 'folate'), ('GO_0098657', 'import into cell', 99, 'uptake'), ('GO_0010467', 'gene expression', 136, 'expression'), ('PR_000013939', 'Ral-GDS-related protein', 154, 'RFC'), ('PR_000012424', 'pecanex-like protein 1', 162, 'PCFT'), ('GO_0006412', 'translation', 204, 'translational')]
PMC5013576	9/2016	S5-PMC5013576	['a series of three Renal biopsies and rapid clinical course showed progression from significant Podocyte injury with mild light microscopy findings to classic Viral-associated cg to esrd in less than 3\xa0months.']	N/A	N/A	[('UBERON_0002113', 'kidney', 18, 'renal'), ('CL_0000653', 'glomerular visceral epithelial cell', 95, 'podocyte'), ('NCBITaxon_1', 'root', 158, 'viral')]
PMC5013576	9/2016	S20-PMC5013576	['prior to the initiation of widely available and effective Antiretroviral therapy, cg was the most common Kidney lesion in hiv positive patients [6].']	N/A	N/A	[('CHEBI_65417', '(+)-aplysinillin', 58, 'antiretroviral'), ('UBERON_0002113', 'kidney', 105, 'kidney')]
PMC5013576	9/2016	S45-PMC5013576	['parvoviral dna was detected in archived Kidney biopsies with a diagnosis of non-hiv related cg significantly more often than in biopsies of other Kidney lesions [7,8].']	N/A	N/A	[('UBERON_0002113', 'kidney', 40, 'kidney'), ('UBERON_0002113', 'kidney', 146, 'kidney')]
PMC5013576	9/2016	S53-PMC5013576	['she had no personal or family history of Kidney disease or immunodeficiency.']	N/A	N/A	[('UBERON_0002113', 'kidney', 41, 'kidney')]
PMC5013576	9/2016	S63-PMC5013576	['Renal ultrasound revealed normal sized Kidneys bilaterally and slight increase in echogenicity, but without hydronephrosis, cysts, or calcifications.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Renal'), ('UBERON_0002113', 'kidney', 39, 'kidneys')]
PMC5013576	9/2016	S64-PMC5013576	['Renal biopsy/diagnosis\nthe patient underwent Renal biopsy (fig.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Renal'), ('UBERON_0002113', 'kidney', 45, 'renal')]
PMC5013576	9/2016	S81-PMC5013576	['1\n\nKidney biopsy images from initial presentation ( a – 40x, b – 10x pas), 2 weeks later ( c – 40x jones, d – 10x pas, e – em 8000x) and 2 months later ( f – 40x, g – 10x pas).']	N/A	N/A	[('UBERON_0002113', 'kidney', 3, 'Kidney')]
PMC5013576	9/2016	S89-PMC5013576	['immunohistochemistry results on patient’s initial Renal biopsy (day 3 of presentation) using primary Antibody to Human Parvovirus B19 capsid proteins Vp1 and Vp2 and anti-Mouse-hrp secondary Antibody.']	N/A	N/A	[('UBERON_0002113', 'kidney', 50, 'renal'), ('GO_0042571', 'immunoglobulin complex, circulating', 101, 'antibody'), ('NCBITaxon_9606', 'Homo sapiens', 113, 'human'), ('NCBITaxon_10088', 'Mus <genus>', 119, 'parvovirus'), ('PR_000012529', 'PDZK1-interacting protein 1', 119, 'parvovirus B19'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 150, 'VP1'), ('PR_000017318', 'vacuolar protein sorting-associated protein 11', 158, 'VP2'), ('NCBITaxon_10088', 'Mus <genus>', 171, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 191, 'antibody')]
PMC5013576	9/2016	S110-PMC5013576	['initially after beginning ivig treatment, the scr reached a nadir of 256 umol/l (2.9\xa0mg/dl), but with her worsening pancytopenia, Kidney function worsened, and scr rose to over 530 umol/l (6\xa0mg/dl).']	N/A	N/A	[('UBERON_0002113', 'kidney', 130, 'kidney')]
PMC5013576	9/2016	S122-PMC5013576	['she was evaluated for transplantation, and successfully received a living donor Kidney transplant from her sister 8.5\xa0months after initial presentation and 6\xa0months after starting hemodialysis.']	N/A	N/A	[('UBERON_0002113', 'kidney', 80, 'kidney')]
PMC5013576	9/2016	S141-PMC5013576	['likely an exaggerated Immune Response, additional Kidney insults, or more direct Kidney targeting (i.e.']	N/A	N/A	[('GO_0006955', 'immune response', 22, 'immune response'), ('UBERON_0002405', 'immune system', 22, 'immune'), ('UBERON_0002113', 'kidney', 50, 'kidney'), ('UBERON_0002113', 'kidney', 81, 'kidney')]
PMC5013576	9/2016	S154-PMC5013576	['abbreviations\nana, Antinuclear Antibody; dsdna, Double-Stranded dna; esrd, end stage Renal disease; fsgs, focal segmental glomerulosclerosis; hiv, Human immunodeficiency Virus; hivan, hiv-associated nephropathy; qpcr, quantitative polymerase chain reaction; scr, Serum creatinine\n\npubmed central:']	N/A	N/A	[('GO_0005642', 'annulate lamellae', 19, 'antinuclear'), ('GO_0042571', 'immunoglobulin complex, circulating', 31, 'antibody'), ('SO_0000985', 'double', 48, 'double-stranded'), ('UBERON_0002113', 'kidney', 85, 'Renal'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'Human'), ('NCBITaxon_10088', 'Mus <genus>', 170, 'Virus'), ('UBERON_0001977', 'blood serum', 263, 'serum')]
PMC5024431	9/2016	S150-PMC5024431	['when reason(s) were directly specified, weight management was the most popular ( n\u2009= \u200975) (note: only n\u2009= \u20092 goals were for weight gain), followed by diabetes ( n\u2009= \u200922), other conditions (e.g., Cholesterol/Heart healthy, surgery preparation, arthritis, cancer, Uric Acid, Acid reflux, irritable Bowel syndrome, gas, bloating, Uric Acid, hypertension, anemia, Kidney stones, pancreatitis, arthritis) ( n\u2009= \u200922), sports nutrition/improving fitness ( n\u2009= \u200912), body composition ( n\u2009= \u20098), Conception, Pregnancy, and/or breastfeeding ( n\u2009= \u20098), and health, energy or Sleep improvements ( n\u2009= \u20095).']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 195, 'cholesterol'), ('UBERON_0000948', 'heart', 207, 'heart'), ('CHEBI_27226', 'uric acid', 262, 'uric acid'), ('CHEBI_37527', 'acid', 273, 'acid'), ('UBERON_0000160', 'intestine', 296, 'bowel'), ('CHEBI_27226', 'uric acid', 327, 'uric acid'), ('UBERON_0002113', 'kidney', 360, 'kidney'), ('GO_0007620', 'copulation', 487, 'conception'), ('GO_0007565', 'female pregnancy', 499, 'pregnancy'), ('GO_0030431', 'sleep', 564, 'sleep')]
PMC5029029	9/2016	S68-PMC5029029	['d, b-blocker asa197299wdiab Neph1.5 (47)36.36.6/3.6yesinsulin, Nifedipine2083817Wfibrillary gn0.6 (116)13.65.8/2.6nonone229326wkidney graft1.2 (60)20.56.9/4.0nopred., Cya, ranitidine, asa,2410205wsle0.6 (132)12.56.8/3.3nopred.2111377wkidney graft1.5 (44)30.87.0/3.9yespred., cya, vitd, Nifedipine, asa epo, Ranitidine2712306Wiga gn1.3 (55)30.76.9/4.1nolevothyroxine18.9132810wiga Gn1 (77)226.6/3.7nonone19.91436pre; 5wdiab Neph1 (68)20.66.4/4.1yeslansoprazole, Levothyroxine, asa, Niphedipine, Insulin,21.515357wdiab Neph1.2 (56)30.77.4/4.3noinsulin18.2164024wdiab Neph0.9 (76)23.16.7/3.3yesinsulin, Levothyroxine, Nifedipine24173620Wiga Gn1.1 (64)22.45.6/4.1nonone22.31836pre; 7wsle2.9 (20)43.46.5/3.9yespred., Levothyroxine, a-md24.519386wfsgs0.6 (116)12.16.3/3.3nocya252033pre; 8wkidney graft1.3 (52)30.27.2/3.9yespred, tac302131pre; 9wsponge Kidney1.6 (43.3)30.36.5/4.0yesasa, a-md23.42233pre; 7wreflux0.7 (110.4)10.86.0/3.7yesasa, b-bloc21.82338pre; 6wpyelonephritis1.2 (59)30.26.5/3.9yesa-md19.724265wsingle Kidney, previous hus1 (78)20.36.8/3.8yesasa23.42541pre; 7wgn0.8 (86.6)20.87.2/3.8yesasa33.626326wiga gn1 (74.7)20.66.8 /3.9noasa24.9273618wdiab Neph0.7 (106.3)10.97.4/4.4yesasa, a-md, Insulin34283327Wllac0.4 (136.2)11.36.0/3.6yesa-md29.7293314wunknown0.8 (105.6)12.25.7/3.0noasa24.8303230wunknown1.7 (39.6)30.16.2/3.6no/26.731318 wdiab Neph1.48 (47)30.16.78/4.68 no asa, Insulin19.532 (twin)3121wdiab neph0.5 (128)15.45.5/2.8noinsulin, Levothyroxine17.933 (twin)3712wunknown0.7 (112)10.87.1/3.5nonone31.434 (twin)3911 wprevious pna0.57 (184.1)10.296.11/3.37noasa32.3235 (termination)2618wmgn0.6 (126)15.55.1/2.3nonone1936 (Miscarriage)377wkidney graft1.7 (38)30.16.9/3.9yespred., tac, epo, asa, Omeprazole, Doxazosin, b-bloc25.1summary data all casesmedian (min-max)34 (20–41)7 (5–30)_scr1.05 (0.4–3.2)gfr-epi66.0 (18.0–184.1)2 (1–4)0.8 (0.1–6.3)pt6.5 (5.1–8.4)Alb3.75 (2.3–4.68)17/3647.2\xa0%_23.4 (17.9–34.0)summary datasingletonsmedian (min-max)33(20–41)7 (5–30)_scr1.20 (0.4–3.2)gfr-epi60.0 (18.0–136.2)3 (1–4)0.9 (0.1–6.3)pt6.5 (5.6–8.4)Alb3.8 (2.6–4.68)16/3151.6\xa0%_23.4 (18.2–34.0)\ndata at referral: data observed at the first follow-up in our unit\nht hypertension, sle systemic lupus erythematosus, iga gn iga nephropathy, fsgs focal segmental glomerlosclerosis, diab neph diabetic nephropathy, bmi body mass index, ptu 24\xa0hour proteinuria, scr serum creatinine, gfr glomerular filtration rate, sle systemic lupus erythematosus.']	N/A	N/A	[('PR_000011193', 'ephexin-1', 28, 'neph1'), ('CHEBI_83472', 'metolachlor ESA', 63, 'nifedipine2083817wfibrillary'), ('CHEBI_30751', 'formic acid', 167, 'CyA'), ('CHEBI_7565', 'nifedipine', 286, 'nifedipine'), ('CHEBI_67985', 'Oleanolic acid 28-O-beta-D-glucopyranoside', 307, 'ranitidine2712306wIgA'), ('PR_000008010', 'glycerol kinase', 380, 'GN1'), ('PR_000011193', 'ephexin-1', 423, 'neph1'), ('CHEBI_6437', 'levetiracetam', 461, 'levothyroxine'), ('CHEBI_7575', 'nimodipine', 481, 'Niphedipine'), ('PR_000045358', 'insulin family protein', 494, 'insulin'), ('PR_000011193', 'ephexin-1', 517, 'neph1'), ('PR_000011041', 'nuclear receptor coactivator 2', 565, 'neph0'), ('CHEBI_6437', 'levetiracetam', 600, 'levothyroxine'), ('CHEBI_80259', 'Neuropeptide B-23', 615, 'Nifedipine24173620wIgA'), ('PR_000008100', 'guanine nucleotide-binding protein subunit beta-4', 638, 'GN1.1'), ('CHEBI_6437', 'levetiracetam', 712, 'levothyroxine'), ('UBERON_0000022', 'feather', 846, 'kidney1'), ('UBERON_0002113', 'kidney', 1014, 'kidney'), ('PR_000011041', 'nuclear receptor coactivator 2', 1158, 'neph0'), ('PR_000037367', 'pro-caspase-8:fadd:rip1:ticam1:activated TLR3 complex', 1198, 'Insulin34283327wLLAC0'), ('PR_000011193', 'ephexin-1', 1350, 'neph1'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 1385, 'Insulin19'), ('CHEBI_6129', 'ketorolac', 1450, 'levothyroxine17'), ('GO_0046660', 'female sex differentiation', 1637, 'miscarriage'), ('CHEBI_7772', 'omeprazole', 1709, 'omeprazole'), ('CHEBI_4708', 'doxazosin', 1721, 'Doxazosin'), ('PR_000000035', 'BMP receptor type-1A', 1875, 'Alb3'), ('PR_000000035', 'BMP receptor type-1A', 2053, 'Alb3')]
PMC5029029	9/2016	S71-PMC5029029	['caption (table-wrap): table 2\n\nbaseline data: “controls”: 47 Pregnant patients on unrestricted diet in Pregnancy (22 singleton Deliveries in cagliari, 20 in torino)caseage (yrs)pre-Conceptional; referral-weekkidney diseasescr mg/dl (epi-gfr ml/min)ckd stageptu (g/24\xa0h)pt/alb (g/dl)httherapy at referralbmi13311wiga gn0.9 (84.3)21.16.0/2.9nopred20.2234pre; 7wsle0.7 (113.4)11.35.8/3.5nosteroids, aza19.6334pre; 6wsle0.7 (113.4)11.36.3/2.9yesa-md, pred., cya20.8438pre; 22wunknown0.8 (93.8)11.7nayesasa, Nifedipine, a-md26529pre; 5wiga gn0.9 (86.7)22.16.3/3.5yesa-md22.1626pre; 8wdiab Neph0.4 (144.2)12.65.6/3.3noasa, Insulin23.4735pre; 7wsle, llac0.5 (129.3)13.95.2 /2.9nopred20.2819pre; 13wsle0.6 (135.6)145.9/3nonone18.8936pre; 13wfsgs0.9 (82.5)24.25.7/3.1yesasa, a-md20.31041pre; 6wsle1 (71.9)25.45.5/3.6yesa-md18.31135pre; 20wdiab Neph1.2 (58.7)30.1nayesa-md, Insulin25.61239pre; 7wsle1.4 (47.4)30.36.5/3.7yespred., aza231332pre; 9wsle1.4 (49.8)30.86.7/4.5yespred21.61435pre; 8wiga gn1.4 (50)31.76.8/3.3nonone24.81538pre; 7wunknown1.6 (40.6)31.46.2/4.3nonone23.916316wiga gn1.6 (42.6)3++7/3.3nonone32.51736pre; 6wgn1.8 (35.7)30.47.3/ 4nonone22.51823pre; 13wunknown1.9 (36.6)32.86.1/ 3nonone30.11930naiga gn1.4 (50)36.2nayesa-md21.62034pre; 12wsle, llac2.2 (28.4)41.25.7/3.2yesa-md, asa, epo21.421287wunknown1.6 (43.9)31.67.4/ 4.3nonone23.72233pre; 12wgn0.5 (127.6)11.17/4nonone21.8summary datacagliari34 (19–41)8 (5–22)scr1.1 (0.4–2.2)gfr-epi65.3 (28.4–144.2)1.6 (0.1–6.2)pt6.2 (5.2–7.4)Alb3.3 (2.9–4.5)1045.5\xa0%21.95 (18.3–32.5)139pre; 8 winterstitial1.6 (40)31.37.3 /3.7yesfelodipine, Doxazosin, levotiroxina, asa26.722714 wreflux1.5 (47)30.36.5/3.4nonone18.033420 wchronic pn1.5 (45)32.0nanonone23.342313 wiga gn1.3 (56)30.56.4/3.1yesa-md, asa22.7532pre; 5 wiga Gn1.2 (58)30.36.1/3.4Nosteroids, Allopurinole19.1635pre; 8 wiga gn1.3 (54)30.56.6/2.7yesa-mp, Niphedipine24.472227 wreflux2.9 (22)40.57.3/3.4noniphedipine22.2839pre; 14 wchronic pn1.4 (47)30.28.1/4.0yesb-bloc, asa18.493120 wreflux1.3 (54)30.67.2/3.7yesb-bloc, Doxazosine, Niphedipine, Isosorbide19.5102533 wreflux1.3 (57)30.86.0/3.1yesa-mp19.311357; winterstitial1.3 (52)30.66.0/3.2yesnone25.61233pre; 12wchronic pn1.2 (60)30.16.4/3.2noclonidine, a-mp, asa19.713306 wkidney graft1.2 (59)30.27.6/3.2notac, pred, Pantoprazole, Allopurinolo20.3143229 whiv neph.1.43 (56)30.47.0/3.1noantiretroviral therapy Omeprazole20.015366 wkidney graft1.1 (56)30.16.9/4.7nopred, Cya, Omeprazole, asa24.71638pre; 8 wsingle Kidney0.8 (56)30.16.8/4.4nocalcium Carbonate15.617275 wsle0.6 (193.6)11.457.09/4.37noasa, Steroids30.4183720 wfsgs0.7 (81.6)22.336.56/3.62nonone23.6192612 wir e proteinuria1.1 (101.2)126.45/3.49noasa32.4203616 wpnc0.6 (122)11.037.55/4.10nothyroxine20.221 (Miscarriage)387 wchronic Pn, single Kidney1.9 (31)30.17.3/5.0nonone24.9)22 (miscarriage)37pre; 8 wsingle Kidney0.8 (58)30.17.6/4.7nonone15.623 (Miscarriage)365 wkidney graft1.3 (53)30.4nanocya, aza25.524 (Miscarriage)37pre; 5 wsingle Kidney0.9 (55)30.1nanocalcium Carbonate,16.225 (Miscarriage)309 wdiab.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 61, 'pregnant'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('GO_0007567', 'parturition', 127, 'deliveries'), ('GO_0007620', 'copulation', 181, 'conceptional'), ('CHEBI_7575', 'nimodipine', 503, 'Nifedipine'), ('PR_000011041', 'nuclear receptor coactivator 2', 584, 'neph0'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 617, 'Insulin23'), ('PR_000011193', 'ephexin-1', 835, 'neph1'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 864, 'Insulin25'), ('PR_000000035', 'BMP receptor type-1A', 1491, 'Alb3'), ('CHEBI_4708', 'doxazosin', 1590, 'Doxazosin'), ('PR_000008010', 'glycerol kinase', 1768, 'GN1'), ('PR_000010222', 'muscleblind-like protein 2', 1772, '2'), ('CHEBI_35818', 'coccidiostat', 1788, '4NoSteroids'), ('CHEBI_65367', '8-acetoxyheterophyllisine', 1801, 'Allopurinole19'), ('CHEBI_27481', 'rhodexin A', 1862, 'Niphedipine24'), ('CHEBI_4708', 'doxazosin', 2028, 'Doxazosine'), ('CHEBI_7575', 'nimodipine', 2040, 'Niphedipine'), ('CHEBI_82473', 'HC Red No. 3', 2053, 'Isosorbide19'), ('CHEBI_7915', 'pantoprazole', 2279, 'Pantoprazole'), ('CHEBI_80139', 'Neuromedin B', 2293, 'Allopurinolo20'), ('CHEBI_63614', 'olsalazine sodium', 2371, 'Omeprazole20'), ('CHEBI_30751', 'formic acid', 2431, 'CyA'), ('CHEBI_7772', 'omeprazole', 2436, 'Omeprazole'), ('UBERON_0002113', 'kidney', 2474, 'kidney0'), ('CHEBI_50750', 'EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor', 2509, 'carbonate15'), ('CHEBI_34975', 'sennoside B', 2564, 'Steroids30'), ('GO_0046660', 'female sex differentiation', 2730, 'miscarriage'), ('UBERON_0002333', 'pulmonary trunk', 2755, 'PN'), ('UBERON_0000022', 'feather', 2766, 'kidney1'), ('UBERON_0002113', 'kidney', 2835, 'kidney0'), ('GO_0046660', 'female sex differentiation', 2874, 'miscarriage'), ('GO_0046660', 'female sex differentiation', 2935, 'miscarriage'), ('UBERON_0002113', 'kidney', 2964, 'kidney0'), ('CHEBI_17120', 'hexanoate', 2994, 'carbonate'), ('GO_0046660', 'female sex differentiation', 3012, 'miscarriage')]
PMC5054480	9/2016	S10-PMC5054480	['prior to Pregnancy, she had had several episodes of acute Thoracic syndrome and multiple hospitalizations for bone pain, cholestasis, chronic Articular pain, retinopathy, and a Kidney infarct.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 9, 'pregnancy'), ('UBERON_0000915', 'thoracic segment of trunk', 58, 'thoracic'), ('UBERON_0004905', 'articulation', 142, 'articular'), ('UBERON_0002113', 'kidney', 177, 'kidney')]
PMC5054480	9/2016	S27-PMC5054480	["patient 2\na 30‐year‐old woman (g1) was transferred to our center at 36 weeks' Gestation for symptomatic urolithiasis, acute Renal insufficiency, and hypercalcemia."]	N/A	N/A	[('GO_0007565', 'female pregnancy', 78, 'gestation'), ('UBERON_0002113', 'kidney', 124, 'renal')]
PMC5054480	9/2016	S34-PMC5054480	['pth was measured at 29.3 pmol/l, Vitamin D levels were normal, and bilateral nephrocalcinosis was detected, along with a large Renal staghorn calculus without hydronephrosis.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0002113', 'kidney', 127, 'renal')]
PMC5054480	9/2016	S59-PMC5054480	['a positron emission tomography (pet) scan showed increased uptake at the Knees, Elbows, Ulnocarpal Joints, Fingers, and Kidneys in a nondiagnostic pattern.']	N/A	N/A	[('UBERON_0001465', 'knee', 73, 'knees'), ('UBERON_0001461', 'elbow', 80, 'elbows'), ('UBERON_0011618', 'basihyal bone', 88, 'ulnocarpal joints'), ('UBERON_0002389', 'manual digit', 107, 'fingers'), ('UBERON_0002113', 'kidney', 120, 'kidneys')]
PMC5054480	9/2016	S61-PMC5054480	['six weeks after termination, an Abdominal ultrasound showed normal Kidneys and the persistence of a 9‐cm fibroma.']	N/A	N/A	[('UBERON_0000916', 'abdomen', 32, 'abdominal'), ('UBERON_0002113', 'kidney', 67, 'kidneys')]
PMC5054480	9/2016	S103-PMC5054480	['Calcitonin decreases hypercalcemia by inhibiting Osteoclast activity (which in turn inhibits Bone Resorption) and enhancing Renal Excretion Of Calcium.']	N/A	N/A	[('CHEBI_17793', 'calycosin', 0, 'Calcitonin'), ('CL_0000092', 'osteoclast', 49, 'osteoclast'), ('GO_0045453', 'bone resorption', 93, 'bone resorption'), ('GO_0006281', 'DNA repair', 124, 'renal'), ('UBERON_0002113', 'kidney', 124, 'renal'), ('GO_0007540', 'sex determination, establishment of X:A ratio', 130, 'excretion of calcium')]
PMC5062906	10/2016	S28-PMC5062906	['dietary Vitamin D is converted in the Liver to the inactive Metabolite 25-Hydroxyvitamin D, 25(Oh)D, before being converted in the Kidney to the active Metabolite 1,25(Oh)2D.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0002107', 'liver', 38, 'liver'), ('CHEBI_39382', 'flufenoxuron', 60, 'metabolite'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 71, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 92, '25(OH)D'), ('UBERON_0002113', 'kidney', 131, 'kidney'), ('CHEBI_39382', 'flufenoxuron', 152, 'metabolite'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 165, '25(OH)2D')]
PMC5084009	10/2016	S12-PMC5084009	['Homocysteine is remethylated to methionine by the ubiquitous Folate and cobalamin-dependent methionine synthase (mtr; ec 2.1.1.13) and by betaine:Homocysteine methyltransferase (bhmt; ec 2.1.1.5) that occurs mainly in the Kidney and Liver [1].']	N/A	N/A	[('CHEBI_5759', 'Honokiol', 0, 'Homocysteine'), ('CHEBI_30863', '5-azaorotic acid', 61, 'folate'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 146, 'homocysteine'), ('UBERON_0002113', 'kidney', 222, 'kidney'), ('UBERON_0002107', 'liver', 233, 'liver')]
PMC5085625	9/2016	S20-PMC5085625	['the most active form of Vitamin D, 1,25-Dihydroxy-Vitamin D, is synthesized in Kidneys, as well as in other Tissues and cells, e.g., Parathyroid Glands, Prostate, Macrophages, Immune and Reproductive Cells [8].']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_67771', 'Xestoproxamine C, (rel)-', 35, '1,25-dihydroxy-'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0002113', 'kidney', 79, 'kidneys'), ('UBERON_0000479', 'tissue', 108, 'tissues'), ('UBERON_0001132', 'parathyroid gland', 133, 'parathyroid glands'), ('UBERON_0002367', 'prostate gland', 153, 'prostate'), ('CL_0000235', 'macrophage', 163, 'macrophages'), ('CL_0000738', 'leukocyte', 176, 'immune ...'), ('UBERON_0002405', 'immune system', 176, 'immune'), ('CL_0000683', 'ependymoglial cell', 187, 'reproductive cells'), ('GO_0000003', 'reproduction', 187, 'reproductive')]
PMC5093678	10/2016	S3-PMC5093678	['methods and analysis\nPregnant women with a singleton Pregnancy <18 weeks Gestation, and without pre-existing diabetes, chronic Renal disease and Autoimmune diseases will be recruited.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 21, 'Pregnant'), ('GO_0007565', 'female pregnancy', 53, 'pregnancy'), ('GO_0007565', 'female pregnancy', 73, 'gestation'), ('UBERON_0002113', 'kidney', 127, 'renal'), ('UBERON_0001442', 'skeleton of manus', 145, 'autoimmune')]
PMC5093678	10/2016	S32-PMC5093678	['participants are excluded if they have a history of pre-existing diabetes, chronic Renal disease and Autoimmune disease or if they are on any Lipid-altering drugs, for example, Statins\n\neligibility for randomisation\nwomen will be randomised to the trial if they have any of the following risk factors: obesity (bmi ≥30\u2005kg/m2), raised serum Triglycerides (≥1.7\u2005mmol/l) or chronic hypertension (≥140\u2005mm\u2005hg systolic or ≥90\u2005mm\u2005hg diastolic blood pressure).']	N/A	N/A	[('UBERON_0002113', 'kidney', 83, 'renal'), ('UBERON_0001442', 'skeleton of manus', 101, 'autoimmune'), ('CHEBI_18059', 'lipid', 142, 'lipid'), ('CHEBI_9290', 'strigol', 177, 'statins'), ('CHEBI_17855', 'triglyceride', 340, 'triglycerides')]
PMC5117700	11/2016	S38-PMC5117700	['exclusion criteria\nwomen with a multiple Pregnancy, type 1 or 2 diabetes diagnosed prior to Pregnancy, or with significant Renal or Hepatic impairment such that Metformin would be contraindicated will be excluded from participation.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('GO_0007565', 'female pregnancy', 92, 'pregnancy'), ('UBERON_0002113', 'kidney', 123, 'renal'), ('UBERON_0002107', 'liver', 132, 'hepatic'), ('CHEBI_6801', 'metformin', 161, 'metformin')]
PMC5133065	10/2016	S29-PMC5133065	['exclusion criteria were: (a) pre-existing clinical conditions such as diabetes, hypertension, Autoimmune diseases, asthma, allergies, Renal or Hepatic diseases, Viral, bacterial or Protozoan infection, anemia (hemoglobin, hb < 10 g/l); (b) twin Pregnancies; (c) Pregnancy disease and preterm Deliveries; (d) smoking more than 10 cigarettes per day; (e) use of other Probiotics during the study protocol.']	N/A	N/A	[('UBERON_0001442', 'skeleton of manus', 94, 'autoimmune'), ('UBERON_0002113', 'kidney', 134, 'renal'), ('UBERON_0002107', 'liver', 143, 'hepatic'), ('NCBITaxon_1', 'root', 161, 'viral'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 181, 'protozoan'), ('GO_0007565', 'female pregnancy', 245, 'pregnancies'), ('GO_0007565', 'female pregnancy', 262, 'pregnancy'), ('GO_0007567', 'parturition', 292, 'deliveries'), ('CHEBI_26346', 'prostaglandins J', 366, 'probiotics')]
PMC5155676	12/2016	S32-PMC5155676	['women with known Metabolic bone disease, Renal stones, hyperparathyroidism or hypercalciuria, those taking medication known to interfere with fetal growth, fetal anomalies on ultrasonography, and women already using more than 400 iu/d Vitamin D supplementation were excluded.']	N/A	N/A	[('GO_0008152', 'metabolic process', 17, 'metabolic'), ('UBERON_0002113', 'kidney', 41, 'renal'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D')]
PMC5187820	12/2016	S25-PMC5187820	['early-Life insults cause structural and functional changes in the developing Kidney by so-called Renal Programming [11].']	N/A	N/A	[('UBERON_0000104', 'life cycle', 6, 'life'), ('UBERON_0002113', 'kidney', 77, 'kidney'), ('GO_0001171', 'reverse transcription', 97, 'renal programming'), ('UBERON_0002113', 'kidney', 97, 'renal')]
PMC5187820	12/2016	S58-PMC5187820	['the top nine related kegg pathways that are significantly overrepresented include the Mitogen-activated protein Kinases (Mapk) Signaling Pathway, the Circadian Rhythm, Colorectal cancer pathways , the nod-like receptor Signaling Pathway, Renal Cell carcinoma, the Wnt Signaling Pathway, prion diseases, and the Chemokine Signaling Pathway [50].']	N/A	N/A	[('CHEBI_52290', 'mitogen', 86, 'mitogen'), ('GO_0000087', 'mitotic M phase', 86, 'mitogen ... kinases ...'), ('GO_0002756', 'MyD88-independent toll-like receptor signaling pathway', 121, 'MAPK ... signaling pathway'), ('GO_0007623', 'circadian rhythm', 150, 'circadian rhythm'), ('UBERON_0012652', 'colorectum', 168, 'colorectal'), ('GO_0045500', 'sevenless signaling pathway', 219, 'signaling pathway'), ('CL_1000497', 'kidney cell', 238, 'renal cell'), ('UBERON_0002113', 'kidney', 238, 'renal'), ('GO_0016055', 'Wnt signaling pathway', 264, 'Wnt signaling pathway'), ('GO_0002753', 'cytoplasmic pattern recognition receptor signaling pathway', 311, 'chemokine signaling pathway')]
PMC5187820	12/2016	S65-PMC5187820	['we next analyzed the Renal transcriptome in response to Adma in the developing Kidney using the ngs approach.']	N/A	N/A	[('UBERON_0002113', 'kidney', 21, 'renal'), ('CHEBI_34018', '(S)-AMPA', 56, 'ADMA'), ('UBERON_0002113', 'kidney', 79, 'kidney')]
PMC5240907	1/2017	S28-PMC5240907	['no child had any clinical signs of Endocrine, Renal or Cardiovascular disease.']	N/A	N/A	[('GO_0006397', 'mRNA processing', 35, 'endocrine'), ('UBERON_0002113', 'kidney', 46, 'renal'), ('UBERON_0004535', 'cardiovascular system', 55, 'cardiovascular')]
PMC5241768	1/2017	S297-PMC5241768	['ascvd risk factors include ldl Cholesterol ≥ 100 mg/dl (2.6 mmol/l), high Blood pressure, smoking, chronic Kidney disease, albuminuria, and family history of premature ascvd .']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 31, 'cholesterol'), ('UBERON_0000178', 'blood', 74, 'blood'), ('UBERON_0002113', 'kidney', 107, 'kidney')]
PMC5241768	1/2017	S311-PMC5241768	['diabetic Kidney disease\nrecommendations\nat least once a year, assess Urinary albumin (e.g., spot uacr) and egfr in patients with type 1 diabetes with a duration of ≥5 years, in all patients with type 2 diabetes, and in all patients with comorbid hypertension.']	N/A	N/A	[('UBERON_0002113', 'kidney', 9, 'Kidney'), ('UBERON_0001088', 'urine', 69, 'urinary')]
PMC5241768	1/2017	S312-PMC5241768	['b\noptimize Glucose Control to reduce the risk or slow the progression of diabetic Kidney disease.']	N/A	N/A	[('CHEBI_17234', 'glucose', 11, 'glucose'), ('GO_0046323', 'glucose import', 11, 'glucose control'), ('UBERON_0002113', 'kidney', 82, 'kidney')]
PMC5241768	1/2017	S337-PMC5241768	['c\nobtain a history of ulceration, amputation, charcot Foot, angioplasty or vascular surgery, cigarette smoking, retinopathy, and Renal disease and assess current symptoms of neuropathy (pain, burning, numbness) and vascular disease (Leg fatigue, claudication).']	N/A	N/A	[('UBERON_0002387', 'pes', 54, 'foot'), ('UBERON_0002113', 'kidney', 129, 'renal'), ('UBERON_0000978', 'leg', 233, 'leg')]
PMC5241768	1/2017	S379-PMC5241768	['factors include hypoglycemia, cost, and coexisting conditions (e.g., Renal status).']	N/A	N/A	[('UBERON_0002113', 'kidney', 69, 'renal')]
PMC5273824	1/2017	S40-PMC5273824	['patients with medical history of bone Mineral Metabolic disease, Liver or Kidney dysfunction were excluded.']	N/A	N/A	[('CHEBI_46662', 'mineral', 38, 'mineral'), ('GO_0008152', 'metabolic process', 46, 'metabolic'), ('UBERON_0002107', 'liver', 65, 'liver'), ('UBERON_0002113', 'kidney', 74, 'kidney')]
PMC5273824	1/2017	S49-PMC5273824	['medical history of Kidney dysfunction.']	N/A	N/A	[('UBERON_0002113', 'kidney', 19, 'kidney')]
PMC5273824	1/2017	S64-PMC5273824	['all participants have normal Liver and Kidney function.']	N/A	N/A	[('UBERON_0002107', 'liver', 29, 'liver'), ('UBERON_0002113', 'kidney', 39, 'kidney')]
PMC5286846	1/2017	S184-PMC5286846	['this was followed in 2005 by a case series of acute Renal failure in 21 patients using these Compounds over a 5\xa0year period [62].']	N/A	N/A	[('UBERON_0002113', 'kidney', 52, 'renal'), ('CHEBI_36357', 'polyatomic entity', 93, 'compounds')]
PMC5298530	12/2016	S16-PMC5298530	['there was no Pulmonary Artery involvement or Renal insufficiency.']	N/A	N/A	[('UBERON_0002012', 'pulmonary artery', 13, 'pulmonary artery'), ('UBERON_0002113', 'kidney', 45, 'renal')]
PMC5332602	3/2017	S46-PMC5332602	['the clinical signs in the affected Piglets were consistent with hypoglycemia and septicemia in addition to extraintestinal (Liver, Kidney, Lung, and Peritoneal Cavity swabs) recovery of clostridium perfringens type a and Nonhemolytic, Avirulent escherichia coli (bacterial identification to the species level was conducted at the ohio department of agriculture).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 35, 'piglets'), ('UBERON_0002107', 'liver', 124, 'liver'), ('UBERON_0002113', 'kidney', 131, 'kidney'), ('UBERON_0002048', 'lung', 139, 'lung'), ('UBERON_0001179', 'peritoneal cavity', 149, 'peritoneal cavity'), ('GO_0001822', 'kidney development', 221, 'nonhemolytic'), ('NCBITaxon_33208', 'Metazoa', 235, 'avirulent')]
PMC5357333	3/2017	S47-PMC5357333	['her medical history was negative for hypertension and diabetes, and negative for Thyroid, Heart, Lung, or Kidney disease.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 81, 'thyroid'), ('UBERON_0000948', 'heart', 90, 'heart'), ('UBERON_0002048', 'lung', 97, 'lung'), ('UBERON_0002113', 'kidney', 106, 'kidney')]
PMC5357333	3/2017	S121-PMC5357333	['[24] at 20 weeks’ Gestation, where a monochorionic-diamniotic twin Pregnancy, a product of intracytoplasmic Sperm injection, demonstrated a multicystic dysplastic Left Kidney in one of the twins.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 18, 'gestation'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('CL_0000019', 'sperm', 108, 'sperm'), ('UBERON_0013698', 'strand of pubic hair', 163, 'left'), ('UBERON_0002113', 'kidney', 168, 'kidney')]
PMC5384134	4/2017	S8-PMC5384134	['most completed reviews were produced by the Pregnancy and Childbirth ( n \u2009=\u200973), neonatal ( n \u2009=\u200964), metabolic and endocrine disorders ( n \u2009=\u200933), developmental, Psychosocial and Learning problems ( n \u2009=\u200926), Kidney and transplant ( n \u2009=\u200918) and Heart ( n \u2009=\u200918)\xa0crgs.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 44, 'Pregnancy'), ('GO_0007567', 'parturition', 58, 'Childbirth'), ('GO_0031269', 'pseudopodium assembly', 163, 'Psychosocial ...'), ('GO_0007612', 'learning', 180, 'Learning'), ('UBERON_0002113', 'kidney', 210, 'Kidney'), ('UBERON_0000948', 'heart', 247, 'Heart')]
PMC5384134	4/2017	S84-PMC5384134	['of the 470 completed nutrition reviews included, most were produced by the Pregnancy and Childbirth ( n \u2009=\u200973), neonatal ( n \u2009=\u200964), Metabolic and Endocrine disorders ( n \u2009=\u200933), developmental, psychosocial and Learning problems ( n \u2009=\u200926), Kidney and transplant ( n \u2009=\u200918), and Heart ( n \u2009=\u200918) groups (table\xa02).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 75, 'Pregnancy'), ('GO_0007567', 'parturition', 89, 'Childbirth'), ('GO_0008152', 'metabolic process', 133, 'Metabolic'), ('GO_0009790', 'embryo development', 147, 'Endocrine'), ('GO_0007612', 'learning', 211, 'Learning'), ('UBERON_0002113', 'kidney', 241, 'Kidney'), ('UBERON_0000948', 'heart', 279, 'Heart')]
PMC5384134	4/2017	S85-PMC5384134	['the greatest numbers of included protocols (reviews in progress) were produced by the public health ( n \u2009=\u200919), Pregnancy and Childbirth ( n \u2009=\u200916), neonatal ( n \u2009=\u200915), developmental, Psychosocial and Learning problems ( n \u2009=\u200911), Kidney and transplant ( n \u2009=\u200910), and Heart ( n \u2009=\u200910) groups (table\xa02).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 112, 'Pregnancy'), ('GO_0007567', 'parturition', 126, 'Childbirth'), ('GO_0031269', 'pseudopodium assembly', 185, 'Psychosocial ...'), ('GO_0007612', 'learning', 202, 'Learning'), ('UBERON_0002113', 'kidney', 232, 'Kidney'), ('UBERON_0000948', 'heart', 270, 'Heart')]
PMC5409656	3/2017	S32-PMC5409656	['women were excluded from participating if they had any co-morbid conditions such as Gestational diabetes, Cardiac or Renal disease, hiv/aids, chronic hypertension, or Autoimmune disease.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 84, 'gestational'), ('UBERON_0000948', 'heart', 106, 'cardiac'), ('UBERON_0002113', 'kidney', 117, 'renal'), ('UBERON_0001442', 'skeleton of manus', 167, 'autoimmune')]
PMC5409656	3/2017	S121-PMC5409656	['the cutoff for Mma, 210 nmol/l, was the reference value (95th percentile) of b12-replete Adults with normal Renal function (determined by Serum creatinine) in the nhanes [22].']	N/A	N/A	[('CHEBI_34840', 'methyl methacrylate', 15, 'MMA'), ('UBERON_0007023', 'adult organism', 89, 'adults'), ('UBERON_0002113', 'kidney', 108, 'renal'), ('UBERON_0001977', 'blood serum', 138, 'serum')]
PMC5418719	5/2017	S82-PMC5418719	['one of the three infants with exceeding level of Vitamin D had both nephrocalcinosis on a Renal ultrasound and increased uca/ucr\u2009>\u20090.8.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0002113', 'kidney', 90, 'renal')]
PMC5418719	5/2017	S134-PMC5418719	['in particular, preterm infants with delayed Renal Maturation and disturbed mineralization are predisposed to developing hypercalciuria and nephrocalcinosis, induced by Excretory immaturity of the Kidneys.']	N/A	N/A	[('UBERON_0002113', 'kidney', 44, 'renal'), ('GO_0007618', 'mating', 50, 'maturation'), ('GO_0007588', 'excretion', 168, 'excretory'), ('UBERON_0002113', 'kidney', 196, 'kidneys')]
PMC5439533	5/2017	S33-PMC5439533	['questionnaire\nthe questionnaire included demographic information (age, race, living environment, education level, type of fuel used for Cooking, number of persons in the household, Delivery hospital), Antenatal care (number of Antenatal visits, vaccinations received during Pregnancy, consumption of Antenatal Supplements), presence of medical conditions prior to Pregnancy (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease), any complications during Pregnancy (hospitalization for any specific complication such as Preeclampsia, eclampsia, hemorrhage, sepsis, Urinary infection, diabetes, severe acute Respiratory infection, or influenza-like illness), other risk factors for adverse Pregnancy outcomes (Alcohol consumption and smoking before and during Pregnancy), obstetric characteristics of the mother (number of Parturitions, number of abortions, number of Livebirths and stillbirths, type of Delivery), and characteristics of the offspring (sex, weight, Gestational age at Delivery).']	N/A	N/A	[('GO_0065007', 'biological regulation', 136, 'cooking'), ('GO_0007567', 'parturition', 181, 'delivery'), ('GO_0007567', 'parturition', 201, 'antenatal'), ('GO_0007567', 'parturition', 227, 'antenatal'), ('GO_0007565', 'female pregnancy', 274, 'pregnancy'), ('GO_0007567', 'parturition', 300, 'antenatal'), ('CHEBI_33341', 'titanium atom', 310, 'supplements'), ('GO_0007565', 'female pregnancy', 364, 'pregnancy'), ('UBERON_0002113', 'kidney', 402, 'renal'), ('UBERON_0002107', 'liver', 417, 'liver'), ('UBERON_0000178', 'blood', 432, 'blood'), ('UBERON_0001016', 'nervous system', 447, 'neurologic'), ('GO_0007565', 'female pregnancy', 493, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 558, 'preeclampsia'), ('UBERON_0001088', 'urine', 603, 'urinary'), ('UBERON_0001004', 'respiratory system', 645, 'respiratory'), ('GO_0007565', 'female pregnancy', 727, 'pregnancy'), ('CHEBI_30879', 'alcohol', 747, 'alcohol'), ('GO_0007565', 'female pregnancy', 797, 'pregnancy'), ('GO_0018989', 'apolysis', 860, 'parturitions'), ('GO_0008610', 'lipid biosynthetic process', 905, 'livebirths'), ('GO_0007567', 'parturition', 941, 'delivery'), ('GO_0007565', 'female pregnancy', 1003, 'gestational'), ('GO_0007567', 'parturition', 1022, 'delivery')]
PMC5439533	5/2017	S53-PMC5439533	['variables included in the psm model that could explain probability of receiving vaccination were selected a priori (age, race, education level, number of Antenatal visits, reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease) and because of a crude association with vaccination and/or Birth outcomes (type of fuel used for cooking, number of People in the household, reporting receiving at least one tetanus vaccine, iron and Vitamin B12 consumption during Pregnancy, Albendazole consumption during Pregnancy, calcium consumption during Pregnancy, Aspirin consumption during Pregnancy, Alcohol consumption before Pregnancy, body mass index (bmi) calculated from height and weight measurements taken at first Antenatal visit, number of Parturitions).']	N/A	N/A	[('GO_0007567', 'parturition', 154, 'antenatal'), ('UBERON_0002113', 'kidney', 241, 'renal'), ('UBERON_0002107', 'liver', 256, 'liver'), ('UBERON_0000178', 'blood', 271, 'blood'), ('UBERON_0001016', 'nervous system', 286, 'neurologic'), ('GO_0007567', 'parturition', 365, 'birth'), ('NCBITaxon_10088', 'Mus <genus>', 422, 'people'), ('CHEBI_33279', 'vitamin D5', 506, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 506, 'vitamin B12'), ('GO_0007565', 'female pregnancy', 537, 'pregnancy'), ('CHEBI_16664', 'albendazole', 548, 'albendazole'), ('GO_0007565', 'female pregnancy', 579, 'pregnancy'), ('GO_0007565', 'female pregnancy', 617, 'pregnancy'), ('CHEBI_2904', 'atenolol', 628, 'aspirin'), ('GO_0007565', 'female pregnancy', 655, 'pregnancy'), ('CHEBI_30879', 'alcohol', 666, 'alcohol'), ('GO_0007565', 'female pregnancy', 693, 'pregnancy'), ('GO_0007567', 'parturition', 788, 'antenatal'), ('GO_0018989', 'apolysis', 815, 'parturitions')]
PMC5439533	5/2017	S82-PMC5439533	['at least one chronic condition of the following: obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease.']	N/A	N/A	[('UBERON_0002113', 'kidney', 76, 'renal'), ('UBERON_0002107', 'liver', 91, 'liver'), ('UBERON_0000178', 'blood', 106, 'blood'), ('UBERON_0001016', 'nervous system', 121, 'neurologic')]
PMC5439533	5/2017	S91-PMC5439533	['model adjusted for reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease), age, race, calcium, Iron, and Folic Acid Consumption during Pregnancy, education level, number of Parturitions, body mass index (bmi) at first Antenatal visit, and sex of the baby.']	N/A	N/A	[('UBERON_0002113', 'kidney', 88, 'renal'), ('UBERON_0002107', 'liver', 103, 'liver'), ('UBERON_0000178', 'blood', 118, 'blood'), ('UBERON_0001016', 'nervous system', 133, 'neurologic'), ('CHEBI_24870', 'ion', 174, 'iron'), ('CHEBI_30751', 'formic acid', 184, 'folic acid'), ('GO_0007631', 'feeding behavior', 195, 'consumption'), ('GO_0007565', 'female pregnancy', 214, 'pregnancy'), ('GO_0018989', 'apolysis', 252, 'parturitions'), ('GO_0007567', 'parturition', 297, 'antenatal')]
PMC5439533	5/2017	S92-PMC5439533	['model adjusted for reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease), age, Albendazol and Aspirin consumption during Pregnancy, hospitalization during Pregnancy for any specific complication (Preeclampsia, eclampsia, hemorrhage, sepsis, Urinary infection, diabetes, severe acute Respiratory infection), Delivery hospital, number of Parturitions, body mass index (bmi) at first Antenatal visit, Alcohol consumption before Pregnancy, number of Antenatal visits, and sex of the baby.']	N/A	N/A	[('UBERON_0002113', 'kidney', 88, 'renal'), ('UBERON_0002107', 'liver', 103, 'liver'), ('UBERON_0000178', 'blood', 118, 'blood'), ('UBERON_0001016', 'nervous system', 133, 'neurologic'), ('CHEBI_31181', 'aklavinone', 159, 'albendazol'), ('CHEBI_2904', 'atenolol', 174, 'aspirin'), ('GO_0007565', 'female pregnancy', 201, 'pregnancy'), ('GO_0007565', 'female pregnancy', 235, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 276, 'preeclampsia'), ('UBERON_0001088', 'urine', 321, 'urinary'), ('UBERON_0001004', 'respiratory system', 363, 'respiratory'), ('GO_0007567', 'parturition', 387, 'delivery'), ('GO_0018989', 'apolysis', 416, 'parturitions'), ('GO_0007567', 'parturition', 461, 'antenatal'), ('CHEBI_30879', 'alcohol', 478, 'alcohol'), ('GO_0007565', 'female pregnancy', 505, 'pregnancy'), ('GO_0007567', 'parturition', 526, 'antenatal')]
PMC5439533	5/2017	S94-PMC5439533	['propensity score models adjusted for age, race, education level, type of fuel used for Cooking, number of people in the household, reporting receiving at least one tetanus vaccine, number of Antenatal visits, fe and Vitamin B12 consumption during Pregnancy, Albendazol consumption during Pregnancy, calcium consumption during Pregnancy, Aspirin consumption during Pregnancy, Alcohol consumption before Pregnancy, body mass index (bmi) at first Antenatal visit, number of Parturitions, and reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease).']	N/A	N/A	[('GO_0065007', 'biological regulation', 87, 'cooking'), ('GO_0007567', 'parturition', 191, 'antenatal'), ('CHEBI_33279', 'vitamin D5', 216, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 216, 'vitamin B12'), ('GO_0007565', 'female pregnancy', 247, 'pregnancy'), ('CHEBI_31181', 'aklavinone', 258, 'albendazol'), ('GO_0007565', 'female pregnancy', 288, 'pregnancy'), ('GO_0007565', 'female pregnancy', 326, 'pregnancy'), ('CHEBI_2904', 'atenolol', 337, 'aspirin'), ('GO_0007565', 'female pregnancy', 364, 'pregnancy'), ('CHEBI_30879', 'alcohol', 375, 'alcohol'), ('GO_0007565', 'female pregnancy', 402, 'pregnancy'), ('GO_0007567', 'parturition', 444, 'antenatal'), ('GO_0018989', 'apolysis', 471, 'parturitions'), ('UBERON_0002113', 'kidney', 558, 'renal'), ('UBERON_0002107', 'liver', 573, 'liver'), ('UBERON_0000178', 'blood', 588, 'blood'), ('UBERON_0001016', 'nervous system', 603, 'neurologic')]
PMC5439533	5/2017	S105-PMC5439533	['models adjusted for race, education level, Iron and Folic Acid Consumption during Pregnancy, number of Parturitions, body mass index (bmi) at first Antenatal visit, number of Antenatal visits and sex of the baby for mothers vaccinated in the first trimester; age, race, education level, Iron and Folic Acid consumption during Pregnancy, number of Parturitions, body mass index (bmi) at first Antenatal visit, number of Antenatal visits, number of People in the household and sex of the baby for mothers vaccinated in the second trimester; number of Parturitions, body mass index (bmi) at first Antenatal visit, reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease) and sex of the baby for mothers vaccinated in the third trimester.']	N/A	N/A	[('CHEBI_24870', 'ion', 43, 'iron'), ('CHEBI_30751', 'formic acid', 52, 'folic acid'), ('GO_0007631', 'feeding behavior', 63, 'consumption'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('GO_0018989', 'apolysis', 103, 'parturitions'), ('GO_0007567', 'parturition', 148, 'antenatal'), ('GO_0007567', 'parturition', 175, 'antenatal'), ('CHEBI_24870', 'ion', 287, 'iron'), ('CHEBI_30751', 'formic acid', 296, 'folic acid'), ('GO_0007565', 'female pregnancy', 326, 'pregnancy'), ('GO_0018989', 'apolysis', 347, 'parturitions'), ('GO_0007567', 'parturition', 392, 'antenatal'), ('GO_0007567', 'parturition', 419, 'antenatal'), ('NCBITaxon_10088', 'Mus <genus>', 447, 'people'), ('GO_0018989', 'apolysis', 549, 'parturitions'), ('GO_0007567', 'parturition', 594, 'antenatal'), ('UBERON_0002113', 'kidney', 680, 'renal'), ('UBERON_0002107', 'liver', 695, 'liver'), ('UBERON_0000178', 'blood', 710, 'blood'), ('UBERON_0001016', 'nervous system', 725, 'neurologic')]
PMC5439533	5/2017	S109-PMC5439533	['propensity score models adjusted for age, race, education level, type of fuel used for Cooking, number of people in the household, reporting receiving at least one tetanus vaccine, number of Antenatal visits, fe and Vitamin B12 consumption during Pregnancy, Albendazol consumption during Pregnancy, calcium consumption during Pregnancy, Aspirin consumption during Pregnancy, Alcohol consumption before Pregnancy, body mass index (bmi) at first Antenatal visit, number of Parturitions, and reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease).']	N/A	N/A	[('GO_0065007', 'biological regulation', 87, 'cooking'), ('GO_0007567', 'parturition', 191, 'antenatal'), ('CHEBI_33279', 'vitamin D5', 216, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 216, 'vitamin B12'), ('GO_0007565', 'female pregnancy', 247, 'pregnancy'), ('CHEBI_31181', 'aklavinone', 258, 'albendazol'), ('GO_0007565', 'female pregnancy', 288, 'pregnancy'), ('GO_0007565', 'female pregnancy', 326, 'pregnancy'), ('CHEBI_2904', 'atenolol', 337, 'aspirin'), ('GO_0007565', 'female pregnancy', 364, 'pregnancy'), ('CHEBI_30879', 'alcohol', 375, 'alcohol'), ('GO_0007565', 'female pregnancy', 402, 'pregnancy'), ('GO_0007567', 'parturition', 444, 'antenatal'), ('GO_0018989', 'apolysis', 471, 'parturitions'), ('UBERON_0002113', 'kidney', 558, 'renal'), ('UBERON_0002107', 'liver', 573, 'liver'), ('UBERON_0000178', 'blood', 588, 'blood'), ('UBERON_0001016', 'nervous system', 603, 'neurologic')]
PMC5471716	1/2017	S94-PMC5471716	['they also have the one of the highest rates of end-stage Renal disease in the world [24].']	N/A	N/A	[('UBERON_0002113', 'kidney', 57, 'renal')]
PMC5472316	6/2017	S68-PMC5472316	['basal vital Organs such as Liver, Heart, Lungs, Spleen, Stomach, Kidneys, and Brain were isolated and weighted.']	N/A	N/A	[('UBERON_0000062', 'organ', 12, 'organs'), ('UBERON_0002107', 'liver', 27, 'liver'), ('UBERON_0000948', 'heart', 34, 'heart'), ('UBERON_0002048', 'lung', 41, 'lungs'), ('UBERON_0002106', 'spleen', 48, 'spleen'), ('UBERON_0000945', 'stomach', 56, 'stomach'), ('UBERON_0002113', 'kidney', 65, 'kidneys'), ('UBERON_0000955', 'brain', 78, 'brain')]
PMC5472316	6/2017	S268-PMC5472316	['the supplementation with Hmb significantly increases the weight of Livers and Kidneys.']	N/A	N/A	[('CHEBI_17883', 'hydrogen chloride', 25, 'HMB'), ('UBERON_0002107', 'liver', 67, 'livers'), ('UBERON_0002113', 'kidney', 78, 'kidneys')]
PMC5487839	3/2016	S14-PMC5487839	['introduction\nin 1975, an editorial in the lancet, entitled Pregnancy and Renal disease, started with the following sentence: children of women with Renal disease used to be Born dangerously or not at all — not at all if their doctors had their way [1].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 59, 'Pregnancy'), ('UBERON_0002113', 'kidney', 73, 'Renal'), ('UBERON_0002113', 'kidney', 148, 'renal'), ('GO_0007567', 'parturition', 173, 'born')]
PMC5487839	3/2016	S42-PMC5487839	['a further position statement will treat Pregnancy in Kidney-transplanted patients.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 40, 'pregnancy'), ('UBERON_0002113', 'kidney', 53, 'kidney')]
PMC5487839	3/2016	S49-PMC5487839	['as already mentioned, the definition of Kidney disease has changed over time and the current ckd definition, which includes all patients with signs of Kidney disease regardless of the Kidney function, dates from the beginning of the new millennium [14–20].']	N/A	N/A	[('UBERON_0002113', 'kidney', 40, 'kidney'), ('UBERON_0002113', 'kidney', 151, 'kidney'), ('UBERON_0002113', 'kidney', 184, 'kidney')]
PMC5487839	3/2016	S280-PMC5487839	['Pregnancy-related hypertension predisposes to chronic hypertension, premature Heart attacks, strokes, and Renal complications [228].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('UBERON_0000948', 'heart', 78, 'heart'), ('UBERON_0002113', 'kidney', 106, 'renal')]
PMC5487839	3/2016	S374-PMC5487839	['Calcium and Phosphate are the most frequent components of Kidney stones in Pregnancy (up to 75\xa0%) [322–324].']	N/A	N/A	[('CHEBI_31341', 'calcium dihydroxide', 0, 'Calcium'), ('CHEBI_18367', 'phosphate(3-)', 12, 'phosphate'), ('UBERON_0002113', 'kidney', 58, 'kidney'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy')]
PMC5504744	7/2017	S39-PMC5504744	['subsequently, Spleen, Kidneys, Heart, Lungs, Liver and Brain were removed and weighed.']	N/A	N/A	[('UBERON_0002106', 'spleen', 14, 'spleen'), ('UBERON_0002113', 'kidney', 22, 'kidneys'), ('UBERON_0000948', 'heart', 31, 'heart'), ('UBERON_0002048', 'lung', 38, 'lungs'), ('UBERON_0002107', 'liver', 45, 'liver'), ('UBERON_0000955', 'brain', 55, 'brain')]
PMC5504744	7/2017	S100-PMC5504744	['the piglets selected from the ol sows compared with those from the in sows were heavier ( p = 0.008) at Birth, and had greater ( p ≤ 0.033) stm, pm, Liver and Kidney weights.']	N/A	N/A	[('GO_0007567', 'parturition', 104, 'birth'), ('UBERON_0002107', 'liver', 149, 'liver'), ('UBERON_0002113', 'kidney', 159, 'kidney')]
PMC5504744	7/2017	S108-PMC5504744	['compared with l-Piglets, m-Piglets Born from sows Fed the arg, but not the ctrl diet, had heavier stm (l-arg = 2.679 vs. m-arg = 3.401 g), pm (l-arg = 2.840 vs. m-arg = 3.547 g), Hearts (l-arg = 8.387 vs. m-arg = 9.538 g), Livers (l-Arg = 33.87 vs. m-arg = 41.07 g), Spleens (l-arg = 1.07 vs. m-arg = 1.42 g), Lungs (l-arg = 17.00 vs. m-arg = 19.90 g) and Kidneys (l-arg = 9.66 vs. m-arg = 12.00 g).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 16, 'piglets'), ('NCBITaxon_33208', 'Metazoa', 27, 'piglets'), ('GO_0007567', 'parturition', 35, 'born'), ('GO_0007631', 'feeding behavior', 50, 'fed'), ('UBERON_0000948', 'heart', 179, 'hearts'), ('UBERON_0002107', 'liver', 223, 'livers'), ('UBERON_0001885', 'dentate gyrus of hippocampal formation', 233, 'ARG'), ('UBERON_0002367', 'prostate gland', 267, 'spleens'), ('UBERON_0002048', 'lung', 310, 'lungs'), ('UBERON_0002113', 'kidney', 356, 'kidneys')]
PMC5513133	7/2017	S33-PMC5513133	['this is followed by two successive hydroxylations - first at the 25 position to form 25-Hydroxyvitamin D [25(Oh)D], which occurs in the Liver, and second to form the active hormonal Metabolite 1,25-Dihydroxyvitamin D [1,25(Oh)2D], also called Calcitriol, which is largely carried out in the Kidney.']	N/A	N/A	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 85, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 106, '25(OH)D'), ('UBERON_0002107', 'liver', 136, 'liver'), ('CHEBI_39382', 'flufenoxuron', 182, 'metabolite'), ('CHEBI_67472', '15-epi-lupulin B', 193, '1,25-dihydroxyvitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 218, '1,25(OH)2D'), ('CHEBI_17823', 'calcitriol', 243, 'calcitriol'), ('UBERON_0002113', 'kidney', 291, 'kidney')]
PMC5521778	7/2017	S118-PMC5521778	['as shown infig 1a, the ~2.5 kb Bco1 mrna is readily detected in Human Heart, Skeletal muscle, Kidney, Liver, Placenta, and Lung.10.1371/journal.pone.0181466.g001\n\ncaption (fig): fig 1\nExpression of Bco1 in Human Lung Tissues and a variety of Human cell lines.']	N/A	N/A	[('PR_000004693', 'Bcl-2-like protein 10', 31, 'BCO1'), ('NCBITaxon_9606', 'Homo sapiens', 64, 'human'), ('UBERON_0000948', 'heart', 70, 'heart'), ('UBERON_0004288', 'skeleton', 77, 'skeletal'), ('UBERON_0002113', 'kidney', 94, 'kidney'), ('UBERON_0002107', 'liver', 102, 'liver'), ('UBERON_0001987', 'placenta', 109, 'placenta'), ('UBERON_0002048', 'lung', 123, 'lung'), ('GO_0010467', 'gene expression', 184, 'Expression'), ('PR_000004693', 'Bcl-2-like protein 10', 198, 'BCO1'), ('NCBITaxon_9606', 'Homo sapiens', 206, 'human'), ('UBERON_0002048', 'lung', 212, 'lung'), ('UBERON_0000479', 'tissue', 217, 'tissues'), ('NCBITaxon_9606', 'Homo sapiens', 242, 'human')]
PMC5521778	7/2017	S124-PMC5521778	['Expression of Bco1 mrna in Human cell lines: Intestinal tc7, Embryonic Kidney hek 293, Placental bewo, and Pulmonary Alveolar Epithelial a549.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000004693', 'Bcl-2-like protein 10', 14, 'BCO1'), ('NCBITaxon_9606', 'Homo sapiens', 27, 'human'), ('UBERON_0000160', 'intestine', 45, 'intestinal'), ('UBERON_0000922', 'embryo', 61, 'embryonic'), ('UBERON_0002113', 'kidney', 71, 'kidney'), ('UBERON_0001987', 'placenta', 87, 'placental'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 107, 'pulmonary alveolar epithelial')]
PMC5521778	7/2017	S131-PMC5521778	['we also examined Placental Trophoblastic bewo Cells, the Embryonic Kidney-derived hek293 cell line, and Pulmonary Alveolar Epithelial-Like A549 Cells.']	N/A	N/A	[('CL_0000577', 'type EC enteroendocrine cell', 17, 'placental'), ('UBERON_0001987', 'placenta', 17, 'placental'), ('CL_0000351', 'trophoblast cell', 27, 'trophoblastic ... cells'), ('UBERON_0000088', 'trophoblast', 27, 'trophoblastic'), ('UBERON_0000922', 'embryo', 57, 'embryonic'), ('UBERON_0002113', 'kidney', 67, 'kidney'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 104, 'pulmonary alveolar epithelial'), ('CL_0002295', 'type-6 epithelial cell of thymus', 123, 'epithelial           cells')]
PMC5521778	7/2017	S279-PMC5521778	['dex is known to increase Pparα mrna and protein levels in Liver Cells [45,46], Kidney [47], and Lung Tissue [48,49].']	N/A	N/A	[('PR_000013057', 'peroxisome proliferator-activated receptor delta', 25, 'PPARα'), ('CL_0000592', 'large luteal cell', 58, 'liver cells'), ('UBERON_0002107', 'liver', 58, 'liver'), ('UBERON_0002113', 'kidney', 79, 'kidney'), ('UBERON_0002048', 'lung', 96, 'lung'), ('UBERON_0000479', 'tissue', 101, 'tissue')]
PMC5526786	8/2017	S20-PMC5526786	['increased Renal Blood flow leads to an increase in Renal size of 1–1.5\xa0cm[67],[68].activation of the Renin-angiotensin system (ras) leads to increased Plasma levels of both Renin and aldosterone and subsequent Salt and Water retention in the Distal Tubule and Collecting Duct.']	N/A	N/A	[('UBERON_0002113', 'kidney', 10, 'renal'), ('UBERON_0000178', 'blood', 16, 'blood'), ('UBERON_0002113', 'kidney', 51, 'renal'), ('PR_000014368', 'RuvB-like 1', 101, 'renin'), ('UBERON_0001969', 'blood plasma', 151, 'plasma'), ('PR_000014368', 'RuvB-like 1', 173, 'renin'), ('CHEBI_24866', 'salt', 210, 'salt'), ('CHEBI_15377', 'water', 219, 'water'), ('UBERON_0004135', 'distal tubule', 242, 'distal tubule'), ('UBERON_0001232', 'collecting duct of renal tubule', 260, 'collecting duct')]
PMC5526786	8/2017	S70-PMC5526786	['the way in which eo is able to Regulate Blood pressure is due to its ability to function as a Na+pump inhibitor thereby preventing Renal Na+reabsorption, to enhance vascular tone and Regulate Ca2+Signalling in Myocytes, Endothelial Cells and Neurons[37],[38],[39].']	N/A	N/A	[('GO_0065007', 'biological regulation', 31, 'regulate'), ('UBERON_0000178', 'blood', 40, 'blood'), ('CHEBI_29101', 'sodium(1+)', 94, 'Na+'), ('UBERON_0002113', 'kidney', 131, 'renal'), ('CHEBI_29101', 'sodium(1+)', 137, 'Na+'), ('GO_0065007', 'biological regulation', 183, 'regulate'), ('CHEBI_29108', 'calcium(2+)', 192, 'Ca2+'), ('GO_0019722', 'calcium-mediated signaling', 192, 'Ca2+signalling'), ('CL_0000187', 'muscle cell', 210, 'myocytes'), ('CL_0000115', 'endothelial cell', 220, 'endothelial cells'), ('UBERON_0001986', 'endothelium', 220, 'endothelial'), ('CL_0000540', 'neuron', 242, 'neurons')]
PMC5526786	8/2017	S72-PMC5526786	['in patients with essential hypertension eo is found to accumulate in those Tissues responsible for Blood Pressure Regulation (e.g Kidneys, Hypothalamus and Posterior Pituitary).']	N/A	N/A	[('UBERON_0000479', 'tissue', 75, 'tissues'), ('GO_0008217', 'regulation of blood pressure', 99, 'blood pressure regulation'), ('UBERON_0000178', 'blood', 99, 'blood'), ('UBERON_0002113', 'kidney', 130, 'kidneys'), ('UBERON_0001898', 'hypothalamus', 139, 'hypothalamus'), ('UBERON_0002198', 'neurohypophysis', 156, 'posterior pituitary')]
PMC5537884	7/2017	S0-PMC5537884	['Pregnancy, Proteinuria, plant-based supplemented diets and focal segmental glomerulosclerosis: a report on three cases and critical appraisal of the literature\n\nabstract\nchronic Kidney disease (ckd) is increasingly recognized in Pregnant patients.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('GO_0019230', 'proprioception', 11, 'Proteinuria'), ('UBERON_0002113', 'kidney', 178, 'kidney'), ('GO_0007565', 'female pregnancy', 229, 'pregnant')]
PMC5537884	7/2017	S26-PMC5537884	['case 1\na caucasian woman, 42 years old at the time of the present report, 38 years old at the start of Pregnancy, had developed a full blown nephrotic syndrome at 17 years of age, which was diagnosed as focal segmental glomerulosclerosis (fsgs); at diagnosis, her Kidney function was normal, and proteinuria ranged between 9 and 11 g/day.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('UBERON_0002113', 'kidney', 264, 'kidney')]
PMC5537884	7/2017	S31-PMC5537884	['while Renal function was always normal, proteinuria remained in the subnephrotic-nephrotic range (2 to 4 g/day) until Pregnancy.']	N/A	N/A	[('UBERON_0002113', 'kidney', 6, 'renal'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy')]
PMC5537884	7/2017	S34-PMC5537884	['she was referred to the unit dedicated to Kidney and Pregnancy at the sixth Gestational week; a low-protein supplemented diet (diet 1, reported inappendix a) was started at the 13th Gestational week.']	N/A	N/A	[('UBERON_0002113', 'kidney', 42, 'kidney'), ('GO_0007565', 'female pregnancy', 53, 'pregnancy'), ('GO_0007565', 'female pregnancy', 76, 'gestational'), ('GO_0007565', 'female pregnancy', 182, 'gestational')]
PMC5537884	7/2017	S42-PMC5537884	['she dropped out again from follow-up for one year; at the time of the present report, her clinical conditions are good, her Kidney function is normal, and the patient is motivated to resume a Plant-based supplemented diet.']	N/A	N/A	[('UBERON_0002113', 'kidney', 124, 'kidney'), ('NCBITaxon_33208', 'Metazoa', 192, 'plant')]
PMC5537884	7/2017	S45-PMC5537884	['case 2\na caucasian woman, 28 years old at the time of the present report, underwent a Kidney biopsy at 18 years of age for a full-blown nephrotic syndrome with abnormal Renal function.']	N/A	N/A	[('UBERON_0002113', 'kidney', 86, 'kidney'), ('UBERON_0002113', 'kidney', 169, 'renal')]
PMC5537884	7/2017	S50-PMC5537884	['while her Kidney function returned to the normal range, subnephrotic proteinuria persisted and she underwent a second Kidney biopsy four years later.']	N/A	N/A	[('UBERON_0002113', 'kidney', 10, 'kidney'), ('UBERON_0002113', 'kidney', 118, 'kidney')]
PMC5537884	7/2017	S51-PMC5537884	['at that time, the Antibodies anti Pla2R tested negative and Kidney function was normal.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 18, 'antibodies'), ('PR_000014698', 'serpin B7', 34, 'PlA2r'), ('UBERON_0002113', 'kidney', 60, 'kidney')]
PMC5537884	7/2017	S67-PMC5537884	['at the time of the Kidney biopsy, which was performed shortly after the diagnosis of hiv infection, she presented a full-blown nephrotic syndrome with low-normal Kidney function (Serum creatinine 1 mg/dl, creatinine clearance on 24 h Urine collection: 65 ml/min, Serum Albumin 2.1 g/dl, further decreased to a minimum of 1.3 g/day, proteinuria between 6 and 8 g/24 h).']	N/A	N/A	[('UBERON_0002113', 'kidney', 19, 'kidney'), ('UBERON_0002113', 'kidney', 162, 'kidney'), ('UBERON_0001977', 'blood serum', 179, 'serum'), ('UBERON_0001088', 'urine', 234, 'urine'), ('UBERON_0001977', 'blood serum', 263, 'serum'), ('PR_000005908', 'alpha-crystallin B chain', 269, 'albumin')]
PMC5537884	7/2017	S74-PMC5537884	['in her case too, proteinuria and Kidney function remained substantially stable throughout her Pregnancy.']	N/A	N/A	[('UBERON_0002113', 'kidney', 33, 'kidney'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy')]
PMC5546866	8/2017	S35-PMC5546866	['women with known Metabolic bone disease, Renal stones, hyperparathyroidism or hypercalciuria, those taking medication known to interfere with fetal growth, fetal anomalies on ultrasonography, and women already using >400 iu/d Vitamin D supplementation were excluded.']	N/A	N/A	[('GO_0008152', 'metabolic process', 17, 'metabolic'), ('UBERON_0002113', 'kidney', 41, 'renal'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D')]
PMC5562975	8/2017	S50-PMC5562975	['fetal Organs including Heart, Liver, Placenta and Kidney as well as the Cow Uterus were dissected free of Connective Tissue and weighed.']	N/A	N/A	[('UBERON_0000062', 'organ', 6, 'organs'), ('UBERON_0000948', 'heart', 23, 'heart'), ('UBERON_0002107', 'liver', 30, 'liver'), ('UBERON_0001987', 'placenta', 37, 'placenta'), ('UBERON_0002113', 'kidney', 50, 'kidney'), ('NCBITaxon_33208', 'Metazoa', 72, 'cow'), ('UBERON_0000995', 'uterus', 76, 'uterus'), ('UBERON_0002384', 'connective tissue', 106, 'connective tissue')]
PMC5603094	9/2017	S49-PMC5603094	['exclusion criteria\nwomen with known hypertension and Renal disease were excluded from the study.']	N/A	N/A	[('UBERON_0002113', 'kidney', 53, 'renal')]
PMC5634602	10/2017	S53-PMC5634602	['exclusion criteria included infants with congenital abnormalities, Gastro-Intestinal, Liver, or Kidney disease, inborn errors of Metabolism, Parathyroid disease, disorders of calcium Metabolism, and infants receiving seizure medication or Steroids.']	N/A	N/A	[('UBERON_0005409', 'alimentary part of gastrointestinal system', 67, 'gastro-intestinal'), ('UBERON_0002107', 'liver', 86, 'liver'), ('UBERON_0002113', 'kidney', 96, 'kidney'), ('GO_0008152', 'metabolic process', 129, 'metabolism'), ('UBERON_0001132', 'parathyroid gland', 141, 'parathyroid'), ('GO_0008152', 'metabolic process', 183, 'metabolism'), ('CHEBI_35341', 'steroid', 239, 'steroids')]
PMC5680205	11/2017	S93-PMC5680205	['furthermore, there was a 36% increase in the Expression of Tfrc in maternal Kidney Tissue from the same cohort of Mice (fig.']	N/A	N/A	[('GO_0010467', 'gene expression', 45, 'expression'), ('PR_000016850', 'tyrosine-protein kinase TXK', 59, 'Tfrc'), ('UBERON_0002113', 'kidney', 76, 'kidney'), ('UBERON_0000479', 'tissue', 83, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 114, 'mice')]
PMC5680205	11/2017	S101-PMC5680205	['however, using qpcr, we did not observe differential Expression of Trf in either Placentas or Kidneys between the two diet groups (fig.']	N/A	N/A	[('GO_0010467', 'gene expression', 53, 'expression'), ('PR_000016850', 'tyrosine-protein kinase TXK', 67, 'Trf'), ('UBERON_0001987', 'placenta', 81, 'placentas'), ('UBERON_0002113', 'kidney', 94, 'kidneys')]
PMC5680205	11/2017	S105-PMC5680205	['qpcr was also used to measure Tfrc Expression within Kidney Tissue at gd18.5 and was also increased in Tissue collected from zinc-deficient dams ( c ).']	N/A	N/A	[('PR_000016850', 'tyrosine-protein kinase TXK', 30, 'Tfrc'), ('GO_0010467', 'gene expression', 35, 'expression'), ('UBERON_0002113', 'kidney', 53, 'kidney'), ('UBERON_0000479', 'tissue', 60, 'tissue'), ('UBERON_0000479', 'tissue', 103, 'tissue')]
PMC5680205	11/2017	S109-PMC5680205	['transferrin ( Trf ) Gene Expression within the Placenta and Kidney was also quantified by qpcr but did not differ between the two diet groups ( g , h ).']	N/A	N/A	[('PR_000016850', 'tyrosine-protein kinase TXK', 14, 'Trf'), ('GO_0010467', 'gene expression', 20, 'gene expression'), ('SO_0000704', 'gene', 20, 'gene'), ('UBERON_0001987', 'placenta', 47, 'placenta'), ('UBERON_0002113', 'kidney', 60, 'kidney')]
PMC5680205	11/2017	S110-PMC5680205	['data are median\u2009and\u2009interquartile range (n\u2009=\u200919 and 12 Placentas [a]; 50 and 32 Placentas [b and g]; 12 and 11 Kidneys [c and h] and 12 and 10 Placentas [e and f] from 12 zinc-replete and 11 zinc-deficient dams, respectively).']	N/A	N/A	[('UBERON_0001987', 'placenta', 55, 'placentas'), ('UBERON_0001987', 'placenta', 80, 'placentas'), ('UBERON_0002113', 'kidney', 111, 'kidneys'), ('UBERON_0001987', 'placenta', 143, 'placentas')]
PMC5680205	11/2017	S161-PMC5680205	['in particular, a 16% reduction in Kidney Expression of angiotensin converting enzyme ( Ace ) ( p \u2009=\u20090.031) and a 44% reduction in Inositol 1,4,5-Triphosphate Receptor Type 2 ( Itpr2 ) ( p \u2009=\u20090.05) in the zinc-deficient dams occurred in association with reduced Blood pressure observed at gd18.5 in Mice implanted with Blood Pressure monitors.']	N/A	N/A	[('UBERON_0002113', 'kidney', 34, 'kidney'), ('GO_0010467', 'gene expression', 41, 'expression'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 87, 'Ace'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 130, 'inositol 1,4,5-triphosphate receptor type 2'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 176, 'Itpr2'), ('UBERON_0000178', 'blood', 261, 'blood'), ('NCBITaxon_10088', 'Mus <genus>', 298, 'mice'), ('UBERON_0013756', 'venous blood', 318, 'blood pressure')]
PMC5680205	11/2017	S169-PMC5680205	['caption (fig): figure 7\n\neffects of marginal zinc deficiency on Renal parameters at gd18.5.']	N/A	N/A	[('UBERON_0002113', 'kidney', 64, 'renal')]
PMC5680205	11/2017	S171-PMC5680205	['representative image of Ace Expression in a zinc-replete ( b ) and zinc-deficient ( c ) Kidney section.']	N/A	N/A	[('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 24, 'Ace'), ('GO_0010467', 'gene expression', 28, 'expression'), ('UBERON_0002113', 'kidney', 88, 'kidney')]
PMC5680205	11/2017	S174-PMC5680205	['representative images of a Glomerulus in a zinc-replete ( e ) and zinc-deficient ( f ) Kidney section.']	N/A	N/A	[('UBERON_0001047', 'neural glomerulus', 27, 'glomerulus'), ('UBERON_0002113', 'kidney', 87, 'kidney')]
PMC5680205	11/2017	S269-PMC5680205	['radio-telemetry surgery, Blood pressure monitoring and Kidney analysis\ndams in cohort 1 were anaesthetised (2.5% Isofluorane and 1\u2009l/minute O2, then maintained at 1.5% Isofluorane and ½ l/minute O2; Attanetmisoflurane, bomac ) and a radio-telemetry probe (pac10, data sciences international ) was inserted into the left Carotid Artery.']	N/A	N/A	[('UBERON_0000178', 'blood', 25, 'blood'), ('UBERON_0002113', 'kidney', 55, 'kidney'), ('CHEBI_6015', 'isoflurane', 113, 'isofluorane'), ('CHEBI_15379', 'dioxygen', 140, 'O2'), ('CHEBI_6015', 'isoflurane', 168, 'isofluorane'), ('CHEBI_15379', 'dioxygen', 195, 'O2'), ('CHEBI_29545', 'Avermectin B2b monosaccharide', 199, 'AttaneTMIsoflurane'), ('UBERON_0005396', 'carotid artery segment', 320, 'carotid artery')]
PMC5685050	10/2014	S5-PMC5685050	['the circulating 25(Oh)D is then Metabolized in the Kidneys to its biologically more active form, 1,25-Dihydroxyvitamin D[1].']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 16, '25(OH)D'), ('GO_0008152', 'metabolic process', 32, 'metabolized'), ('UBERON_0002113', 'kidney', 51, 'kidneys'), ('CHEBI_67472', '15-epi-lupulin B', 97, '1,25-dihydroxyvitamin D')]
PMC5758844	12/2017	S56-PMC5758844	['the following biochemical assays were performed: full Blood count, Liver function tests, Renal function, total Cholesterol, high-density lipoprotein (hdl), low-density lipoprotein (ldl), Triglycerides, Glucose, Insulin, hba1c, Vitamin D, and crp.']	N/A	N/A	[('UBERON_0000178', 'blood', 54, 'blood'), ('UBERON_0002107', 'liver', 67, 'liver'), ('UBERON_0002113', 'kidney', 89, 'renal'), ('CHEBI_16113', 'cholesterol', 111, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 187, 'triglycerides'), ('CHEBI_17234', 'glucose', 202, 'glucose'), ('PR_000045358', 'insulin family protein', 211, 'insulin'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
PMC5827025	2/2018	S11-PMC5827025	['introduction\nVitamin D, a Secosteroid Hormone, is synthesized primarily in the skin upon exposure to sunlight and is converted to active Vitamin D3 in the Liver and the Kidney.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 13, 'Vitamin D'), ('CHEBI_26661', 'shidasterone', 26, 'secosteroid hormone'), ('CHEBI_33279', 'vitamin D5', 137, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 137, 'vitamin D3'), ('UBERON_0002107', 'liver', 155, 'liver'), ('UBERON_0002113', 'kidney', 169, 'kidney')]
PMC5941617	5/2018	S15-PMC5941617	['then 25(Oh)D reaches the Kidney, where it undergoes a further hydroxylation by 25(Oh)D-1α-hydroxylase (Cyp27B1) into 1,25-Dihydroxyvitamin D [1,25(Oh)2D or Calcitriol], the bioactive hormonal form of Vitamin D [2,4].']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 5, '25(OH)D'), ('UBERON_0002113', 'kidney', 25, 'kidney'), ('CHEBI_71657', 'versiconol acetate', 79, '25(OH)D'), ('PR_000006101', 'cytochrome P450 1A1', 103, 'CYP27B1'), ('CHEBI_67472', '15-epi-lupulin B', 117, '1,25-dihydroxyvitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 142, '1,25(OH)2D'), ('CHEBI_17823', 'calcitriol', 156, 'calcitriol'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC5941617	5/2018	S18-PMC5941617	['Calcitriol acts synergistically with parathormone (pth) that acts in bone stimulating calcium absorption by the Osteoclasts, and in the Kidney where it promotes calcium reuptake in the Tubules, Phosphorus Excretion, and Vitamin D conversion into its active hormone form [2].']	N/A	N/A	[('CHEBI_17823', 'calcitriol', 0, 'Calcitriol'), ('CL_0000092', 'osteoclast', 112, 'osteoclasts'), ('UBERON_0002113', 'kidney', 136, 'kidney'), ('UBERON_0000025', 'tube', 185, 'tubules'), ('CHEBI_35885', 'secondary phosphine', 194, 'phosphorus'), ('GO_0007588', 'excretion', 205, 'excretion'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D')]
PMC5941617	5/2018	S131-PMC5941617	['vegan diet)• chronic Kidney disease• Hepatic failure and/or cholestasis• Malabsorption syndromes (i.e.']	N/A	N/A	[('UBERON_0002113', 'kidney', 21, 'kidney'), ('UBERON_0002107', 'liver', 37, 'Hepatic'), ('GO_0046661', 'male sex differentiation', 73, 'Malabsorption')]
PMC5941617	5/2018	S193-PMC5941617	['vegan diet)• chronic Kidney disease• Hepatic failure and/or cholestasis• Malabsorption syndromes (i.e.']	N/A	N/A	[('UBERON_0002113', 'kidney', 21, 'kidney'), ('UBERON_0002107', 'liver', 37, 'Hepatic'), ('GO_0046661', 'male sex differentiation', 73, 'Malabsorption')]
PMC5941617	5/2018	S204-PMC5941617	['Ketoconazole)xxxxon Rifampicinxxmalabsorption syndromesxxxxxxxxxxchronic Kidney diseasexxxxxxxxxnephrotic syndromexhepatic failure and/or cholestasisxxxxxxxxgranulomatous disorders (e.g.']	N/A	N/A	[('CHEBI_47519', 'ketoconazole', 0, 'ketoconazole'), ('CHEBI_52911', 'sodium green(4-)', 20, 'rifampicinXXMalabsorption'), ('UBERON_0002113', 'kidney', 73, 'kidney')]
PMC5941617	5/2018	S245-PMC5941617	['moreover, Vitamin D stimulates Skeletal Calcium and Phosphorus and Renal calcium reabsorption.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0004288', 'skeleton', 31, 'skeletal'), ('CHEBI_22313', 'alkaline earth metal atom', 40, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 52, 'phosphorus'), ('GO_0006281', 'DNA repair', 67, 'renal'), ('UBERON_0002113', 'kidney', 67, 'renal')]
PMC5991930	4/2018	S52-PMC5991930	['the patient\xa0developed acute Renal failure due to preeclampsia and has developed Magnesium Sulfate toxicity.']	N/A	N/A	[('UBERON_0002113', 'kidney', 28, 'renal'), ('CHEBI_32599', 'magnesium sulfate', 80, 'magnesium sulfate')]
PMC5991930	4/2018	S119-PMC5991930	['the team will request Blood work to assess Blood count, Kidney and Liver function, and electrolytes, including magnesium levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood'), ('UBERON_0000178', 'blood', 43, 'blood'), ('UBERON_0002113', 'kidney', 56, 'kidney'), ('UBERON_0002107', 'liver', 67, 'liver')]
PMC6056931	7/2018	S60-PMC6056931	['the exclusion criteria are 1) <\u200918 and\u2009>\u200939\xa0years; 2) multiple Pregnancy; 3) using Illicit Drugs (self-confessed); 4) smoking (current and/or in past year); 5) known non-communicable disease (ncd) namely diabetes, Renal disease, high Cholesterol, and hypertension; 6) known infectious disease namely tuberculosis and hepatitis; 7) known serious illness namely cancer, lupus or psychosis.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('CHEBI_35276', 'ammonium compound', 83, 'illicit drugs'), ('UBERON_0002113', 'kidney', 214, 'renal'), ('CHEBI_16113', 'cholesterol', 234, 'cholesterol')]
